OBO_ID (LABEL):	CHEBI_27300 (vitamin D)

IGNORANCE CATEGORY:	full_unknown

ARTICLE	ARTICLE DATE	SENTENCE NUM	SENTENCE	IGNORANCE CATEGORIES	NUM IGNORANCE CATEGORIES	OBO ID (LABEL)
PMC2290997	4/2008	S76-PMC2290997	['“NEVERTHELESS, considering the SAFETY of Vitamin D EVEN in high doses, there is NO CLEAR contraindication, and BECAUSE Vitamin D deficiency is very PREVALENT, especially among ms patients, taking Vitamin D supplements and getting moderate sun exposure is more LIKELY to be beneficial than not.”\nas with ms, there APPEARS TO be a latitudinal gradient for type 1 diabetes, with a higher incidence at higher latitudes.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 1), ('IMPORTANT_CONSIDERATION', 31), ('ANOMALY_CURIOUS_FINDING', 51), ('FULL_UNKNOWN', 80), ('PROBABLE_UNDERSTANDING', 111), ('IMPORTANT_CONSIDERATION', 148), ('PROBABLE_UNDERSTANDING', 260), ('ANOMALY_CURIOUS_FINDING', 313)]	8	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 119, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 196, 'vitamin D')]
PMC2290997	4/2008	S83-PMC2290997	['SOME STUDIES have DEMONSTRATED high prevalence of low Vitamin D levels in People with type 2 diabetes, ALTHOUGH it is NOT CLEAR WHETHER this is a cause of the disease or an EFFECT of another causative FACTOR—for example, lower levels of physical activity (in this case, outdoor activity in particular).']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 18), ('ANOMALY_CURIOUS_FINDING', 103), ('FULL_UNKNOWN', 118), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 128), ('SUPERFICIAL_RELATIONSHIP', 173), ('SUPERFICIAL_RELATIONSHIP', 201)]	7	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 74, 'people')]
PMC2685863	5/2009	S1-PMC2685863	['dietary Vitamin D intake HAS BEEN ASSOCIATED with lower ms risk, and Vitamin D deficiency HAS BEEN ASSOCIATED with INCREASED RISK, BUT direct LINKS between Vitamin D and ms have NOT BEEN IDENTIFIED.']	[('INCOMPLETE_EVIDENCE', 25), ('SUPERFICIAL_RELATIONSHIP', 34), ('INCOMPLETE_EVIDENCE', 90), ('SUPERFICIAL_RELATIONSHIP', 99), ('IMPORTANT_CONSIDERATION', 115), ('ANOMALY_CURIOUS_FINDING', 131), ('SUPERFICIAL_RELATIONSHIP', 142), ('FULL_UNKNOWN', 178)]	8	[('CHEBI_27300', 'vitamin D', 8, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 156, 'vitamin D')]
PMC4188019	1/2010	S1-PMC4188019	['LITTLE IS KNOWN on Vitamin D deficiency in Pregnant women in belgium, non on the IMPACT of wearing Head and/or body cover.']	[('FULL_UNKNOWN', 0), ('SUPERFICIAL_RELATIONSHIP', 81)]	2	[('CHEBI_27300', 'vitamin D', 19, 'vitamin D'), ('GO_0007565', 'female pregnancy', 43, 'pregnant'), ('UBERON_0000033', 'head', 99, 'head')]
PMC4188019	1/2010	S81-PMC4188019	['conclusion\nlow Vitamin D levels are frequently FOUND in Pregnancy but the optimal Serum concentration REMAINS UNKNOWN.']	[('INCOMPLETE_EVIDENCE', 47), ('FULL_UNKNOWN', 102)]	2	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D'), ('GO_0007565', 'female pregnancy', 56, 'pregnancy'), ('UBERON_0001977', 'blood serum', 82, 'serum')]
PMC2821652	2/2010	S5-PMC2821652	["one measurement of adherence was obtained via pill counts remaining COMPARED to a NOVEL definition for adherence using Serum 25-Hydroxy-Vitamin D (25-Oh-d) levels (absolute change in 25(Oh)D over the study period and the subject's steady-state variation in their 25(Oh)d levels)."]	[('ANOMALY_CURIOUS_FINDING', 68), ('FULL_UNKNOWN', 82)]	2	[('UBERON_0001977', 'blood serum', 119, 'serum'), ('CHEBI_70487', '(-)-sanguinolignan C', 125, '25-hydroxy-'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin D'), ('CHEBI_75393', 'Y-27632', 147, '25-OH-'), ('CHEBI_71657', 'versiconol acetate', 183, '25(OH)D'), ('CHEBI_63056', 'zinc cation', 263, '25(OH')]
PMC2821652	2/2010	S119-PMC2821652	['in THIS TRIAL, we SOUGHT TO DETERMINE WHETHER there was a significant ASSOCIATION between adherence to Vitamin D supplementation as measured by pill count and assessment of a NOVEL measure of adherence BASED UPON Serum levels of Vitamin D Metabolites in a Pregnant population.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 18), ('QUESTION_ANSWERED_BY_THIS_WORK', 25), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 38), ('SUPERFICIAL_RELATIONSHIP', 70), ('FULL_UNKNOWN', 175), ('QUESTION_ANSWERED_BY_THIS_WORK', 202), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 208)]	8	[('CHEBI_27300', 'vitamin D', 103, 'vitamin D'), ('UBERON_0001977', 'blood serum', 213, 'serum'), ('CHEBI_27300', 'vitamin D', 229, 'vitamin D'), ('CHEBI_25212', 'metabolite', 239, 'metabolites'), ('GO_0007565', 'female pregnancy', 256, 'pregnant')]
PMC3257641	3/2010	S4-PMC3257641	['the EVIDENCE to date SUPPORTS that women SHOULD BE monitored and treated for Vitamin D deficiency during Pregnancy BUT OPTIMAL and upper limit Serum 25(Oh)D levels during Pregnancy are NOT KNOWN.']	[('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 21), ('FUTURE_WORK', 41), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 115), ('IMPORTANT_CONSIDERATION', 119), ('FULL_UNKNOWN', 185)]	6	[('CHEBI_27300', 'vitamin D', 77, 'vitamin D'), ('GO_0007565', 'female pregnancy', 105, 'pregnancy'), ('UBERON_0001977', 'blood serum', 143, 'serum'), ('CHEBI_71657', 'versiconol acetate', 149, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 149, '25(OH ... D'), ('GO_0007565', 'female pregnancy', 171, 'pregnancy')]
PMC3257641	3/2010	S78-PMC3257641	['HOWEVER, it is NOT CLEAR that the Vitamin D REQUIREMENTS of these largely nocturnal Animals REFLECT Human NEEDS.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FULL_UNKNOWN', 15), ('IMPORTANT_CONSIDERATION', 44), ('SUPERFICIAL_RELATIONSHIP', 92), ('IMPORTANT_CONSIDERATION', 106)]	5	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('NCBITaxon_33208', 'Metazoa', 84, 'animals'), ('NCBITaxon_9606', 'Homo sapiens', 100, 'human')]
PMC3257641	3/2010	S153-PMC3257641	['HOWEVER, the MAJORITY of POTENTIAL adverse offspring health outcomes pertain to low Prenatal Vitamin D status and the EVOLVING EVIDENCE has provided greater IMPETUS for PUBLIC HEALTH EFFORTS to ensure mothers are not frankly Vitamin D deficient (<25 nmol/l) in Pregnancy, ALTHOUGH the value of treating relative Vitamin D insufficiency in Pregnancy is NOT clearly ESTABLISHED.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 13), ('INCOMPLETE_EVIDENCE', 25), ('INCOMPLETE_EVIDENCE', 118), ('IMPORTANT_CONSIDERATION', 157), ('IMPORTANT_CONSIDERATION', 169), ('FUTURE_WORK', 183), ('ANOMALY_CURIOUS_FINDING', 272), ('FULL_UNKNOWN', 352)]	9	[('GO_0007565', 'female pregnancy', 84, 'prenatal'), ('CHEBI_27300', 'vitamin D', 93, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 225, 'vitamin D'), ('GO_0007565', 'female pregnancy', 261, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 312, 'vitamin D'), ('GO_0007565', 'female pregnancy', 339, 'pregnancy')]
BMJ_2010_Apr_29_340_c1640	4/2010	S18-BMJ_2010_Apr_29_340_c1640	['this EVIDENCE comes from both case-control and cohort studies and INDICATES that age of operation for such a PROTECTIVE EFFECT MIGHT include both childhood and early Adulthood.67891011\nexposure to ultraviolet radiation in early Life has NOT YET been formally examined but MIGHT be LINKED to excess risk of multiple sclerosis at Birth through seasonal deficiency in maternal Vitamin D concentrations.12A study of half siblings with multiple sclerosis has ALSO SHOWN that risk CAN be maternally MEDIATED.13pregnancy is a vulnerable time for Vitamin d deficiency BECAUSE of increased physiological needs and reduced maternal outdoor activity.14experimental data on Animal Fetal Development INDICATE that Cerebral White Matter is responsive to Vitamin D and that Oligodendrocytes in the Brain and Spinal Cord have Vitamin D Receptors.1516furthermore, maternal Vitamin D depletion alters Neurogenesis in the developing Rat Brain,17with subsequent altered Gene Expression in Adult Life.18a RECENT Genetic STUDY in Humans has FURTHER IMPLICATED Vitamin D as a strong environmental CANDIDATE by SHOWING direct functional INTERACTION with the major locus that determines susceptibility to multiple sclerosis.19ALTHOUGH Human EVIDENCE pertaining to fetal development HAS BEEN DIFFICULT to obtain, the body of RELATED EVIDENCE to date has led SOME to RECOMMEND Antenatal supplementation with Vitamin D to prevent multiple sclerosis.14\nAS an indicator of POSSIBLE Perinatal environmental exposures, such as ultraviolet radiation, individual studies in the northern hemisphere have examined month of Birth and risk of multiple sclerosis with VARIED results.2021222324a large RECENT pooled analysis of Births in the northern hemisphere, HOWEVER, SHOWED an excess of multiple sclerosis among People Born in may and a relative deficit among those Born in november; these results were stronger in familial cases and SUGGESTED INTERACTIONS between Genes and environment that are RELATED to climate and that MIGHT act during Gestation or shortly after Birth.12we EXAMINED month of Birth and risk of multiple sclerosis in australia.']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 66), ('SUPERFICIAL_RELATIONSHIP', 109), ('SUPERFICIAL_RELATIONSHIP', 120), ('INCOMPLETE_EVIDENCE', 127), ('FULL_UNKNOWN', 237), ('INCOMPLETE_EVIDENCE', 272), ('SUPERFICIAL_RELATIONSHIP', 281), ('INCOMPLETE_EVIDENCE', 399), ('INCOMPLETE_EVIDENCE', 454), ('INCOMPLETE_EVIDENCE', 475), ('SUPERFICIAL_RELATIONSHIP', 493), ('PROBABLE_UNDERSTANDING', 560), ('INCOMPLETE_EVIDENCE', 687), ('INCOMPLETE_EVIDENCE', 984), ('INCOMPLETE_EVIDENCE', 1019), ('SUPERFICIAL_RELATIONSHIP', 1027), ('INCOMPLETE_EVIDENCE', 1074), ('INCOMPLETE_EVIDENCE', 1087), ('SUPERFICIAL_RELATIONSHIP', 1113), ('ANOMALY_CURIOUS_FINDING', 1199), ('ANOMALY_CURIOUS_FINDING', 1199), ('INCOMPLETE_EVIDENCE', 1216), ('INCOMPLETE_EVIDENCE', 1257), ('DIFFICULT_TASK', 1266), ('INCOMPLETE_EVIDENCE', 1299), ('SUPERFICIAL_RELATIONSHIP', 1299), ('INCOMPLETE_EVIDENCE', 1332), ('FUTURE_WORK', 1340), ('PROBABLE_UNDERSTANDING', 1424), ('INCOMPLETE_EVIDENCE', 1443), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1629), ('INCOMPLETE_EVIDENCE', 1662), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1723), ('INCOMPLETE_EVIDENCE', 1732), ('INCOMPLETE_EVIDENCE', 1899), ('SUPERFICIAL_RELATIONSHIP', 1909), ('SUPERFICIAL_RELATIONSHIP', 1961), ('INCOMPLETE_EVIDENCE', 1989), ('QUESTION_ANSWERED_BY_THIS_WORK', 2044)]	40	[('UBERON_0000113', 'post-juvenile adult stage', 166, 'adulthood'), ('UBERON_0000104', 'life cycle', 228, 'life'), ('GO_0007567', 'parturition', 328, 'birth'), ('CHEBI_27300', 'vitamin D', 374, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 539, 'vitamin'), ('NCBITaxon_33208', 'Metazoa', 662, 'animal'), ('GO_0002065', 'columnar/cuboidal epithelial cell differentiation', 669, 'fetal development'), ('UBERON_0002437', 'cerebral hemisphere white matter', 701, 'cerebral white matter'), ('CHEBI_27300', 'vitamin D', 740, 'vitamin D'), ('CL_0000128', 'oligodendrocyte', 759, 'oligodendrocytes'), ('UBERON_0000955', 'brain', 783, 'brain'), ('UBERON_0002240', 'spinal cord', 793, 'spinal cord'), ('CHEBI_27300', 'vitamin D', 810, 'vitamin D'), ('PR_000001708', 'sphingosine 1-phosphate receptor 3', 810, 'vitamin D receptors'), ('CHEBI_27300', 'vitamin D', 856, 'vitamin D'), ('GO_0022008', 'neurogenesis', 883, 'neurogenesis'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 914, 'rat'), ('UBERON_0000955', 'brain', 918, 'brain'), ('GO_0010467', 'gene expression', 950, 'gene expression'), ('SO_0000704', 'gene', 950, 'gene'), ('UBERON_0000113', 'post-juvenile adult stage', 969, 'adult life'), ('SO_0000704', 'gene', 991, 'genetic'), ('NCBITaxon_9606', 'Homo sapiens', 1008, 'humans'), ('CHEBI_27300', 'vitamin D', 1038, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 1210, 'human'), ('GO_0007567', 'parturition', 1350, 'antenatal'), ('CHEBI_27300', 'vitamin D', 1381, 'vitamin D'), ('GO_0036268', 'swimming', 1452, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 1452, 'perinatal'), ('GO_0007567', 'parturition', 1587, 'birth'), ('GO_0007567', 'parturition', 1688, 'births'), ('NCBITaxon_10088', 'Mus <genus>', 1777, 'people'), ('GO_0007567', 'parturition', 1784, 'born'), ('GO_0007567', 'parturition', 1831, 'born'), ('SO_0000704', 'gene', 1930, 'genes'), ('GO_0007565', 'female pregnancy', 2006, 'gestation'), ('GO_0007567', 'parturition', 2033, 'birth'), ('GO_0007567', 'parturition', 2062, 'birth')]
BMJ_2010_Apr_29_340_c1640	4/2010	S96-BMJ_2010_Apr_29_340_c1640	['by the time of Delivery, maternal and infant Cord Serum 25-Hydroxyvitamin d3concentrations are highly CORRELATED.37UNFORTUNATELY, much REMAINS UNKNOWN, leading to large international variations in maternal Vitamin D monitoring and supplementation during Pregnancy.353839\na maternal EFFECT operating Antenatally would also be CONSISTENT with the stronger maternal than paternal “parent of origin” EFFECT in familial multiple sclerosis.1340it HAS BEEN PREVIOUSLY PROPOSED14THAT maternal Vitamin D deficiency, a PROBLEM for SOME dark skinned women migrating to regions with low ambient ultraviolet radiation, such as the uk, MIGHT EXPLAIN the increase in incidence of disease SEEN among second generation migrants in such locations.41our FINDINGS are CONSISTENT with this EXPLANATION.']	[('SUPERFICIAL_RELATIONSHIP', 102), ('ANOMALY_CURIOUS_FINDING', 113), ('ANOMALY_CURIOUS_FINDING', 113), ('FULL_UNKNOWN', 135), ('SUPERFICIAL_RELATIONSHIP', 282), ('INCOMPLETE_EVIDENCE', 325), ('SUPERFICIAL_RELATIONSHIP', 396), ('INCOMPLETE_EVIDENCE', 441), ('INCOMPLETE_EVIDENCE', 450), ('INCOMPLETE_EVIDENCE', 461), ('IMPORTANT_CONSIDERATION', 509), ('INCOMPLETE_EVIDENCE', 521), ('INCOMPLETE_EVIDENCE', 622), ('PROBABLE_UNDERSTANDING', 628), ('INCOMPLETE_EVIDENCE', 673), ('INCOMPLETE_EVIDENCE', 735), ('INCOMPLETE_EVIDENCE', 748), ('PROBABLE_UNDERSTANDING', 769)]	18	[('GO_0007567', 'parturition', 15, 'delivery'), ('UBERON_0002240', 'spinal cord', 45, 'cord'), ('UBERON_0001977', 'blood serum', 50, 'serum'), ('CHEBI_67376', 'dihydrooroxylin A', 56, '25-hydroxyvitamin'), ('CHEBI_27300', 'vitamin D', 206, 'vitamin D'), ('GO_0007565', 'female pregnancy', 254, 'pregnancy'), ('GO_0007288', 'sperm axoneme assembly', 299, 'antenatally'), ('CHEBI_27300', 'vitamin D', 485, 'vitamin D')]
PMC2889879	5/2010	S36-PMC2889879	['HOWEVER, TO OUR KNOWLEDGE, NO STUDY has investigated the ASSOCIATION between dietary Intake of fish, Omega-3 and Omega-6 Pufa or Vitamin D and the risk of having positive psychotic symptoms in the general Adult population.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 9), ('FULL_UNKNOWN', 27), ('SUPERFICIAL_RELATIONSHIP', 57)]	4	[('GO_0007631', 'feeding behavior', 85, 'intake'), ('CHEBI_79370', 'ibho#10', 101, 'omega-3'), ('CHEBI_82670', 'ELQ-271', 113, 'omega-6 PUFA'), ('CHEBI_27300', 'vitamin D', 129, 'vitamin D'), ('UBERON_0007023', 'adult organism', 205, 'adult')]
PMC2889879	5/2010	S134-PMC2889879	['NO earlier STUDIES that we ARE AWARE OF have evaluated the RELATIONSHIP between Adult Vitamin D levels and psychotic symptoms.']	[('FULL_UNKNOWN', 0), ('PROBABLE_UNDERSTANDING', 27), ('SUPERFICIAL_RELATIONSHIP', 59)]	3	[('UBERON_0007023', 'adult organism', 80, 'adult'), ('CHEBI_27300', 'vitamin D', 86, 'vitamin D')]
PMC2889879	5/2010	S137-PMC2889879	['results from the northern finland 1966 Birth cohort SHOWED that Vitamin D supplementation during the first year of Life was ASSOCIATED with a reduced risk of schizophrenia in males, BUT NOT in women [32].']	[('INCOMPLETE_EVIDENCE', 52), ('SUPERFICIAL_RELATIONSHIP', 124), ('FULL_UNKNOWN', 182)]	3	[('GO_0007567', 'parturition', 39, 'Birth'), ('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('UBERON_0000104', 'life cycle', 115, 'life')]
PMC2889879	5/2010	S141-PMC2889879	['our results of a PROTECTIVE EFFECT of Vitamin D intake MUST BE CONSIDERED AS ROUGH, SINCE we ONLY measure the dietary intake of Vitamin D. a more complete picture of the Vitamin D status COULD have been supplied through Vitamin D levels in Blood; HOWEVER, NO biological samples are AVAILABLE.']	[('SUPERFICIAL_RELATIONSHIP', 17), ('SUPERFICIAL_RELATIONSHIP', 28), ('IMPORTANT_CONSIDERATION', 55), ('IMPORTANT_CONSIDERATION', 63), ('PROBABLE_UNDERSTANDING', 74), ('INCOMPLETE_EVIDENCE', 77), ('PROBLEM_COMPLICATION', 84), ('INCOMPLETE_EVIDENCE', 93), ('INCOMPLETE_EVIDENCE', 187), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 247), ('FULL_UNKNOWN', 256)]	11	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 128, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 170, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 220, 'vitamin D'), ('UBERON_0000178', 'blood', 240, 'blood')]
PMC2889879	5/2010	S196-PMC2889879	['UNFORTUNATELY, we DO NOT HAVE information about specific Vitamin D supplementation.']	[('IMPORTANT_CONSIDERATION', 0), ('FULL_UNKNOWN', 18)]	2	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D')]
PMC3032617	5/2010	S109-PMC3032617	['in second place , the higher increase achieved with the Vitamin C supplementation (8mmhg vs. 4.5mmhg), with a TREND towards SIGNIFICANCE, can be INTERPRETED in two ways; as an increased Gastric absorption of iron in the presence of Ascorbic Acid that HAS BEEN DEMONSTRATED in SEVERAL STUDIES [1,3,9,22] and also, the Red Blood Cell protection from oxidation in the presence of high amounts of Ascorbic Acid which HAS BEEN DEMONSTRATED to be an Electron Donor of Glutathione, a vital antioxidant of Red Blood Cells [1,3,24].']	[('INCOMPLETE_EVIDENCE', 110), ('IMPORTANT_CONSIDERATION', 124), ('FULL_UNKNOWN', 145), ('INCOMPLETE_EVIDENCE', 251), ('INCOMPLETE_EVIDENCE', 260), ('INCOMPLETE_EVIDENCE', 276), ('INCOMPLETE_EVIDENCE', 413)]	7	[('CHEBI_27300', 'vitamin D', 56, 'vitamin C'), ('UBERON_0001844', 'cochlea', 186, 'gastric'), ('CHEBI_22652', 'ascorbic acid', 232, 'ascorbic acid'), ('CL_0000232', 'erythrocyte', 317, 'red blood cell'), ('UBERON_0000178', 'blood', 321, 'blood'), ('CHEBI_22652', 'ascorbic acid', 393, 'ascorbic acid'), ('CHEBI_10545', 'electron', 444, 'electron'), ('CHEBI_13193', 'hydrogen acceptor', 453, 'donor'), ('CHEBI_16856', 'glutathione', 462, 'glutathione'), ('CL_0000232', 'erythrocyte', 498, 'red blood cells'), ('UBERON_0000178', 'blood', 502, 'blood')]
PMC2874518	6/2010	S114-PMC2874518	['ANOTHER STUDY FOUND that use of supplements for Vitamins C and E was ASSOCIATED with an INCREASED RISK of premature rupture of membranes.24unfortunately, this information was NOT RECORDED in our study.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 14), ('SUPERFICIAL_RELATIONSHIP', 69), ('IMPORTANT_CONSIDERATION', 88), ('FULL_UNKNOWN', 175)]	5	[('CHEBI_27300', 'vitamin D', 48, 'vitamins C'), ('PR_000004900', 'complement C3', 57, 'C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 63, 'E')]
PMC3075531	7/2010	S0-PMC3075531	['a comparative study of 25 (Oh) Vitamin D Serum levels in patients with multiple sclerosis and control group in isfahan, iran\n\nabstract\n\nobjectives:\nthere is NO STUDY about CORRELATION between Vitamin D Serum level and multiple sclerosis (ms) in iran.']	[('FULL_UNKNOWN', 157), ('SUPERFICIAL_RELATIONSHIP', 172)]	2	[('CHEBI_30778', 'gallic acid', 23, '25 (OH)'), ('CHEBI_28384', 'vitamin K', 31, 'Vitamin D'), ('UBERON_0001977', 'blood serum', 41, 'Serum'), ('CHEBI_27300', 'vitamin D', 192, 'vitamin D'), ('UBERON_0001977', 'blood serum', 202, 'serum')]
PMC3075531	7/2010	S10-PMC3075531	['introduction\nmultiple sclerosis (ms) is a chronic PROBABLY with Autoimmune basis and UNCERTAIN etiology characterized by Demyelinative and inflammatory physiopathology causing Axonal damages.12this disease AFFECTS females more than males with ordinary 10 years Relapsing-remitting course and secondary progressive phase.2on histological basis, T Helper Cells type 1 (th1) is the MOST RESPONSIBLE cause for pathologies SEEN in ms.1–3there are multiple RISK FACTORS for ms in a COMPLEX RELATIONSHIP with each other from Genetic ones to environmental FACTORS BUT exact mechanism leading to ms has REMAINED UNCLEAR yet.45from GUESSED environmental RISK FACTORS for ms, past infection with Ebv, smoking and low Serum level of Vitamin D are more favorable.67the MOST IMPORTANT Vitamin in calcium and Phosphor Homeostasis is Vitamin D. this Vitamin has PROPOSED POTENTIAL power for Modulating Immune System.48this is achieved via enhancing the Phagocytic function of Monocytes9And decreasing the secretion of Il-6, Il-12, Tnf-Α and Pge2 by Monocytes.10also, immature or semi mature Apc’S cannot mature in presence of 1,25 (Oh)2D.8MANY STUDIES SHOWED a ROLE of paracrine function and Nerve Growth Factor Synthesis Of Vitamin D in Cns and also, SHOWED that deficiency of this Vitamin in Pregnancy Period CAN cause Neural System disorder in Animal cases.811–14then, Vitamin D has a near RELATION with ms and the results of DIFFERENT studies can be summarized as follows: first, the EFFECT of latitude via exposure to sun light and Serum level of Vitamin D on ms prevalence, that increases with distance from equator, with ONLY one EXCEPTION in norway.23815second, vander et al.']	[('PROBABLE_UNDERSTANDING', 50), ('FULL_UNKNOWN', 85), ('SUPERFICIAL_RELATIONSHIP', 206), ('PROBABLE_UNDERSTANDING', 379), ('PROBABLE_UNDERSTANDING', 384), ('INCOMPLETE_EVIDENCE', 418), ('SUPERFICIAL_RELATIONSHIP', 451), ('DIFFICULT_TASK', 476), ('SUPERFICIAL_RELATIONSHIP', 484), ('SUPERFICIAL_RELATIONSHIP', 548), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 556), ('INCOMPLETE_EVIDENCE', 594), ('FULL_UNKNOWN', 603), ('INCOMPLETE_EVIDENCE', 622), ('SUPERFICIAL_RELATIONSHIP', 644), ('PROBABLE_UNDERSTANDING', 756), ('IMPORTANT_CONSIDERATION', 761), ('INCOMPLETE_EVIDENCE', 846), ('INCOMPLETE_EVIDENCE', 855), ('INCOMPLETE_EVIDENCE', 1123), ('INCOMPLETE_EVIDENCE', 1136), ('SUPERFICIAL_RELATIONSHIP', 1145), ('INCOMPLETE_EVIDENCE', 1236), ('INCOMPLETE_EVIDENCE', 1295), ('SUPERFICIAL_RELATIONSHIP', 1377), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1413), ('SUPERFICIAL_RELATIONSHIP', 1472), ('ANOMALY_CURIOUS_FINDING', 1612), ('ANOMALY_CURIOUS_FINDING', 1621)]	29	[('UBERON_0001442', 'skeleton of manus', 64, 'autoimmune'), ('GO_0006188', 'IMP biosynthetic process', 121, 'demyelinative'), ('GO_0030424', 'axon', 176, 'axonal'), ('GO_0065007', 'biological regulation', 261, 'relapsing'), ('CL_0000545', 'T-helper 1 cell', 344, 'T helper cells'), ('SO_0000704', 'gene', 518, 'genetic'), ('NCBITaxon_10088', 'Mus <genus>', 685, 'EBV'), ('UBERON_0001977', 'blood serum', 706, 'serum'), ('CHEBI_27300', 'vitamin D', 721, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 771, 'vitamin'), ('CHEBI_30215', 'muonide', 794, 'phosphor'), ('GO_0042592', 'homeostatic process', 803, 'homeostasis'), ('CHEBI_27300', 'vitamin D', 818, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 834, 'vitamin'), ('GO_0065007', 'biological regulation', 875, 'modulating'), ('UBERON_0002405', 'immune system', 886, 'immune system'), ('GO_0006909', 'phagocytosis', 937, 'phagocytic'), ('CL_0002198', 'oncocyte', 960, 'monocytes9and'), ('PR_000001470', 'interleukin-28B', 1002, 'IL-6'), ('PR_000001470', 'interleukin-28B', 1008, 'IL-12'), ('PR_000000134', 'tumor necrosis factor alpha', 1015, 'TNF-α'), ('PR_000012560', 'peroxisomal membrane protein PEX14', 1025, 'PGE2'), ('CL_0000576', 'monocyte', 1033, 'monocytes'), ('PR_000004122', 'adenomatous polyposis coli protein', 1075, 'APC'), ('PR_000011000', 'N-alpha-acetyltransferase 60', 1079, 's'), ('CHEBI_82784', 'PVP38-Ag NP', 1110, '1,25 (OH)2D'), ('UBERON_0001021', 'nerve', 1176, 'nerve'), ('GO_0040007', 'growth', 1182, 'growth factor'), ('GO_0030474', 'spindle pole body duplication', 1196, 'synthesis of vitamin D'), ('CHEBI_27300', 'vitamin D', 1209, 'vitamin D'), ('UBERON_0001017', 'central nervous system', 1222, 'CNS'), ('CHEBI_33229', 'vitamin (role)', 1267, 'vitamin'), ('GO_0007565', 'female pregnancy', 1278, 'pregnancy'), ('UBERON_0018298', 'stylocone', 1278, 'pregnancy period'), ('UBERON_0023879', 'neural system', 1305, 'neural system'), ('NCBITaxon_33208', 'Metazoa', 1331, 'animal'), ('CHEBI_27300', 'vitamin D', 1356, 'vitamin D'), ('UBERON_0001977', 'blood serum', 1521, 'serum'), ('CHEBI_27300', 'vitamin D', 1536, 'vitamin D')]
PMC3075531	7/2010	S55-PMC3075531	['in a pooled analysis of data from canada, uk, denmark, and sweden including more than 40,000 Individuals with ms, significantly fewer (8.5%) People with ms were Born in november and significantly more (9.1%) were Born in may.39THIS FINDING SUGGESTS that Prenatal exposures or exposures in the first months of Life COULD BE IMPORTANT in ms etiology, BUT the LINK to Vitamin D is UNCLEAR.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 227), ('INCOMPLETE_EVIDENCE', 232), ('INCOMPLETE_EVIDENCE', 240), ('INCOMPLETE_EVIDENCE', 314), ('IMPORTANT_CONSIDERATION', 323), ('ANOMALY_CURIOUS_FINDING', 349), ('SUPERFICIAL_RELATIONSHIP', 357), ('FULL_UNKNOWN', 378)]	8	[('NCBITaxon_1', 'root', 93, 'individuals'), ('NCBITaxon_10088', 'Mus <genus>', 141, 'people'), ('GO_0007567', 'parturition', 161, 'born'), ('GO_0007567', 'parturition', 213, 'born'), ('GO_0007565', 'female pregnancy', 254, 'prenatal'), ('UBERON_0000104', 'life cycle', 309, 'life'), ('CHEBI_27300', 'vitamin D', 365, 'vitamin D')]
PMC2913107	8/2010	S15-PMC2913107	['even more INTRIGUING, BOTH PAPERS REPORT that the mental condition in rickets IMPROVED with Vitamin D.\nANOTHER of the MYSTERIES of autism is the APPARENT INCREASED INCIDENCE of autism in the children of richer college-educated parents, ESPECIALLY women, a FINDING announced a few months ago (12).']	[('ANOMALY_CURIOUS_FINDING', 10), ('INCOMPLETE_EVIDENCE', 22), ('INCOMPLETE_EVIDENCE', 27), ('INCOMPLETE_EVIDENCE', 34), ('SUPERFICIAL_RELATIONSHIP', 78), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 103), ('FULL_UNKNOWN', 118), ('ANOMALY_CURIOUS_FINDING', 145), ('IMPORTANT_CONSIDERATION', 154), ('ANOMALY_CURIOUS_FINDING', 236), ('INCOMPLETE_EVIDENCE', 256)]	11	[('CHEBI_27300', 'vitamin D', 92, 'vitamin D')]
PMC2963768	10/2010	S13-PMC2963768	['HOWEVER, SINCE Vitamin D status has become READILY estimable BASED on Serum/Plasma 25-Hydroxyvitamin D concentration [25(Oh)D] (2), epidemiologic RESEARCH aimed at identifying PREVIOUSLY-UNCHARACTERIZED AT-risk populations and characterizing NOVEL disease ASSOCIATIONS with Vitamin D status HAS BEEN greatly facilitated.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBLEM_COMPLICATION', 9), ('PROBABLE_UNDERSTANDING', 43), ('QUESTION_ANSWERED_BY_THIS_WORK', 61), ('FUTURE_WORK', 146), ('INCOMPLETE_EVIDENCE', 176), ('INCOMPLETE_EVIDENCE', 187), ('IMPORTANT_CONSIDERATION', 203), ('FULL_UNKNOWN', 242), ('SUPERFICIAL_RELATIONSHIP', 256), ('INCOMPLETE_EVIDENCE', 291)]	11	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D'), ('UBERON_0001977', 'blood serum', 70, 'serum'), ('UBERON_0001969', 'blood plasma', 76, 'plasma'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 83, '25-hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 118, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 274, 'vitamin D')]
PMC2963768	10/2010	S116-PMC2963768	['the amount of Vitamin D in the local diet is UNKNOWN but low calcium intake (or reduced absorption of Calcium due to high Phytate intake), typical of low-income diets in bangladesh (30,31), MAY accelerate 25(Oh)D use, leading to relatively-increased Vitamin D demands (32).']	[('FULL_UNKNOWN', 45), ('INCOMPLETE_EVIDENCE', 190)]	2	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 102, 'calcium'), ('CHEBI_15361', 'pyruvate', 122, 'phytate'), ('CHEBI_71657', 'versiconol acetate', 205, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 250, 'vitamin D')]
PMC2963768	10/2010	S125-PMC2963768	['Vitamin D Receptor, 24-hydroxylase\nDESPITE the current enthusiasm for Vitamin D supplementation in the usa (22), the EFFECTS of Vitamin D deficits during early infancy are STILL NOT FULLY UNDERSTOOD, and meaningful inflection points in 25(Oh)D-outcome RELATIONSHIPS have NOT BEEN ESTABLISHED.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 35), ('ANOMALY_CURIOUS_FINDING', 35), ('SUPERFICIAL_RELATIONSHIP', 117), ('FULL_UNKNOWN', 172), ('IMPORTANT_CONSIDERATION', 172), ('INCOMPLETE_EVIDENCE', 178), ('SUPERFICIAL_RELATIONSHIP', 252), ('FULL_UNKNOWN', 271), ('ANOMALY_CURIOUS_FINDING', 275)]	9	[('CHEBI_27300', 'vitamin D', 0, 'vitamin D'), ('PR_000001683', 'vasopressin V2 receptor', 0, 'vitamin D receptor'), ('CHEBI_27300', 'vitamin D', 70, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 128, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 236, '25(OH)D'), ('PR_000005506', 'Cbp/p300-interacting transactivator 2', 236, '25'), ('PR_000012046', 'oxysterol-binding protein-related protein 11', 239, 'OH ... D')]
PMC2963768	10/2010	S133-PMC2963768	['the incidence of symptomatic hypocalcaemia secondary to Vitamin D deficiency in early Infancy is UNKNOWN.']	[('FULL_UNKNOWN', 97)]	1	[('CHEBI_27300', 'vitamin D', 56, 'vitamin D'), ('UBERON_0000023', 'wing', 86, 'infancy')]
PMC2996405	11/2010	S163-PMC2996405	['DESPITE the consistence of this RELATIONSHIP, TO OUR KNOWLEDGE studies CONNECTING schizophrenia and Vitamin D at a molecular level are NOT YET AVAILABLE.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 32), ('PROBABLE_UNDERSTANDING', 46), ('SUPERFICIAL_RELATIONSHIP', 71), ('FULL_UNKNOWN', 135), ('FUTURE_WORK', 139)]	7	[('CHEBI_27300', 'vitamin D', 100, 'vitamin D')]
PMC2996405	11/2010	S227-PMC2996405	['for example, we cannot exclude the presence of an UNKNOWN common FACTOR, different from Vitamin D, LINKING together schizophrenia and latitude.']	[('FULL_UNKNOWN', 50), ('SUPERFICIAL_RELATIONSHIP', 65), ('SUPERFICIAL_RELATIONSHIP', 99)]	3	[('CHEBI_27300', 'vitamin D', 88, 'vitamin D')]
PMC3355895	1/2011	S50-PMC3355895	['the Regulation of this process is AS YET UNKNOWN, but at least one of the Isoforms of Pmca HAS BEEN shown to be Regulated by 1,25(Oh)-Vitamin D (kip and strehler,2004), and in SOME Animals, BUT NOT OTHERS, 1,25(Oh)2-Vitamin D APPEARS necessary for maintenance of the maternofetal calcium gradient (lester,1986).']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 34), ('FULL_UNKNOWN', 37), ('INCOMPLETE_EVIDENCE', 91), ('INCOMPLETE_EVIDENCE', 176), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 190), ('ANOMALY_CURIOUS_FINDING', 226)]	7	[('GO_0065007', 'biological regulation', 4, 'regulation'), ('SO_0001060', 'sequence_variant', 74, 'isoforms'), ('PR_000012924', 'bifunctional polynucleotide phosphatase/kinase', 86, 'PMCA'), ('GO_0065007', 'biological regulation', 112, 'regulated'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 130, 'OH)-'), ('CHEBI_27300', 'vitamin D', 134, 'vitamin D'), ('NCBITaxon_33208', 'Metazoa', 181, 'animals'), ('CHEBI_75874', 'para-terphenyl', 206, '1,25(OH)2-'), ('CHEBI_27300', 'vitamin D', 216, 'vitamin D')]
PMC3061267	2/2011	S5-PMC3061267	['it is UNCLEAR WHETHER maternal Vitamin A supplementation will LEAD TO improved health outcomes for mother OR child.']	[('FULL_UNKNOWN', 6), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 14), ('SUPERFICIAL_RELATIONSHIP', 62)]	3	[('CHEBI_27300', 'vitamin D', 31, 'vitamin A')]
PMC3277098	12/2011	S3-PMC3277098	['there is a GROWING BODY of LITERATURE LINKING Vitamin D (Serum 25(Oh)D, Oral Intake and SURROGATE indicators such as latitude) to various immune-RELATED conditions, including allergy, ALTHOUGH the nature of this RELATIONSHIP is STILL UNCLEAR.']	[('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 27), ('SUPERFICIAL_RELATIONSHIP', 38), ('SUPERFICIAL_RELATIONSHIP', 88), ('SUPERFICIAL_RELATIONSHIP', 145), ('ANOMALY_CURIOUS_FINDING', 184), ('SUPERFICIAL_RELATIONSHIP', 212), ('FULL_UNKNOWN', 228)]	8	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('UBERON_0001977', 'blood serum', 57, 'serum'), ('CHEBI_71657', 'versiconol acetate', 63, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 63, '25 ... OH ... D'), ('UBERON_0000165', 'mouth', 72, 'oral'), ('GO_0007631', 'feeding behavior', 77, 'intake')]
PMC3277098	12/2011	S26-PMC3277098	['ALTHOUGH often not significant in terms of rickets or osteomalacia, it REMAINS UNKNOWN WHAT, if any, are the clinical outcomes of Vitamin D insufficiency.']	[('ANOMALY_CURIOUS_FINDING', 0), ('FULL_UNKNOWN', 71), ('EXPLICIT_QUESTION', 87)]	3	[('CHEBI_27300', 'vitamin D', 130, 'vitamin D')]
PMC3271033	1/2012	S16-PMC3271033	['ALTHOUGH Calcium and Phosphorus are transported transplacentally without Vitamin D, the EFFECTS of low Vitamin D in utero or shortly after Birth are UNCERTAIN [7].']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 88), ('FULL_UNKNOWN', 149)]	3	[('CHEBI_22313', 'alkaline earth metal atom', 9, 'calcium'), ('CHEBI_35885', 'secondary phosphine', 21, 'phosphorus'), ('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin D'), ('GO_0007567', 'parturition', 139, 'birth')]
PMC3347028	3/2012	S17-PMC3347028	['in the sections ahead, we will FOCUS on one Micronutrient—Vitamin D—and will discuss WHAT we KNOW and what we surely do NOT KNOW in the context of the Pregnant woman and her developing fetus.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 31), ('EXPLICIT_QUESTION', 85), ('INCOMPLETE_EVIDENCE', 93), ('FULL_UNKNOWN', 120)]	4	[('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 44, 'micronutrient'), ('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('GO_0007565', 'female pregnancy', 151, 'pregnant')]
PMC3347028	3/2012	S161-PMC3347028	['WHILE there are numerous epidemiological studies that bear EVIDENCE of the ASSOCIATION between Vitamin D deficiency and altered health, definitive proof in terms of randomized controlled trials is often LACKING.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 59), ('SUPERFICIAL_RELATIONSHIP', 75), ('FULL_UNKNOWN', 203)]	4	[('CHEBI_27300', 'vitamin D', 95, 'vitamin D')]
PMC3347028	3/2012	S216-PMC3347028	['having a higher 25(Oh)D concentration was ASSOCIATED with improved health outcomes in both studies, BUT WHETHER improved Vitamin D status is a MARKER of some OTHER parameter or a direct EFFECT of Vitamin D supplementation REMAINS UNCLEAR at this time.']	[('SUPERFICIAL_RELATIONSHIP', 42), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 100), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 104), ('SUPERFICIAL_RELATIONSHIP', 143), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 158), ('SUPERFICIAL_RELATIONSHIP', 186), ('FULL_UNKNOWN', 222)]	7	[('CHEBI_71657', 'versiconol acetate', 16, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 121, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 196, 'vitamin D')]
PMC3347028	3/2012	S238-PMC3347028	['in the last five years, there has been an explosion of published data concerning the Immune EFFECTS of Vitamin D, YET LITTLE IS KNOWN in this regard about the specific Immune EFFECTS of Vitamin D during Pregnancy.']	[('SUPERFICIAL_RELATIONSHIP', 92), ('ANOMALY_CURIOUS_FINDING', 114), ('FULL_UNKNOWN', 118), ('SUPERFICIAL_RELATIONSHIP', 175)]	4	[('UBERON_0002405', 'immune system', 85, 'immune'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin D'), ('UBERON_0002405', 'immune system', 168, 'immune'), ('CHEBI_27300', 'vitamin D', 186, 'vitamin D'), ('GO_0007565', 'female pregnancy', 203, 'pregnancy')]
PMC3338544	4/2012	S171-PMC3338544	['taken together these findings INDICATE that attentional processing is largely intact in a c57bl/6 Mouse MODEL of Prenatal Vitamin D deficiency, SUGGESTING that Dvd deficiency has LITTLE TO NO effect on the systems Governing attention in the Mouse.']	[('INCOMPLETE_EVIDENCE', 30), ('INCOMPLETE_EVIDENCE', 104), ('INCOMPLETE_EVIDENCE', 144), ('FULL_UNKNOWN', 179)]	4	[('NCBITaxon_10088', 'Mus <genus>', 98, 'mouse'), ('GO_0007565', 'female pregnancy', 113, 'prenatal'), ('CHEBI_27300', 'vitamin D', 122, 'vitamin D'), ('PR_000006770', 'cytoplasmic dynein 1 heavy chain 1', 160, 'DVD'), ('GO_0065007', 'biological regulation', 214, 'governing'), ('NCBITaxon_10088', 'Mus <genus>', 241, 'mouse')]
PMC3347007	4/2012	S57-PMC3347007	['the database is NOT VALIDATED but validation of a similar database from the norwegian Birth cohort (moba) SHOWED good agreement between supplementary Vitamin D measured by ffq and 25(Oh)D-levels [24].']	[('FULL_UNKNOWN', 16), ('INCOMPLETE_EVIDENCE', 106)]	2	[('GO_0007567', 'parturition', 86, 'birth'), ('CHEBI_27300', 'vitamin D', 150, 'vitamin D'), ('CHEBI_73376', 'Ala-Met-Ser-Arg', 180, '25(OH)D-')]
PMC3347007	4/2012	S173-PMC3347007	['SOME analytical data SUGGEST that actual levels of Nutrients exceed labeled levels but ACCORDING TO the us department of agriculture, the INFORMATION on Vitamin D deviation from labels has NOT YET BEEN ESTIMATED [30,31].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 21), ('INCOMPLETE_EVIDENCE', 87), ('INCOMPLETE_EVIDENCE', 138), ('FULL_UNKNOWN', 189), ('INCOMPLETE_EVIDENCE', 189), ('INCOMPLETE_EVIDENCE', 202)]	7	[('CHEBI_33284', 'nutrient', 51, 'nutrients'), ('CHEBI_27300', 'vitamin D', 153, 'vitamin D')]
PMC3348565	4/2012	S121-PMC3348565	['ALTHOUGH this is PROBABLY TRUE, a sufficient Serum concentrations for the immunological EFFECTS of Vitamin D is UNKNOWN and COULD BE higher or lower than that of the Skeletal system accepted concentrations.6THE NEED for a steady state is currently highly SPECULATIVE and RELATES to Vitamin D2Supplementation for negative cancer22and bone outcomes.23\nour findings are AT ODDS with SMALLER case-control hospital STUDIES that show an enhanced rate of Vitamin D deficiency or rickets in children with pneumonia and the INCREASING EVIDENCE SUGGESTING that Calcitriol, the biologically active Metabolite of Vitamin D, has an IMPORTANT ROLE in the Human Immune System.4a systematic review of the ROLE of Vitamin D supplementation in infectious diseases had MIXED findings, CONCLUDING that more rigorously designed clinical trials ARE NEEDED (panel).25NO STUDIES report the EFFECT of Vitamin D on radiologically confirmed pneumonias.']	[('ANOMALY_CURIOUS_FINDING', 0), ('PROBABLE_UNDERSTANDING', 17), ('PROBABLE_UNDERSTANDING', 26), ('SUPERFICIAL_RELATIONSHIP', 88), ('FULL_UNKNOWN', 112), ('INCOMPLETE_EVIDENCE', 124), ('INCOMPLETE_EVIDENCE', 207), ('INCOMPLETE_EVIDENCE', 255), ('SUPERFICIAL_RELATIONSHIP', 271), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 367), ('INCOMPLETE_EVIDENCE', 380), ('INCOMPLETE_EVIDENCE', 515), ('INCOMPLETE_EVIDENCE', 535), ('IMPORTANT_CONSIDERATION', 619), ('SUPERFICIAL_RELATIONSHIP', 629), ('SUPERFICIAL_RELATIONSHIP', 689), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 750), ('PROBABLE_UNDERSTANDING', 766), ('FUTURE_WORK', 823), ('INCOMPLETE_EVIDENCE', 844), ('SUPERFICIAL_RELATIONSHIP', 866)]	21	[('UBERON_0001977', 'blood serum', 45, 'serum'), ('CHEBI_27300', 'vitamin D', 99, 'vitamin D'), ('UBERON_0004288', 'skeleton', 166, 'skeletal'), ('CHEBI_52910', 'delta-lactam ring', 282, 'vitamin D2supplementation'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 282, 'vitamin D2supplementation'), ('CHEBI_27300', 'vitamin D', 448, 'vitamin D'), ('CHEBI_17823', 'calcitriol', 551, 'calcitriol'), ('CHEBI_39382', 'flufenoxuron', 587, 'metabolite'), ('CHEBI_27300', 'vitamin D', 601, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 641, 'human'), ('UBERON_0002405', 'immune system', 647, 'immune system'), ('CHEBI_27300', 'vitamin D', 697, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 876, 'vitamin D')]
PMC3356951	4/2012	S61-PMC3356951	['[5455] the SIGNIFICANCE of the ROLE that sunscreen MAY play in reducing Vitamin D Synthesis is STILL UNCLEAR.']	[('IMPORTANT_CONSIDERATION', 11), ('SUPERFICIAL_RELATIONSHIP', 31), ('INCOMPLETE_EVIDENCE', 51), ('FULL_UNKNOWN', 95)]	4	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('GO_0042368', 'vitamin D biosynthetic process', 72, 'vitamin D synthesis')]
PMC3356951	4/2012	S89-PMC3356951	['Vitamin D crosses the Blood–Brain barrier and the receptors for Vitamin D are found across the Brain, but its precise ROLE is STILL NOT KNOWN.']	[('SUPERFICIAL_RELATIONSHIP', 118), ('FULL_UNKNOWN', 126)]	2	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 0, 'Vitamin'), ('UBERON_0000178', 'blood', 22, 'blood'), ('UBERON_0000955', 'brain', 28, 'brain'), ('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('UBERON_0000955', 'brain', 95, 'brain')]
PMC3427192	4/2012	S40-PMC3427192	['HOWEVER, 25(Oh)D concentrations in the non-asthmatic group were significantly higher than PREVIOUSLY-REPORTED average values in african american children.21the childhood asthma management program study, which consisted of a racially diverse population, also FOUND that 24% of Vitamin D deficient subjects were african american, compared with only 7% in the Vitamin D sufficient group.69the FACTORS responsible for the racial DISPARITY in Vitamin D status are UNCLEAR and WARRANT FURTHER STUDY.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 90), ('INCOMPLETE_EVIDENCE', 101), ('INCOMPLETE_EVIDENCE', 258), ('SUPERFICIAL_RELATIONSHIP', 390), ('IMPORTANT_CONSIDERATION', 425), ('FULL_UNKNOWN', 459), ('FUTURE_WORK', 471), ('FUTURE_WORK', 479)]	10	[('CHEBI_71657', 'versiconol acetate', 9, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 276, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 357, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 438, 'vitamin D')]
PMC3395583	7/2012	S85-PMC3395583	['furthermore, the seasonal variation of 25-Oh-D levels WAS NOT INVESTIGATED AND NO other STUDIES have tried to answer the same QUESTION in id OTHER than ms. we FOUND that the risk of id was inversely ASSOCIATED with PREDICTED second trimester Uvb exposure and third trimester Vitamin D status.']	[('INCOMPLETE_EVIDENCE', 54), ('FULL_UNKNOWN', 58), ('QUESTION_ANSWERED_BY_THIS_WORK', 62), ('EXPLICIT_QUESTION', 126), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 141), ('INCOMPLETE_EVIDENCE', 159), ('SUPERFICIAL_RELATIONSHIP', 199), ('SUPERFICIAL_RELATIONSHIP', 215)]	8	[('CHEBI_46744', 'DDT-2,3-dihydrodiol', 39, '25-OH-D'), ('CHEBI_37043', "pyrimidine 2'-deoxyribonucleoside 5'-triphosphate", 242, 'UVB'), ('CHEBI_27300', 'vitamin D', 275, 'vitamin D')]
PMC3427250	8/2012	S1-PMC3427250	['there are NO representative country data AVAILABLE on Vitamin D status of Pregnant women in europe.']	[('FULL_UNKNOWN', 10)]	1	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('GO_0007565', 'female pregnancy', 74, 'pregnant')]
PMC3427250	8/2012	S18-PMC3427250	['HOWEVER there is so far NO CONCLUSIVE EVIDENCE about the causality of these RELATIONSHIPS, as NO randomised controlled TRIALS of Vitamin D supplementation with an appropriate assessment of a VARIETY of health outcomes have been carried out to date[21].']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 24), ('SUPERFICIAL_RELATIONSHIP', 76), ('FULL_UNKNOWN', 94), ('DIFFICULT_TASK', 191)]	5	[('CHEBI_27300', 'vitamin D', 129, 'vitamin D')]
PMC3427250	8/2012	S106-PMC3427250	['smoking increased the risk of both Vitamin D deficiency and severe Vitamin D deficiency; the mechanism for this APPEARS TO BE UNCLEAR[50].']	[('ANOMALY_CURIOUS_FINDING', 112), ('FULL_UNKNOWN', 126)]	2	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 67, 'vitamin D')]
PMC3427250	8/2012	S116-PMC3427250	['the adequate intake of Vitamin D during Pregnancy and Lactation is UNKNOWN, ALTHOUGH it APPEARS TO BE greater than the current dietary RECOMMENDATIONS of 400 iu/d or 10 µg/d[58].']	[('FULL_UNKNOWN', 67), ('ANOMALY_CURIOUS_FINDING', 76), ('ANOMALY_CURIOUS_FINDING', 88), ('FUTURE_WORK', 135)]	4	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('GO_0007565', 'female pregnancy', 40, 'pregnancy'), ('GO_0007595', 'lactation', 54, 'lactation')]
PMC3427250	8/2012	S118-PMC3427250	['as those authors recognize that the EVIDENCE to propose such Intakes IS SCARCE and as long as the health benefits of having Serum 25(Oh)D levels higher than 30 ng/ml are NOT clearly ESTABLISHED particularly in Pregnant women, the belgian superior health council STILL RECOMMENDS a Vitamin D supplement of 20 µg/day or 800 iu during Pregnancy[58].']	[('INCOMPLETE_EVIDENCE', 36), ('FULL_UNKNOWN', 170), ('IMPORTANT_CONSIDERATION', 262), ('FUTURE_WORK', 268)]	4	[('GO_0007631', 'feeding behavior', 61, 'intakes'), ('UBERON_0001977', 'blood serum', 124, 'serum'), ('CHEBI_71657', 'versiconol acetate', 130, '25(OH)D'), ('PR_000003010', 'moesin isoform 1', 132, '(OH ... D'), ('GO_0007565', 'female pregnancy', 210, 'pregnant'), ('CHEBI_27300', 'vitamin D', 281, 'vitamin D'), ('GO_0007565', 'female pregnancy', 332, 'pregnancy')]
PMC3427250	8/2012	S120-PMC3427250	['in the ABSENCE OF survey data from other european countries, we SUSPECT that the prevalence of Vitamin D deficiency in belgium LIKELY reflects the situation in other western european countries.']	[('FULL_UNKNOWN', 7), ('PROBABLE_UNDERSTANDING', 64), ('PROBABLE_UNDERSTANDING', 127)]	3	[('CHEBI_27300', 'vitamin D', 95, 'vitamin D')]
PMC3427250	8/2012	S122-PMC3427250	['in addition to the UNCERTAINTY CONCERNING the optimal Vitamin D intakes preventing Vitamin D deficiency, there exists also a LACK OF RECOMMENDATIONS to treat Vitamin D deficient Pregnant women.']	[('FULL_UNKNOWN', 19), ('PROBLEM_COMPLICATION', 31), ('INCOMPLETE_EVIDENCE', 125), ('FUTURE_WORK', 133)]	4	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 83, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 158, 'vitamin D'), ('GO_0007565', 'female pregnancy', 178, 'pregnant')]
PMC3427250	8/2012	S124-PMC3427250	['the UNCOVERING of the magnitude of Vitamin D deficiency in Pregnant women in belgium (and western europe) SHOULD BE translated into NEW RESEARCH in order to fill the huge KNOWLEDGE GAP CONCERNING the adequate amount of Vitamin D to prevent and treat Vitamin D deficient Pregnant women.']	[('INCOMPLETE_EVIDENCE', 4), ('FUTURE_WORK', 106), ('INCOMPLETE_EVIDENCE', 132), ('FULL_UNKNOWN', 171), ('PROBLEM_COMPLICATION', 185)]	5	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('GO_0007565', 'female pregnancy', 59, 'pregnant'), ('CHEBI_27300', 'vitamin D', 219, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 250, 'vitamin D'), ('GO_0007565', 'female pregnancy', 270, 'pregnant')]
PMC3476426	8/2012	S100-PMC3476426	['three NOVEL structural variants of the Vitamin D Receptor were REPORTED in psychiatric disease [33].']	[('FULL_UNKNOWN', 6), ('INCOMPLETE_EVIDENCE', 63)]	2	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D'), ('PR_000001683', 'vasopressin V2 receptor', 39, 'vitamin D receptor')]
PMC3470091	9/2012	S21-PMC3470091	['a dose of 600,000 iu Vitamin D resulted in hypercalcemia, THEREFORE, it can not be REGARDED a SAFE dose.17there is NO STUDY to evaluate Vitamin D status in mothers with previous gdm, and present oral Vitamin D products are not fully EFFECTIVE,16THEREFORE, THIS STUDY was DESIGNED TO EVALUATE the EFFECT of intramuscular injection of 300,000 iu during a three-month period.']	[('PROBABLE_UNDERSTANDING', 58), ('PROBABLE_UNDERSTANDING', 83), ('IMPORTANT_CONSIDERATION', 94), ('FULL_UNKNOWN', 115), ('SUPERFICIAL_RELATIONSHIP', 233), ('PROBABLE_UNDERSTANDING', 245), ('QUESTION_ANSWERED_BY_THIS_WORK', 256), ('QUESTION_ANSWERED_BY_THIS_WORK', 271), ('QUESTION_ANSWERED_BY_THIS_WORK', 280), ('SUPERFICIAL_RELATIONSHIP', 296)]	10	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 200, 'vitamin D')]
PMC3471827	10/2012	S2-PMC3471827	['ttp and Vitamin E are ESSENTIAL for Productive Pregnancy in rodents, but their precise physiological ROLE in Embryogenesis is UNKNOWN.']	[('IMPORTANT_CONSIDERATION', 22), ('SUPERFICIAL_RELATIONSHIP', 101), ('FULL_UNKNOWN', 126)]	3	[('CHEBI_27300', 'vitamin D', 8, 'vitamin E'), ('GO_0007128', 'meiotic prophase I', 36, 'productive'), ('GO_0007565', 'female pregnancy', 47, 'pregnancy'), ('GO_0009790', 'embryo development', 109, 'embryogenesis')]
PMC3501517	11/2012	S218-PMC3501517	['WHETHER Vitamin D Modulates Neutrophil function with infectious pneumonia REMAINS UNKNOWN.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('EXPLICIT_QUESTION', 0), ('FULL_UNKNOWN', 74)]	3	[('CHEBI_27300', 'vitamin D', 8, 'vitamin D'), ('GO_0065007', 'biological regulation', 18, 'modulates'), ('CL_0000775', 'neutrophil', 28, 'neutrophil')]
PMC3515553	12/2012	S1-PMC3515553	['Brain Development occurs primarily in utero and early infancy, BUT the ROLE of maternal Vitamin B-12 status during Pregnancy on offspring Cognitive function is UNCLEAR.']	[('ANOMALY_CURIOUS_FINDING', 63), ('SUPERFICIAL_RELATIONSHIP', 71), ('FULL_UNKNOWN', 160)]	3	[('GO_0060132', 'prolactin secreting cell development', 0, 'Brain development'), ('UBERON_0000955', 'brain', 0, 'Brain'), ('CHEBI_27300', 'vitamin D', 88, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 88, 'vitamin B-12'), ('GO_0007565', 'female pregnancy', 115, 'pregnancy'), ('GO_0050890', 'cognition', 138, 'cognitive')]
PMC3515553	12/2012	S15-PMC3515553	['DESPITE the IMPORTANCE of Vitamin B-12 to Neuronal Development and the dependency of the developing foetus and infant on maternal Vitamin B-12 status, it is UNKNOWN WHETHER variation in maternal Pregnancy Vitamin B-12, across the normal range, INFLUENCES offspring Neurodevelopment.']	[('ANOMALY_CURIOUS_FINDING', 0), ('IMPORTANT_CONSIDERATION', 12), ('FULL_UNKNOWN', 157), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 165), ('SUPERFICIAL_RELATIONSHIP', 244)]	5	[('CHEBI_27300', 'vitamin D', 26, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 26, 'vitamin B-12'), ('CL_0000540', 'neuron', 42, 'neuronal'), ('GO_0007399', 'nervous system development', 42, 'neuronal development'), ('CHEBI_27300', 'vitamin D', 130, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 130, 'vitamin B-12'), ('GO_0007565', 'female pregnancy', 195, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 205, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 205, 'vitamin B-12'), ('GO_0007399', 'nervous system development', 265, 'neurodevelopment')]
PMC3515553	12/2012	S154-PMC3515553	['YET, LITTLE IS KNOWN about the INFLUENCE that low Plasma Vitamin B-12 during Pregnancy MAY have on the Cognitive ability of children later in Life.']	[('ANOMALY_CURIOUS_FINDING', 0), ('FULL_UNKNOWN', 5), ('SUPERFICIAL_RELATIONSHIP', 31), ('INCOMPLETE_EVIDENCE', 87)]	4	[('UBERON_0001969', 'blood plasma', 50, 'plasma'), ('CHEBI_27300', 'vitamin D', 57, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 57, 'vitamin B-12'), ('GO_0007565', 'female pregnancy', 77, 'pregnancy'), ('GO_0050890', 'cognition', 103, 'cognitive'), ('UBERON_0000104', 'life cycle', 142, 'life')]
PMC3552819	12/2012	S12-PMC3552819	['there is considerable SPECULATION regarding the POTENTIAL EFFECTS of Vitamin D on both Skeletal and Extra-Skeletal aspects of Reproductive physiology and Fetal Development, YET it REMAINS UNKNOWN WHETHER there are benefits to improving maternal Antenatal Vitamin D status beyond the correction of SEVERE deficiency [2,3].']	[('INCOMPLETE_EVIDENCE', 22), ('INCOMPLETE_EVIDENCE', 48), ('SUPERFICIAL_RELATIONSHIP', 58), ('ANOMALY_CURIOUS_FINDING', 173), ('FULL_UNKNOWN', 180), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 196), ('IMPORTANT_CONSIDERATION', 297)]	7	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('UBERON_0004288', 'skeleton', 87, 'skeletal'), ('UBERON_0001431', 'distal carpal bone 2', 100, 'extra-skeletal'), ('GO_0000003', 'reproduction', 126, 'reproductive'), ('GO_0002065', 'columnar/cuboidal epithelial cell differentiation', 154, 'fetal development'), ('GO_0007567', 'parturition', 245, 'antenatal'), ('CHEBI_27300', 'vitamin D', 255, 'vitamin D')]
PMC3659910	1/2013	S52-PMC3659910	['ALTHOUGH transplacental Transport has NOT BEEN STUDIED in Humans, Vitamin D passage from the mother to the fetus WOULD BE facilitated by Serum concentrations of 1,25(Oh) 2D being higher in the maternal compared to the fetal Circulations.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FULL_UNKNOWN', 38), ('FUTURE_PREDICTION', 113)]	3	[('GO_0006809', 'nitric oxide biosynthetic process', 24, 'transport'), ('NCBITaxon_9606', 'Homo sapiens', 58, 'humans'), ('CHEBI_27300', 'vitamin D', 66, 'vitamin D'), ('UBERON_0001977', 'blood serum', 137, 'serum'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 166, 'OH) 2D'), ('UBERON_0002595', 'orbital sulcus', 224, 'circulations')]
PMC3659910	1/2013	S131-PMC3659910	['RESEARCH has FOUND direct CONNECTIONS between Vitamin D and the Genes KNOWN to be INVOLVED in ms, BUT exact pathology and WHETHER Vitamin D supplements during Pregnancy OR childhood can lessen the likelihood of the child developing ms later in Life is NOT KNOWN.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 13), ('SUPERFICIAL_RELATIONSHIP', 26), ('INCOMPLETE_EVIDENCE', 70), ('SUPERFICIAL_RELATIONSHIP', 82), ('ANOMALY_CURIOUS_FINDING', 98), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 122), ('FULL_UNKNOWN', 252)]	8	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('SO_0000704', 'gene', 64, 'genes'), ('CHEBI_27300', 'vitamin D', 130, 'vitamin D'), ('GO_0007565', 'female pregnancy', 159, 'pregnancy'), ('UBERON_0000104', 'life cycle', 244, 'life')]
PMC3659910	1/2013	S170-PMC3659910	['the reality is that the actual Vitamin D REQUIREMENT during Pregnancy is NOT KNOWN.']	[('IMPORTANT_CONSIDERATION', 41), ('FULL_UNKNOWN', 73)]	2	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('GO_0007565', 'female pregnancy', 60, 'pregnancy')]
PMC3659910	1/2013	S172-PMC3659910	['there is NO dietary RECOMMENDED intake (dri) for Vitamin D. what IS KNOWN today is that for a Pregnant woman, the adequate intake for Vitamin D is 200 iu per day.']	[('FULL_UNKNOWN', 9), ('FUTURE_WORK', 20), ('INCOMPLETE_EVIDENCE', 65)]	3	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('GO_0007565', 'female pregnancy', 94, 'pregnant'), ('CHEBI_27300', 'vitamin D', 134, 'vitamin D')]
PMC3613945	2/2013	S3-PMC3613945	['WHETHER these variants also INFLUENCE the ROLE of Vitamin D in an Immunologic milieu is NOT KNOWN.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('EXPLICIT_QUESTION', 0), ('SUPERFICIAL_RELATIONSHIP', 28), ('SUPERFICIAL_RELATIONSHIP', 42), ('FULL_UNKNOWN', 88)]	5	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D'), ('UBERON_0000913', 'interstitial fluid', 66, 'immunologic')]
PMC3613945	2/2013	S12-PMC3613945	['the functions of dbp are STILL BEING DEFINED, but they include the Transport Of Vitamin D and its Metabolites in the circulation5,6, as well as actin scavenging and Fatty Acid binding7–12.']	[('FULL_UNKNOWN', 25)]	1	[('GO_0006415', 'translational termination', 67, 'transport of vitamin D'), ('CHEBI_27300', 'vitamin D', 80, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 88, 'D'), ('CHEBI_25212', 'metabolite', 98, 'metabolites'), ('GO_0008152', 'metabolic process', 98, 'metabolites'), ('CHEBI_35366', 'fatty acid', 165, 'fatty acid'), ('GO_0019401', 'alditol biosynthetic process', 171, 'acid')]
PMC3613945	2/2013	S189-PMC3613945	['a molecular mechanism by which Vitamin D MAY AFFECT asthma is UNKNOWN and its RELATIONSHIP to atopy is UNCLEAR.']	[('INCOMPLETE_EVIDENCE', 41), ('SUPERFICIAL_RELATIONSHIP', 45), ('FULL_UNKNOWN', 62), ('SUPERFICIAL_RELATIONSHIP', 78), ('FULL_UNKNOWN', 103)]	5	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D')]
PMC3613945	2/2013	S208-PMC3613945	['the UNDERLYING mechanism by which Vitamin D status AFFECTS cancer RISK is UNKNOWN, HOWEVER, 1,25(Oh)2D3Has BEEN SHOWN to Modulate Cell Proliferation and Differentiation Of both normal and malignant Cells.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('SUPERFICIAL_RELATIONSHIP', 51), ('IMPORTANT_CONSIDERATION', 66), ('FULL_UNKNOWN', 74), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 83), ('ANOMALY_CURIOUS_FINDING', 83), ('INCOMPLETE_EVIDENCE', 107)]	7	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('CHEBI_76957', 'N-2-hydroxytetracosenoylsphingosine', 92, '1,25(OH)2D3has'), ('GO_0065007', 'biological regulation', 121, 'modulate'), ('GO_0008283', 'cell proliferation', 130, 'cell proliferation'), ('GO_0030154', 'cell differentiation', 153, 'differentiation of ... cells')]
PMC3613945	2/2013	S210-PMC3613945	['Breast cancer\necological case-control studies INDICATE an inverse CORRELATION between Vitamin D status and Breast cancer RISK, HOWEVER, the RELATIONSHIP is LESS CLEAR in longitudinal studies150,151.']	[('INCOMPLETE_EVIDENCE', 46), ('SUPERFICIAL_RELATIONSHIP', 66), ('IMPORTANT_CONSIDERATION', 121), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 127), ('ANOMALY_CURIOUS_FINDING', 127), ('SUPERFICIAL_RELATIONSHIP', 140), ('FULL_UNKNOWN', 156)]	7	[('UBERON_0000310', 'breast', 0, 'Breast'), ('CHEBI_27300', 'vitamin D', 86, 'vitamin D'), ('UBERON_0000310', 'breast', 107, 'breast')]
PMC3613945	2/2013	S243-PMC3613945	['ongoing interventional trials with Vitamin D and ASSOCIATION studies with larger cohorts MAY offer FURTHER OPPORTUNITY to explore an INTERACTIVE ROLE of dbp Snps with Vitamin D in ms.\n\namyotrophic lateral sclerosis\namyotrophic lateral sclerosis (als) is another neuropathy of UNKNOWN etiology that is characterized by the progressive loss of Motor Neurons in the Brain and spinal Cord, leading to debilitating, USUALLY fatal, muscle atrophy180.']	[('SUPERFICIAL_RELATIONSHIP', 49), ('INCOMPLETE_EVIDENCE', 89), ('FUTURE_WORK', 99), ('SUPERFICIAL_RELATIONSHIP', 133), ('SUPERFICIAL_RELATIONSHIP', 145), ('FULL_UNKNOWN', 276), ('INCOMPLETE_EVIDENCE', 411)]	7	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('SO_0000694', 'SNP', 157, 'SNPs'), ('CHEBI_27300', 'vitamin D', 167, 'vitamin D'), ('CL_0000100', 'motor neuron', 342, 'motor neurons'), ('UBERON_0000955', 'brain', 363, 'brain'), ('UBERON_0002240', 'spinal cord', 380, 'cord')]
PMC3613945	2/2013	S250-PMC3613945	['the UNDERLYING molecular mechanism governing this ASSOCIATION is NOT KNOWN, but Prenatal Vitamin D deficiency is ASSOCIATED with structural and functional deficits common to schizophrenic patients.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('SUPERFICIAL_RELATIONSHIP', 50), ('FULL_UNKNOWN', 65), ('SUPERFICIAL_RELATIONSHIP', 113)]	4	[('GO_0007565', 'female pregnancy', 80, 'prenatal'), ('CHEBI_27300', 'vitamin D', 89, 'vitamin D')]
PMC3705320	3/2013	S13-PMC3705320	['introduction\nthe maternal-infant health benefits of Vitamin D supplementation during Pregnancy remain UNCERTAIN [1,2].']	[('FULL_UNKNOWN', 102)]	1	[('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('GO_0007565', 'female pregnancy', 85, 'pregnancy')]
PMC3705320	3/2013	S180-PMC3705320	['HOWEVER, SINCE the ROLE of pth as a Vitamin D status BIOMARKER during Pregnancy is UNCLEAR [26], the clinical significance of the APPARENT dose-response EFFECT of Vitamin D on pth REQUIRES FURTHER STUDY.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBLEM_COMPLICATION', 9), ('SUPERFICIAL_RELATIONSHIP', 19), ('SUPERFICIAL_RELATIONSHIP', 53), ('FULL_UNKNOWN', 83), ('ANOMALY_CURIOUS_FINDING', 130), ('SUPERFICIAL_RELATIONSHIP', 153), ('IMPORTANT_CONSIDERATION', 180), ('FUTURE_WORK', 189)]	9	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('GO_0007565', 'female pregnancy', 70, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 163, 'vitamin D')]
PMC3629265	4/2013	S17-PMC3629265	['the incidence of Vitamin D deficiency in canada is NOT KNOWN.']	[('FULL_UNKNOWN', 51)]	1	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D')]
PMC3641012	4/2013	S0-PMC3641012	['randomized placebo-controlled trial of high-dose Prenatal third-Trimester Vitamin D3 supplementation in bangladesh: the avidd trial\n\nabstract\n\nbackground\nantenatal Vitamin D status MAY be ASSOCIATED with the RISK of adverse Pregnancy and neonatal outcomes; HOWEVER, the benefits of Vitamin D supplementation during Pregnancy remain UNKNOWN.']	[('INCOMPLETE_EVIDENCE', 181), ('SUPERFICIAL_RELATIONSHIP', 188), ('IMPORTANT_CONSIDERATION', 208), ('ANOMALY_CURIOUS_FINDING', 257), ('FULL_UNKNOWN', 332)]	5	[('GO_0007565', 'female pregnancy', 49, 'prenatal'), ('GO_0009294', 'DNA mediated transformation', 64, 'trimester'), ('CHEBI_33279', 'vitamin D5', 74, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 74, 'vitamin D3'), ('CHEBI_27300', 'vitamin D', 164, 'vitamin D'), ('GO_0007565', 'female pregnancy', 224, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 282, 'vitamin D'), ('GO_0007565', 'female pregnancy', 315, 'pregnancy')]
PMC3641012	4/2013	S13-PMC3641012	['HOWEVER, the EFFECTS of Vitamin D on maternal, Placental or Fetal Tissues are UNCERTAIN [2], and the extent to which health outcomes are responsive to changes in maternal-fetal Vitamin D status REMAINS UNKNOWN [2,6,7].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 13), ('FULL_UNKNOWN', 78), ('FULL_UNKNOWN', 194)]	4	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('UBERON_0001987', 'placenta', 47, 'placental'), ('UBERON_0000922', 'embryo', 60, 'fetal'), ('UBERON_0000479', 'tissue', 66, 'tissues'), ('CHEBI_27300', 'vitamin D', 177, 'vitamin D')]
PMC3773018	4/2013	S19-PMC3773018	['HOWEVER, FINDINGS regarding the combined EFFECTS of Prenatal and Postnatal Vitamin D status on fs, two of the most CRITICAL periods for Immune System Development (19,20), are UNCLEAR.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 9), ('SUPERFICIAL_RELATIONSHIP', 41), ('IMPORTANT_CONSIDERATION', 115), ('FULL_UNKNOWN', 175)]	5	[('GO_0007565', 'female pregnancy', 52, 'prenatal'), ('GO_0007567', 'parturition', 65, 'postnatal'), ('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('GO_0002520', 'immune system development', 136, 'immune system development'), ('UBERON_0002405', 'immune system', 136, 'immune system')]
PMC3672018	5/2013	S41-PMC3672018	['ALTHOUGH mechanisms RELATING low Perinatal Vitamin D to later obesity are NOT WELL KNOWN, PROPOSED mediators include epigenetic changes leading to initiation of Adipogenesis, or induction of permanent functional changes in Hypothalamic Appetite Regulation [17,18].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 20), ('FULL_UNKNOWN', 74), ('FUTURE_WORK', 78), ('INCOMPLETE_EVIDENCE', 90), ('SUPERFICIAL_RELATIONSHIP', 245)]	7	[('GO_0036268', 'swimming', 33, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 33, 'perinatal'), ('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('GO_0060612', 'adipose tissue development', 161, 'adipogenesis'), ('UBERON_0001898', 'hypothalamus', 223, 'hypothalamic'), ('GO_0034205', 'amyloid-beta formation', 236, 'appetite regulation')]
PMC3717170	5/2013	S20-PMC3717170	['the mechanism of 1,25(Oh)2D3Suppression of Il-17 was found to be transcriptional and to involve blocking of Nuclear factor for Activated T Cells (Nfat, which is IMPORTANT for T Cell receptor–mediated transcriptional Regulation of Il-17), recruitment of Histone deacetylase to the Il-17 Promoter, and Sequestration of Runt-Related Transcription Factor 1 (runx1) by the vdr.31,25(Oh)2D3Was also FOUND to have a direct EFFECT on the induction of Foxp3, a transcription factor that ASSOCIATES with Nfat and runx1 for transcriptional repression.3THESE results DESCRIBE NOVEL mechanisms and new CONCEPTS with regard to Vitamin D and the Immune System and SUGGEST THERAPEUTIC TARGETS for the Control of Autoimmune diseases.']	[('IMPORTANT_CONSIDERATION', 161), ('ANOMALY_CURIOUS_FINDING', 393), ('SUPERFICIAL_RELATIONSHIP', 416), ('SUPERFICIAL_RELATIONSHIP', 478), ('INCOMPLETE_EVIDENCE', 540), ('INCOMPLETE_EVIDENCE', 555), ('FULL_UNKNOWN', 564), ('INCOMPLETE_EVIDENCE', 589), ('FUTURE_WORK', 649), ('INCOMPLETE_EVIDENCE', 649), ('FUTURE_WORK', 657), ('FUTURE_WORK', 669)]	12	[('CHEBI_42976', 'L-glycero-alpha-D-manno-heptopyranose', 17, '1,25(OH)2D3suppression'), ('PR_000001470', 'interleukin-28B', 43, 'IL-17'), ('GO_0005634', 'nucleus', 108, 'nuclear'), ('CL_0002129', 'regular atrial cardiac myocyte', 127, 'activated T cells'), ('PR_000011111', 'N-terminal EF-hand calcium-binding protein 3', 146, 'NFAT'), ('CL_0000084', 'T cell', 175, 'T cell'), ('GO_0065007', 'biological regulation', 216, 'regulation'), ('PR_000001470', 'interleukin-28B', 230, 'IL-17'), ('CHEBI_15358', 'histone', 253, 'histone'), ('PR_000043452', 'core histone', 253, 'histone'), ('PR_000001470', 'interleukin-28B', 280, 'IL-17'), ('SO_0000167', 'promoter', 286, 'promoter'), ('GO_0051235', 'maintenance of location', 300, 'sequestration'), ('PR_000014373', 'retinoic acid receptor RXR-beta', 317, 'Runt-related transcription factor 1'), ('CHEBI_73386', 'Ala-Val-Asp-Ser', 375, '25(OH)2D3was'), ('PR_000007655', 'GSK-3-binding protein FRAT2', 443, 'Foxp3'), ('PR_000011111', 'N-terminal EF-hand calcium-binding protein 3', 494, 'NFAT'), ('CHEBI_27300', 'vitamin D', 613, 'vitamin D'), ('UBERON_0002405', 'immune system', 631, 'immune system'), ('GO_0065007', 'biological regulation', 685, 'control'), ('UBERON_0001442', 'skeleton of manus', 696, 'autoimmune')]
PMC3717170	5/2013	S82-PMC3717170	['the EFFECTS of the hormonal form of Vitamin D, 1,25(Oh)2D3, on Apoptotic Cell Death are MEDIATED via multiple signaling pathways that involve common regulators and Effectors CONVERGING on cellular Ca2+.19,21sergeev and colleagues HAVE SHOWN that the CRITICAL characteristic of the apoptotic Ca2+signal is a sustained increase in the concentration of Intracellular Ca2+, reaching elevated BUT NOT cytotoxic levels.22HOWEVER, 1,25(Oh)2D3-Regulated, Ca2+-dependent apoptotic molecular targets HAVE NOT BEEN IDENTIFIED in Adipose Tissue.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('SUPERFICIAL_RELATIONSHIP', 88), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 174), ('INCOMPLETE_EVIDENCE', 230), ('IMPORTANT_CONSIDERATION', 250), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 388), ('ANOMALY_CURIOUS_FINDING', 392), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 413), ('FULL_UNKNOWN', 490)]	9	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('CHEBI_72779', '11-trans-LTE4', 47, '1,25(OH)2D3'), ('CL_0000445', 'apoptosis fated cell', 63, 'apoptotic cell'), ('GO_0006915', 'apoptotic process', 63, 'apoptotic cell death'), ('CHEBI_35224', 'effector', 164, 'effectors'), ('CHEBI_29108', 'calcium(2+)', 197, 'Ca2+.'), ('CHEBI_29108', 'calcium(2+)', 291, 'Ca2+'), ('GO_0005622', 'intracellular anatomical structure', 350, 'intracellular'), ('CHEBI_3312', 'calcium dichloride', 364, 'Ca2+,'), ('CHEBI_17996', 'chloride', 425, ','), ('CHEBI_73394', 'Ala-Ser', 426, '25(OH)2D3'), ('GO_0065007', 'biological regulation', 436, 'regulated'), ('CHEBI_81233', 'Schizonepetoside B', 447, 'Ca2+-'), ('UBERON_0001013', 'adipose tissue', 518, 'adipose tissue')]
PMC3717170	5/2013	S184-PMC3717170	['WHETHER Vitamin D supplementation MAY positively IMPACT the Aging process REMAINS UNKNOWN and will REQUIRE FURTHER long-term intervention STUDIES.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 34), ('SUPERFICIAL_RELATIONSHIP', 49), ('FULL_UNKNOWN', 74), ('FUTURE_WORK', 99), ('FUTURE_WORK', 107)]	6	[('CHEBI_27300', 'vitamin D', 8, 'vitamin D'), ('GO_0007568', 'aging', 60, 'aging')]
PMC3685533	6/2013	S126-PMC3685533	['ALTHOUGH SEVERAL STUDIES are AVAILABLE on Vitamin D supplementation during Pregnancy, its APPROPRIATE dose is NOT CLEAR [19-21].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 29), ('IMPORTANT_CONSIDERATION', 90), ('FULL_UNKNOWN', 110)]	5	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('GO_0007565', 'female pregnancy', 75, 'pregnancy')]
PMC3691177	6/2013	S127-PMC3691177	['it HAS RECENTLY BEEN SHOWN that doses of 4000 iu of Vitamin D daily are SAFE and effective for short term treatment of Vitamin D deficiency during Pregnancy[30], ALTHOUGH the long term EFFECTS on child health have NOT BEEN STUDIED.']	[('INCOMPLETE_EVIDENCE', 3), ('IMPORTANT_CONSIDERATION', 72), ('ANOMALY_CURIOUS_FINDING', 162), ('SUPERFICIAL_RELATIONSHIP', 185), ('FULL_UNKNOWN', 214)]	5	[('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 119, 'vitamin D'), ('GO_0007565', 'female pregnancy', 147, 'pregnancy')]
PMC3702245	6/2013	S38-PMC3702245	['the RELATIONSHIP between maternal Vitamin D status and small-for-Gestational age infants was found to be u-shaped in a study from pittsburgh in the us,81BUT this WAS NOT CONFIRMED in the above studies.68,80the REASONS for this DIFFERENCE are UNCLEAR.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 151), ('INCOMPLETE_EVIDENCE', 162), ('PROBABLE_UNDERSTANDING', 210), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 227), ('FULL_UNKNOWN', 242)]	6	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('GO_0007565', 'female pregnancy', 65, 'gestational')]
PMC3695234	7/2013	S20-PMC3695234	['a GROWING body of LITERATURE has LINKED decreased Serum Vitamin D levels with allergic diseases, PARTICULARLY ad.2-4HOWEVER, large-scale prospective and randomized studies are LACKING.']	[('INCOMPLETE_EVIDENCE', 2), ('SUPERFICIAL_RELATIONSHIP', 33), ('IMPORTANT_CONSIDERATION', 97), ('IMPORTANT_CONSIDERATION', 114), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 115), ('FULL_UNKNOWN', 176)]	6	[('UBERON_0001977', 'blood serum', 50, 'serum'), ('CHEBI_27300', 'vitamin D', 56, 'vitamin D')]
PMC3713405	7/2013	S0-PMC3713405	['altered Dopamine ontogeny in the developmentally Vitamin D deficient Rat and its relevance to schizophrenia\n\nabstract\nschizophrenia is a heterogeneous group of disorders with UNKNOWN etiology.']	[('FULL_UNKNOWN', 175)]	1	[('CHEBI_18243', 'dopamine', 8, 'dopamine'), ('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 69, 'rat')]
PMC3713405	7/2013	S49-PMC3713405	['most RECENTLY, and most IMPORTANTLY, a danish population-based case-control study (423 cases and 423 control) that directly assessed Vitamin D levels in Blood Spots from NEW born infants provided SOLID EVIDENCE SHOWING that low Prenatal Vitamin D levels are ASSOCIATED with an INCREASED RISK of schizophrenia (mcgrath et al., 2010).']	[('INCOMPLETE_EVIDENCE', 5), ('IMPORTANT_CONSIDERATION', 24), ('FULL_UNKNOWN', 170), ('INCOMPLETE_EVIDENCE', 196), ('INCOMPLETE_EVIDENCE', 211), ('SUPERFICIAL_RELATIONSHIP', 258), ('IMPORTANT_CONSIDERATION', 277)]	7	[('CHEBI_27300', 'vitamin D', 133, 'vitamin D'), ('UBERON_0001969', 'blood plasma', 153, 'blood spots'), ('GO_0007565', 'female pregnancy', 228, 'prenatal'), ('CHEBI_27300', 'vitamin D', 237, 'vitamin D')]
PMC3713405	7/2013	S133-PMC3713405	['the mechanism for HOW the developmental absence of Vitamin D MAY INFLUENCE Da Signaling in the Adult REMAINS UNKNOWN.']	[('EXPLICIT_QUESTION', 18), ('INCOMPLETE_EVIDENCE', 61), ('SUPERFICIAL_RELATIONSHIP', 65), ('FULL_UNKNOWN', 101)]	4	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('GO_0038162', 'erythropoietin-mediated signaling pathway', 75, 'DA signaling'), ('UBERON_0007023', 'adult organism', 95, 'adult')]
PMC3713405	7/2013	S157-PMC3713405	['HOW the absence (or presence) of Vitamin D COULD alter nurr1 levels REMAINS UNKNOWN.']	[('EXPLICIT_QUESTION', 0), ('INCOMPLETE_EVIDENCE', 43), ('FULL_UNKNOWN', 68)]	3	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D')]
PMC3739737	8/2013	S20-PMC3739737	['WHILE there is now a considerable body of research examining the IMPACT of developmental Vitamin D (dvd) deficiency on Brain outcomes, there is relatively LITTLE KNOWN about the IMPACT of Adult Vitamin D (avd) deficiency on Rodent behaviour.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 65), ('FULL_UNKNOWN', 155), ('SUPERFICIAL_RELATIONSHIP', 178)]	4	[('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('UBERON_0000955', 'brain', 119, 'brain'), ('UBERON_0007023', 'adult organism', 188, 'adult'), ('CHEBI_27300', 'vitamin D', 194, 'vitamin D'), ('NCBITaxon_33208', 'Metazoa', 224, 'rodent')]
PMC3798907	8/2013	S143-PMC3798907	['the mechanisms by which Vitamins E and C MEDIATED their COMPLEX EFFECTS on cbmc responses in THE CURRENT STUDY are UNCLEAR.']	[('SUPERFICIAL_RELATIONSHIP', 41), ('DIFFICULT_TASK', 56), ('SUPERFICIAL_RELATIONSHIP', 64), ('QUESTION_ANSWERED_BY_THIS_WORK', 93), ('FULL_UNKNOWN', 115)]	5	[('CHEBI_27300', 'vitamin D', 24, 'vitamins E'), ('CHEBI_18245', 'carboxylato group', 39, 'C'), ('PR_000004900', 'complement C3', 39, 'C')]
PMC3760821	9/2013	S165-PMC3760821	['in 2011, the uk scientific advisory committee on nutrition decided, based on NEW DATA, including the iom report of dietary reference values, that there is now SUFFICIENT evidence for an update on Vitamin D, which is expected june 2014[3].']	[('FULL_UNKNOWN', 77), ('FUTURE_WORK', 81), ('IMPORTANT_CONSIDERATION', 159), ('IMPORTANT_CONSIDERATION', 159)]	4	[('CHEBI_27300', 'vitamin D', 196, 'vitamin D')]
PMC3827489	10/2013	S22-PMC3827489	['ALTHOUGH Vitamin D deficiency IS KNOWN to be prevalent in Adults, epidemiologic data on the prevalence of Vitamin D deficiency are LACKING in korean infants, children, and adolescents.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 30), ('FULL_UNKNOWN', 131)]	3	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('UBERON_0007023', 'adult organism', 58, 'adults'), ('CHEBI_27300', 'vitamin D', 106, 'vitamin D')]
PMC3827489	10/2013	S48-PMC3827489	['HOWEVER, there are NO epidemiologic DATA comparing asians with whites or blacks with regard to Serum Vitamin D levels.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FULL_UNKNOWN', 19)]	2	[('UBERON_0001977', 'blood serum', 95, 'serum'), ('CHEBI_27300', 'vitamin D', 101, 'vitamin D')]
PMC3827489	10/2013	S100-PMC3827489	['it is NOT KNOWN, however, HOW much amount of Vitamin D supplementation is NEEDED for korean children and Pregnant women in order to maintain adequate concentrations of vitamin D. CONSIDERING the high prevalence of Vitamin D insufficiency or deficiency in koreans, ESPECIALLY children and adolscents6,22-24), this ISSUE NEEDS TO BE addressed URGENTLY by FUTURE STUDIES.']	[('FULL_UNKNOWN', 6), ('EXPLICIT_QUESTION', 26), ('IMPORTANT_CONSIDERATION', 74), ('INCOMPLETE_EVIDENCE', 179), ('IMPORTANT_CONSIDERATION', 264), ('PROBLEM_COMPLICATION', 313), ('IMPORTANT_CONSIDERATION', 319), ('IMPORTANT_CONSIDERATION', 341), ('FUTURE_WORK', 353)]	9	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('GO_0007565', 'female pregnancy', 105, 'pregnant'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 176, 'D'), ('CHEBI_27300', 'vitamin D', 214, 'vitamin D')]
PMC3873449	12/2013	S1-PMC3873449	['LITTLE IS KNOWN about Vitamin D status in chinese Pregnant women.']	[('FULL_UNKNOWN', 0)]	1	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('GO_0007565', 'female pregnancy', 50, 'pregnant')]
PMC3873449	12/2013	S36-PMC3873449	['also, LITTLE IS KNOWN about maternal FACTORS INFLUENCING Vitamin D status in chinese Pregnant women.']	[('FULL_UNKNOWN', 6), ('SUPERFICIAL_RELATIONSHIP', 37), ('SUPERFICIAL_RELATIONSHIP', 45)]	3	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('GO_0007565', 'female pregnancy', 85, 'pregnant')]
PMC3873449	12/2013	S177-PMC3873449	['higher amounts of Vitamin D MAY BE REQUIRED, THOUGH the precise dose REMAINS UNKNOWN.']	[('INCOMPLETE_EVIDENCE', 28), ('IMPORTANT_CONSIDERATION', 35), ('ANOMALY_CURIOUS_FINDING', 45), ('FULL_UNKNOWN', 69)]	4	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D')]
PMC3873449	12/2013	S188-PMC3873449	['HOWEVER, SINCE there is INSUFFICIENT DATA to evaluate the EFFECTIVENESS of Vitamin D supplementation during Pregnancy Vitamin D supplementation as routine Antenatal care is YET TO BE DETERMINED.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBLEM_COMPLICATION', 9), ('INCOMPLETE_EVIDENCE', 24), ('SUPERFICIAL_RELATIONSHIP', 58), ('FULL_UNKNOWN', 173)]	5	[('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('GO_0007565', 'female pregnancy', 108, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 118, 'vitamin D'), ('GO_0007567', 'parturition', 155, 'antenatal')]
PMC4045304	2/2014	S275-PMC4045304	['recruitment for an OPEN LABEL clinical trial TO EVALUATE large doses of Vitamin D in autistic children as a new treatment modality, with target 25-Hydroxyvitamin D3 levels of 80\u2009ng/ml is UNDERWAY [99].']	[('FULL_UNKNOWN', 19), ('QUESTION_ANSWERED_BY_THIS_WORK', 45), ('INCOMPLETE_EVIDENCE', 187)]	3	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('CHEBI_63991', '15-epi-lipoxin B4', 144, '25-hydroxyvitamin D3'), ('PR_000001177', 'D(2) dopamine receptor', 162, 'D3')]
PMC3973641	4/2014	S35-PMC3973641	['DESPITE these STUDIES, LITTLE IS KNOWN about the EFFECTS of Vitamin B deficiency in fetuses and neonates on their Methionine-Homocysteine Metabolism programming and subsequent consequences to the Brain.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 14), ('FULL_UNKNOWN', 23), ('SUPERFICIAL_RELATIONSHIP', 49)]	5	[('CHEBI_27300', 'vitamin D', 60, 'vitamin B'), ('GO_0006555', 'methionine metabolic process', 114, 'methionine- ... metabolism'), ('CHEBI_17088', 'monoacyl-sn-glycerol 3-phosphate', 125, 'homocysteine'), ('UBERON_0000955', 'brain', 196, 'brain')]
PMC4071151	6/2014	S84-PMC4071151	['the precise pathogenesis of these conditions REMAINS UNKNOWN, BUT non-Genetic and non-infectious causes HAVE BEEN POSTULATED and include maternal Vitamin A deficiency [25].']	[('FULL_UNKNOWN', 45), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 62), ('INCOMPLETE_EVIDENCE', 104), ('INCOMPLETE_EVIDENCE', 114)]	4	[('SO_0000704', 'gene', 70, 'genetic'), ('CHEBI_27300', 'vitamin D', 146, 'vitamin A')]
PMC4072587	6/2014	S1-PMC4072587	['it has an IMPORTANT ROLE in Bone Homeostasis, Brain Development and Modulation Of the Immune System and YET the IMPACT of Antenatal Vitamin D deficiency on infant outcomes is POORLY UNDERSTOOD.']	[('IMPORTANT_CONSIDERATION', 10), ('SUPERFICIAL_RELATIONSHIP', 20), ('ANOMALY_CURIOUS_FINDING', 104), ('SUPERFICIAL_RELATIONSHIP', 112), ('FULL_UNKNOWN', 175), ('PROBABLE_UNDERSTANDING', 182)]	6	[('GO_0055064', 'chloride ion homeostasis', 28, 'bone homeostasis'), ('GO_0007420', 'brain development', 46, 'brain development'), ('UBERON_0000955', 'brain', 46, 'brain'), ('GO_0002022', 'detection of dietary excess', 68, 'modulation of ... immune system'), ('UBERON_0002405', 'immune system', 86, 'immune system'), ('GO_0007567', 'parturition', 122, 'antenatal'), ('CHEBI_27300', 'vitamin D', 132, 'vitamin D')]
PMC4072587	6/2014	S24-PMC4072587	['the ROLE of Vitamin D deficiency during Pregnancy on longer term infant outcomes, PARTICULARLY with regard to early Childhood development is UNCLEAR.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('IMPORTANT_CONSIDERATION', 82), ('FULL_UNKNOWN', 141)]	3	[('CHEBI_27300', 'vitamin D', 12, 'vitamin D'), ('GO_0007565', 'female pregnancy', 40, 'pregnancy'), ('UBERON_0013628', 'pollical pad', 116, 'childhood')]
PMC4113768	7/2014	S169-PMC4113768	['however, the RELATIONSHIP between Vitamin D RELATED measures and survival amongst Colorectal cancer patients REMAINS UNCLEAR.']	[('SUPERFICIAL_RELATIONSHIP', 13), ('SUPERFICIAL_RELATIONSHIP', 44), ('FULL_UNKNOWN', 109)]	3	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('UBERON_0012652', 'colorectum', 82, 'colorectal')]
PMC4113768	7/2014	S321-PMC4113768	['AT PRESENT, THERE ARE NO DATA about Vitamin D (vd) supplementation, osteopenia and bone Mineral density (bmd) in Adult burn patients.']	[('INCOMPLETE_EVIDENCE', 0), ('FULL_UNKNOWN', 12)]	2	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('CHEBI_46662', 'mineral', 88, 'mineral'), ('UBERON_0007023', 'adult organism', 113, 'adult')]
PMC4113768	7/2014	S579-PMC4113768	['background: SEVERAL STUDIES have investigated the ASSOCIATION between Vitamin D in Pregnancy and Birth weight, but the conclusion of the studies are NOT CLEAR.']	[('INCOMPLETE_EVIDENCE', 12), ('SUPERFICIAL_RELATIONSHIP', 50), ('FULL_UNKNOWN', 149)]	3	[('CHEBI_27300', 'vitamin D', 70, 'vitamin D'), ('GO_0007565', 'female pregnancy', 83, 'pregnancy'), ('GO_0007567', 'parturition', 97, 'birth')]
PMC4113768	7/2014	S599-PMC4113768	['this NOVEL FINDING SUPPORTED an A priori HYPOTHESIS that low uvb exposure and low Vitamin D status have an etiologic ROLE in Food allergy.']	[('FULL_UNKNOWN', 5), ('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 19), ('FUTURE_WORK', 32), ('INCOMPLETE_EVIDENCE', 41), ('SUPERFICIAL_RELATIONSHIP', 117)]	6	[('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('CHEBI_33290', 'food', 125, 'food')]
PMC4113768	7/2014	S635-PMC4113768	['to date, LITTLE IS KNOWN about the EFFECT of low Vitamin D status at Birth on body composition during the Neonatal Period.']	[('FULL_UNKNOWN', 9), ('SUPERFICIAL_RELATIONSHIP', 35)]	2	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('GO_0007567', 'parturition', 69, 'birth'), ('UBERON_0007221', 'neonate stage', 106, 'neonatal period')]
PMC4113768	7/2014	S825-PMC4113768	['there is wide VARIATION in the content and availability of Vitamin D supplements, and DESPITE nice guidelines on Vitamin D supplementation implementation REMAINS UNCERTAIN.']	[('DIFFICULT_TASK', 14), ('ANOMALY_CURIOUS_FINDING', 86), ('INCOMPLETE_EVIDENCE', 154), ('FULL_UNKNOWN', 162)]	4	[('CHEBI_27300', 'vitamin D', 59, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 113, 'vitamin D')]
PMC4113768	7/2014	S917-PMC4113768	['what is LESS CLEAR is the RELEVANT SIGNIFICANCE of Vitamin D deficiency to Tooth Development, at a population level, in the uk at present.']	[('FULL_UNKNOWN', 8), ('INCOMPLETE_EVIDENCE', 8), ('IMPORTANT_CONSIDERATION', 26), ('IMPORTANT_CONSIDERATION', 35), ('SUPERFICIAL_RELATIONSHIP', 35)]	5	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('GO_0048538', 'thymus development', 75, 'tooth development'), ('UBERON_0001091', 'calcareous tooth', 75, 'tooth')]
PMC4113768	7/2014	S958-PMC4113768	['studies investigating the prevalence and DETERMINANTS of Vitamin D deficiency among copd patients in the uk are LACKING.']	[('SUPERFICIAL_RELATIONSHIP', 41), ('FULL_UNKNOWN', 112)]	2	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D')]
PMC4113768	7/2014	S1375-PMC4113768	['HOWEVER the mechanism is UNCLEAR, with studies examining the RELATIONSHIP between Vitamin D and Insulin resistance showing CONFLICTING results.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FULL_UNKNOWN', 25), ('SUPERFICIAL_RELATIONSHIP', 61), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 123)]	4	[('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('PR_000045358', 'insulin family protein', 96, 'insulin')]
PMC4113768	7/2014	S1392-PMC4113768	['there is NO INFORMATION about Vitamin D: s EFFECT on Brain Steroidogenesis.']	[('FULL_UNKNOWN', 9), ('SUPERFICIAL_RELATIONSHIP', 43)]	2	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('UBERON_0000955', 'brain', 53, 'brain'), ('GO_0001501', 'skeletal system development', 59, 'steroidogenesis')]
PMC4113768	7/2014	S1445-PMC4113768	['suboptimal Vitamin D status APPEARS TO increase an Individual’s RISK of developing cvd, ALTHOUGH the OPTIMAL level REQUIRED is UNCLEAR and the results of intervention studies REMAIN HETEROGENEOUS and INCONCLUSIVE.']	[('ANOMALY_CURIOUS_FINDING', 28), ('IMPORTANT_CONSIDERATION', 64), ('ANOMALY_CURIOUS_FINDING', 88), ('IMPORTANT_CONSIDERATION', 101), ('IMPORTANT_CONSIDERATION', 115), ('FULL_UNKNOWN', 127), ('INCOMPLETE_EVIDENCE', 175), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 182), ('DIFFICULT_TASK', 182), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 200)]	10	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('NCBITaxon_1', 'root', 51, 'individual')]
PMC4113768	7/2014	S1540-PMC4113768	['background: Vitamin D IS KNOWN to AFFECT Immune function; HOWEVER it is UNCERTAIN IF Vitamin D CAN alter the Immune Response towards the persistent herpesviruses, Ebv and Cmv.']	[('INCOMPLETE_EVIDENCE', 22), ('SUPERFICIAL_RELATIONSHIP', 34), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 58), ('FULL_UNKNOWN', 72), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 82), ('INCOMPLETE_EVIDENCE', 95)]	6	[('CHEBI_28384', 'vitamin K', 12, 'Vitamin D'), ('UBERON_0002405', 'immune system', 41, 'immune'), ('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('GO_0006955', 'immune response', 109, 'immune response'), ('UBERON_0002405', 'immune system', 109, 'immune'), ('NCBITaxon_10088', 'Mus <genus>', 163, 'EBV'), ('NCBITaxon_10088', 'Mus <genus>', 171, 'CMV')]
PMC4113768	7/2014	S1598-PMC4113768	['it is STILL UNCLEAR WHETHER the altered 25(Oh)D levels SEEN AFFECT the active Vitamin D Metabolite 1,25(Oh)2D and health outcomes (such as bone mineralization).']	[('FULL_UNKNOWN', 6), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 20), ('INCOMPLETE_EVIDENCE', 55), ('SUPERFICIAL_RELATIONSHIP', 60)]	4	[('CHEBI_71657', 'versiconol acetate', 40, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('CHEBI_39382', 'flufenoxuron', 88, 'metabolite'), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 101, '25(OH)2D')]
PMC4113768	7/2014	S1642-PMC4113768	['low-dose Vitamin D supplementation is already RECOMMENDED in older Adults for PREVENTION of fractures and falls, but clinical trials investigating WHETHER higher doses COULD provide additional protection against ari are LACKING.']	[('FUTURE_WORK', 46), ('SUPERFICIAL_RELATIONSHIP', 78), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 147), ('INCOMPLETE_EVIDENCE', 168), ('FULL_UNKNOWN', 220)]	5	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('UBERON_0007023', 'adult organism', 67, 'adults')]
PMC4113768	7/2014	S1709-PMC4113768	['data on the prevalence of Vitamin D deficiency and its clinical CORRELATES among asthma patients in the uk are LACKING.']	[('SUPERFICIAL_RELATIONSHIP', 64), ('FULL_UNKNOWN', 111)]	2	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D')]
PMC4113768	7/2014	S2024-PMC4113768	['HOWEVER, a causal RELATIONSHIP between Vitamin D status and cardiovascular disease (cvd) risk factors, such as hypertension or an atherogenic Lipid profile, has NOT BEEN ESTABLISHED.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 18), ('FULL_UNKNOWN', 161)]	3	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D'), ('CHEBI_18059', 'lipid', 142, 'lipid')]
PMC4113768	7/2014	S2097-PMC4113768	['background: ACCUMULATING EVIDENCE SUGGESTS that Vitamin D deficiency MAY BE a risk FACTOR for Cardiovascular disease BUT its ASSOCIATION with the risk of stroke is UNCERTAIN.']	[('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 34), ('INCOMPLETE_EVIDENCE', 69), ('SUPERFICIAL_RELATIONSHIP', 83), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 117), ('SUPERFICIAL_RELATIONSHIP', 125), ('FULL_UNKNOWN', 164)]	7	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('UBERON_0004535', 'cardiovascular system', 94, 'cardiovascular')]
PMC4113768	7/2014	S2143-PMC4113768	['the ROLE of these pathways in Vitamin D deficiency induced muscle wasting has NOT BEEN STUDIED.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('FULL_UNKNOWN', 78)]	2	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D')]
PMC4113768	7/2014	S2421-PMC4113768	['conclusions: in addition to the mechanistic INSIGHTS afforded by ASSOCIATIONS between maternal free 25(oh)-Vitamin D index, rxra methylation in Umbilical Cord dna, and childhood bmc, such epigenetic marks in early Life MIGHT represent NOVEL BIOMARKERS for adverse bone outcomes in the offspring.']	[('INCOMPLETE_EVIDENCE', 44), ('SUPERFICIAL_RELATIONSHIP', 65), ('INCOMPLETE_EVIDENCE', 219), ('FULL_UNKNOWN', 235), ('SUPERFICIAL_RELATIONSHIP', 241)]	5	[('CHEBI_27300', 'vitamin D', 107, 'vitamin D'), ('UBERON_0002331', 'umbilical cord', 144, 'umbilical cord'), ('UBERON_0000104', 'life cycle', 214, 'life')]
PMC4113768	7/2014	S2469-PMC4113768	['Vitamin D and tuberculosis in Adults in selected districts in the provinces baghlan, bamyan and badakhshan, afghanistan\n\nsarin, p.; manaseki-holland, s.; duffy, j.c.\nbackground: EVIDENCE for an ASSOCIATION between Vitamin D and tuberculosis (tb) is INCONSISTENT and NO previous STUDIES HAVE BEEN conducted in afghanistan.']	[('INCOMPLETE_EVIDENCE', 178), ('SUPERFICIAL_RELATIONSHIP', 194), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 249), ('FULL_UNKNOWN', 266), ('INCOMPLETE_EVIDENCE', 278), ('INCOMPLETE_EVIDENCE', 286)]	6	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 0, 'Vitamin'), ('UBERON_0007023', 'adult organism', 30, 'Adults'), ('CHEBI_27300', 'vitamin D', 214, 'vitamin D')]
PMC4113768	7/2014	S2638-PMC4113768	['THERE IS EVIDENCE TO SUPPORT a ROLE for Vitamin D in muscle function, YET LITTLE IS KNOWN about the ROLE of Antenatal 25(Oh)D exposure in programming muscle development.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 31), ('ANOMALY_CURIOUS_FINDING', 70), ('FULL_UNKNOWN', 74), ('SUPERFICIAL_RELATIONSHIP', 100)]	5	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('GO_0007567', 'parturition', 108, 'antenatal'), ('CHEBI_71657', 'versiconol acetate', 118, '25(OH)D')]
PMC4113768	7/2014	S2725-PMC4113768	['OF CONCERN is that People taking 10,000 iu/day or less are SHOWING high to toxic levels of 25Ohd, ALTHOUGH we do NOT KNOW HOW many, if any, of these users are displaying signs of Vitamin D toxicity.']	[('ANOMALY_CURIOUS_FINDING', 0), ('PROBLEM_COMPLICATION', 3), ('INCOMPLETE_EVIDENCE', 59), ('ANOMALY_CURIOUS_FINDING', 98), ('FULL_UNKNOWN', 113), ('EXPLICIT_QUESTION', 122)]	6	[('NCBITaxon_10088', 'Mus <genus>', 19, 'people'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 91, '25OHD'), ('CHEBI_27300', 'vitamin D', 179, 'vitamin D')]
PMC4113768	7/2014	S2821-PMC4113768	['dietary Intakes of Vitamin D were recorded using a 4-day weighed Food record (wfr) and the NEWLY developed ffq.']	[('FULL_UNKNOWN', 91)]	1	[('GO_0007631', 'feeding behavior', 8, 'intakes'), ('CHEBI_27300', 'vitamin D', 19, 'vitamin D'), ('CHEBI_33290', 'food', 65, 'food')]
PMC4113768	7/2014	S3249-PMC4113768	['to date, there is NO STUDY investigating the EFFECT of maternal Vitamin D deficiency on the Human fetus.']	[('FULL_UNKNOWN', 18), ('SUPERFICIAL_RELATIONSHIP', 45)]	2	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 92, 'human')]
PMC4113768	7/2014	S3268-PMC4113768	['multi-centre trials of Vitamin D supplementation for PREVENTION of exacerbation and uri in patients with less SEVERE copd are LACKING.']	[('SUPERFICIAL_RELATIONSHIP', 53), ('IMPORTANT_CONSIDERATION', 110), ('FULL_UNKNOWN', 126)]	3	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D')]
PMC4113768	7/2014	S3336-PMC4113768	['; xiao, j.p.; zang, j.; fei, x.; zhu, y.; pei, j.j.\nbackground: thereare LITTLE DATA about the status of Vitamin D in Pregnant women and their newborns in china, and we EVALUATED the Vitamin D status in Pregnant women and their newborns all the year around in wuxi city (north latitude 32°), jiangsu province, china.']	[('FULL_UNKNOWN', 73), ('INCOMPLETE_EVIDENCE', 73), ('QUESTION_ANSWERED_BY_THIS_WORK', 169)]	3	[('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('GO_0007565', 'female pregnancy', 118, 'pregnant'), ('CHEBI_27300', 'vitamin D', 183, 'vitamin D'), ('GO_0007565', 'female pregnancy', 203, 'pregnant')]
PMC4169453	9/2014	S19-PMC4169453	['HOWEVER, the OPTIMAL Vitamin D intake as well as OPTIMAL 25(Oh)D level for Lactating women (BASED ON ESTIMATED maternal NEEDS) STILL REMAINS NOT fully ESTABLISHED, or AT LEAST not accepted worldwide.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 13), ('IMPORTANT_CONSIDERATION', 49), ('INCOMPLETE_EVIDENCE', 92), ('SUPERFICIAL_RELATIONSHIP', 92), ('INCOMPLETE_EVIDENCE', 101), ('IMPORTANT_CONSIDERATION', 120), ('IMPORTANT_CONSIDERATION', 127), ('FULL_UNKNOWN', 133), ('PROBABLE_UNDERSTANDING', 167)]	10	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 57, '25(OH)D'), ('GO_0007594', 'puparial adhesion', 75, 'lactating')]
PMC4169453	9/2014	S27-PMC4169453	['TO THE BEST OF OUR KNOWLEDGE, bone mass and body composition have NOT BEEN EXAMINED in Lactating women and their offspring BASED ON the level of maternal Vitamin D Intake in randomized control trials.']	[('PROBABLE_UNDERSTANDING', 0), ('FULL_UNKNOWN', 66), ('SUPERFICIAL_RELATIONSHIP', 123)]	3	[('GO_0007594', 'puparial adhesion', 87, 'lactating'), ('CHEBI_27300', 'vitamin D', 154, 'vitamin D'), ('GO_0007631', 'feeding behavior', 164, 'intake')]
PMC4380518	9/2014	S7-PMC4380518	['introduction\nPerinatal health outcomes VARY dramatically by race in the united states.1african american women develop Preeclampsia more OFTEN than their white counterparts2and are more LIKELY to develop preterm labor.3the result is that black infants are 60% more LIKELY BE preterm and four times more LIKELY to die due to prematurity than white infants.1BECAUSE of less efficient Vitamin D Synthesis in the skin of darker Pigmented Individuals, african americans are at higher RISK than white americans of Vitamin D deficiency.4,5black women are also more LIKELY than white women to be overweight or obese6which is of CONCERN BECAUSE obesity is another RISK FACTOR for Vitamin D deficiency5,7and poor Perinatal outcomes.8in OBSERVATIONAL studies, 25-Hydroxyvitamin D (25[Oh]D) levels HAVE BEEN SHOWN to be ASSOCIATED with higher risk of several adverse Perinatal outcomes including Gestational diabetes9,10, preeclampsia,11preterm Birth12And small-for-Gestational age status.13,14,15,16,17BECAUSE of the PAUCITY of Vitamin D trial data with respect to Perinatal outcomes, WHETHER DIFFERENCES in Vitamin D status during Pregnancy explains or partially explains Perinatal DISPARITIES is PLAUSIBLE18but REMAINS UNKNOWN.']	[('DIFFICULT_TASK', 39), ('PROBABLE_UNDERSTANDING', 136), ('PROBABLE_UNDERSTANDING', 185), ('PROBABLE_UNDERSTANDING', 264), ('PROBABLE_UNDERSTANDING', 302), ('PROBABLE_UNDERSTANDING', 355), ('IMPORTANT_CONSIDERATION', 478), ('PROBABLE_UNDERSTANDING', 557), ('PROBLEM_COMPLICATION', 619), ('PROBABLE_UNDERSTANDING', 627), ('SUPERFICIAL_RELATIONSHIP', 654), ('INCOMPLETE_EVIDENCE', 725), ('INCOMPLETE_EVIDENCE', 785), ('SUPERFICIAL_RELATIONSHIP', 807), ('PROBABLE_UNDERSTANDING', 990), ('INCOMPLETE_EVIDENCE', 1005), ('EXPLICIT_QUESTION', 1073), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1081), ('IMPORTANT_CONSIDERATION', 1171), ('INCOMPLETE_EVIDENCE', 1186), ('FULL_UNKNOWN', 1201)]	21	[('GO_0036268', 'swimming', 13, 'Perinatal'), ('UBERON_0012101', 'perinatal stage', 13, 'Perinatal'), ('GO_0007128', 'meiotic prophase I', 118, 'preeclampsia'), ('CHEBI_27300', 'vitamin D', 381, 'vitamin D'), ('GO_0042368', 'vitamin D biosynthetic process', 381, 'vitamin D synthesis'), ('CHEBI_26130', 'biological pigment', 423, 'pigmented'), ('NCBITaxon_1', 'root', 433, 'individuals'), ('CHEBI_27300', 'vitamin D', 507, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 670, 'vitamin D'), ('GO_0036268', 'swimming', 702, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 702, 'perinatal'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 748, '25-hydroxyvitamin D'), ('CHEBI_15643', '(6R)-6-(L-erythro-1,2-dihydroxypropyl)-7,8-dihydro-6H-pterin', 769, '25[OH]D'), ('GO_0036268', 'swimming', 854, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 854, 'perinatal'), ('GO_0007565', 'female pregnancy', 883, 'gestational'), ('GO_0007594', 'puparial adhesion', 932, 'birth12and'), ('GO_0007565', 'female pregnancy', 953, 'gestational'), ('CHEBI_27300', 'vitamin D', 1016, 'vitamin D'), ('GO_0036268', 'swimming', 1053, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 1053, 'perinatal'), ('CHEBI_27300', 'vitamin D', 1096, 'vitamin D'), ('GO_0007565', 'female pregnancy', 1120, 'pregnancy'), ('GO_0036268', 'swimming', 1161, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 1161, 'perinatal')]
PMC4380518	9/2014	S8-PMC4380518	['furthermore, WHILE multivitamin intake HAS BEEN SHOWN to VARY by race,19it REMAINS UNKNOWN WHETHER multivitamin intake improves Vitamin D status among the HIGHEST RISK groups (african americans and overweight/obese) during Pregnancy.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 13), ('INCOMPLETE_EVIDENCE', 39), ('DIFFICULT_TASK', 57), ('FULL_UNKNOWN', 75), ('EXPLICIT_QUESTION', 91), ('IMPORTANT_CONSIDERATION', 155)]	6	[('CHEBI_27300', 'vitamin D', 128, 'vitamin D'), ('GO_0007565', 'female pregnancy', 223, 'pregnancy')]
PMC4380518	9/2014	S58-PMC4380518	['we had NO INFORMATION as to the duration of use or the Vitamin D dose in the pnv which typically is 400–600 iu per tablet, BUT can VARY.']	[('FULL_UNKNOWN', 7), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 123), ('DIFFICULT_TASK', 131)]	3	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D')]
PMC4380518	9/2014	S59-PMC4380518	['we DID NOT HAVE DATA on WHETHER women were taking separate Calcium or Vitamin D supplements beyond what is contained in pnvs.']	[('FULL_UNKNOWN', 3), ('EXPLICIT_QUESTION', 24)]	2	[('CHEBI_22313', 'alkaline earth metal atom', 59, 'calcium'), ('CHEBI_27300', 'vitamin D', 70, 'vitamin D')]
PMC4380518	9/2014	S62-PMC4380518	['we also LACKED DATA on Vitamin D binding protein which MAY DIFFER by race/ethnicity and COULD AFFECT the ASSOCIATION between pnv use and 25(Oh)D measured in the Plasma.']	[('FULL_UNKNOWN', 8), ('INCOMPLETE_EVIDENCE', 55), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 59), ('INCOMPLETE_EVIDENCE', 88), ('SUPERFICIAL_RELATIONSHIP', 94), ('SUPERFICIAL_RELATIONSHIP', 105)]	6	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 137, '25(OH)D'), ('UBERON_0001969', 'blood plasma', 161, 'plasma')]
PMC4329404	10/2014	S0-PMC4329404	['Vitamin D deficiency induces th2 skewing and Eosinophilia in neonatal allergic Airways disease\n\nabstract\n\nbackground\nASSOCIATIONS between Vitamin D status and childhood asthma are increasingly REPORTED, but direct causation and mechanisms UNDERLYING an EFFECT remain UNKNOWN.']	[('SUPERFICIAL_RELATIONSHIP', 117), ('INCOMPLETE_EVIDENCE', 193), ('SUPERFICIAL_RELATIONSHIP', 239), ('SUPERFICIAL_RELATIONSHIP', 253), ('FULL_UNKNOWN', 267)]	5	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CL_0000771', 'eosinophil', 45, 'eosinophilia'), ('UBERON_0001005', 'respiratory airway', 79, 'airways'), ('CHEBI_27300', 'vitamin D', 138, 'vitamin D')]
PMC4329404	10/2014	S181-PMC4329404	['a PROMISING ROLE of Vitamin D supplementation in children with asthma is the POTENTIAL of minimizing the development of a very early feature of Airway Remodelling, increased thickness of the reticular basement membrane (41,42), which would incorporate a NOVEL therapeutic target in asthma.']	[('PROBABLE_UNDERSTANDING', 2), ('SUPERFICIAL_RELATIONSHIP', 12), ('INCOMPLETE_EVIDENCE', 77), ('FULL_UNKNOWN', 254)]	4	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('GO_0003313', 'heart rudiment development', 144, 'airway remodelling'), ('UBERON_0001005', 'respiratory airway', 144, 'airway')]
PMC4251419	12/2014	S71-PMC4251419	['YET, DESPITE PLAUSIBLE immunological pathways whereby Vitamin D (through stimulation of tregsand dampening of T Helper Type 1 over-reactivity) COULD diminish the risk of multiple sclerosis or disease activity, Vitamin D supplementation trials HAVE SHOWN immunological [42] and radiological [43], BUT NOT CLINICAL, benefit for People with multiple sclerosis.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 5), ('ANOMALY_CURIOUS_FINDING', 5), ('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 143), ('INCOMPLETE_EVIDENCE', 243), ('FULL_UNKNOWN', 296), ('ANOMALY_CURIOUS_FINDING', 300)]	9	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('CL_0002061', 'T-helper 9 cell', 110, 'T helper'), ('PR_000016293', 'protein-glutamine gamma-glutamyltransferase 2', 110, 'T helper type 1'), ('CHEBI_27300', 'vitamin D', 210, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 326, 'people')]
PMC4256222	12/2014	S21-PMC4256222	['TO OUR KNOWLEDGE, NO earlier STUDIES have focused on the INFLUENCE of Vitamin D status during Pregnancy on incident occurrences of offspring bone fractures during childhood.']	[('PROBABLE_UNDERSTANDING', 0), ('FULL_UNKNOWN', 18), ('SUPERFICIAL_RELATIONSHIP', 57)]	3	[('CHEBI_27300', 'vitamin D', 70, 'vitamin D'), ('GO_0007565', 'female pregnancy', 94, 'pregnancy')]
PMC4302429	1/2015	S168-PMC4302429	['the IMPORTANCE of Vitamin D for the resistance to infections HAS long BEEN appreciated but POORLY UNDERSTOOD.']	[('IMPORTANT_CONSIDERATION', 4), ('INCOMPLETE_EVIDENCE', 61), ('FULL_UNKNOWN', 91), ('PROBABLE_UNDERSTANDING', 98)]	4	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D')]
PMC4302429	1/2015	S174-PMC4302429	['the INFLUENCE of Vitamin D on the course of Cns infections is NOT KNOWN.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('FULL_UNKNOWN', 62)]	2	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('UBERON_0001017', 'central nervous system', 44, 'CNS')]
PMC4383226	2/2015	S15-PMC4383226	['it is LESS CLEAR WHETHER vaccines OR Vitamin A have antimalarial EFFECTS in Humans.']	[('FULL_UNKNOWN', 6), ('INCOMPLETE_EVIDENCE', 6), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 17), ('SUPERFICIAL_RELATIONSHIP', 65)]	4	[('CHEBI_27300', 'vitamin D', 37, 'vitamin A'), ('NCBITaxon_9606', 'Homo sapiens', 76, 'humans')]
PMC4383226	2/2015	S31-PMC4383226	['SEVERAL STUDIES have SUGGESTED that childhood immunization MAY confer non-specific health EFFECTS beyond targeted diseases, BUT the IMPACT of standard vaccination and Vitamin A supplementation on malaria Infection is UNCLEAR.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 21), ('INCOMPLETE_EVIDENCE', 59), ('SUPERFICIAL_RELATIONSHIP', 90), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 124), ('SUPERFICIAL_RELATIONSHIP', 132), ('FULL_UNKNOWN', 217)]	7	[('CHEBI_27300', 'vitamin D', 167, 'vitamin A'), ('GO_0007586', 'digestion', 204, 'infection')]
PMC4383226	2/2015	S43-PMC4383226	['the underlying mechanisms of these EFFECTS are UNCLEAR, ALTHOUGH it HAS BEEN THEORIZED that Vitamin A MAY act as Adjuvant to dtp, which is POSTULATED to cause DETRIMENTAL EFFECTS (jorgensen et al., 2011).']	[('SUPERFICIAL_RELATIONSHIP', 35), ('FULL_UNKNOWN', 47), ('ANOMALY_CURIOUS_FINDING', 56), ('INCOMPLETE_EVIDENCE', 68), ('INCOMPLETE_EVIDENCE', 77), ('PROBABLE_UNDERSTANDING', 77), ('INCOMPLETE_EVIDENCE', 102), ('INCOMPLETE_EVIDENCE', 139), ('IMPORTANT_CONSIDERATION', 159), ('SUPERFICIAL_RELATIONSHIP', 171)]	10	[('CHEBI_27300', 'vitamin D', 92, 'vitamin A'), ('CHEBI_60809', 'adjuvant', 113, 'adjuvant')]
PMC4383226	2/2015	S103-PMC4383226	['it is UNCLEAR HOW Vitamin A COULD INTERACT with G6Pd to INFLUENCE the risk of malaria infection; the ONLY literature discussion regarding Vitamin A and G6Pd is LIMITED to Animal FINDINGS on Adipose and Lipogenic activities (higueret et al., 1989;arana et al., 2008).']	[('FULL_UNKNOWN', 6), ('EXPLICIT_QUESTION', 14), ('INCOMPLETE_EVIDENCE', 28), ('SUPERFICIAL_RELATIONSHIP', 34), ('SUPERFICIAL_RELATIONSHIP', 56), ('INCOMPLETE_EVIDENCE', 101), ('INCOMPLETE_EVIDENCE', 160), ('INCOMPLETE_EVIDENCE', 178)]	8	[('CHEBI_27300', 'vitamin D', 18, 'vitamin A'), ('PR_000008060', 'glycine N-acyltransferase-like protein 1', 48, 'G6PD'), ('CHEBI_27300', 'vitamin D', 138, 'vitamin A'), ('PR_000008060', 'glycine N-acyltransferase-like protein 1', 152, 'G6PD'), ('NCBITaxon_33208', 'Metazoa', 171, 'animal'), ('UBERON_2000251', 'adipose fin', 190, 'adipose'), ('GO_0008610', 'lipid biosynthetic process', 202, 'lipogenic')]
PMC4340999	3/2015	S94-PMC4340999	['for latitudes with distinct seasonal changes in availability of uvb, there is a WELL-DOCUMENTED seasonal cycle in Vitamin D status, with a maximum in late summer and a minimum in late winter.32low Vitamin D during Gestation MAY STRONGLY INFLUENCE susceptibility to obesity later in Life.33\nhowever, relatively LITTLE IS KNOWN about the critical period of fetal growth at which low Vitamin D is of particular IMPORTANCE.']	[('PROBABLE_UNDERSTANDING', 80), ('INCOMPLETE_EVIDENCE', 85), ('INCOMPLETE_EVIDENCE', 224), ('PROBABLE_UNDERSTANDING', 228), ('SUPERFICIAL_RELATIONSHIP', 237), ('FULL_UNKNOWN', 310), ('IMPORTANT_CONSIDERATION', 408)]	7	[('CHEBI_27300', 'vitamin D', 114, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 197, 'vitamin D'), ('GO_0007565', 'female pregnancy', 214, 'gestation'), ('UBERON_0000104', 'life cycle', 282, 'life'), ('CHEBI_27300', 'vitamin D', 381, 'vitamin D')]
PMC4340999	3/2015	S101-PMC4340999	['month of Birth and three trimesters in relation to the calendar month of year, season, and the level of uvb radiation\nto OUR KNOWLEDGE, NO PREVIOUS STUDY has examined the RELATIONSHIP between Prenatal Vitamin D status and ll.']	[('PROBABLE_UNDERSTANDING', 121), ('FULL_UNKNOWN', 136), ('SUPERFICIAL_RELATIONSHIP', 171)]	3	[('GO_0007567', 'parturition', 9, 'birth'), ('GO_0007565', 'female pregnancy', 192, 'prenatal'), ('CHEBI_27300', 'vitamin D', 201, 'vitamin D')]
PMC4377870	3/2015	S103-PMC4377870	['the CONFLICTING results from these supplementation studies are LIKELY to be INFLUENCED by baseline Tissue levels of Vitamin E [72], with Α-Tocopherol supplementation leading to improved Lung function and wheeze in europe, where Γ-Tocopherol levels are low [78,79,80], BUT NOT in the us, where γ-Tocopherol Intake is high due to Soybean oil Consumption [81,82,83].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 4), ('PROBABLE_UNDERSTANDING', 63), ('SUPERFICIAL_RELATIONSHIP', 76), ('FULL_UNKNOWN', 268), ('ANOMALY_CURIOUS_FINDING', 272)]	5	[('UBERON_0000479', 'tissue', 99, 'tissue'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin E'), ('CHEBI_27725', 'butin', 137, 'α-tocopherol'), ('UBERON_0002048', 'lung', 186, 'lung'), ('CHEBI_27725', 'butin', 228, 'γ-tocopherol'), ('CHEBI_27013', 'tocopherol', 295, 'tocopherol'), ('GO_0007631', 'feeding behavior', 306, 'intake'), ('CHEBI_36933', 'oxygen-19 atom', 328, 'soybean'), ('GO_0007631', 'feeding behavior', 340, 'consumption')]
PMC4377870	3/2015	S137-PMC4377870	['Vitamin D\nepidemiological studies SHOW PROMISING ASSOCIATIONS between Vitamin D and Lung health; HOWEVER the mechanisms responsible for these EFFECTS are POORLY UNDERSTOOD.']	[('INCOMPLETE_EVIDENCE', 34), ('PROBABLE_UNDERSTANDING', 39), ('SUPERFICIAL_RELATIONSHIP', 49), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 97), ('SUPERFICIAL_RELATIONSHIP', 142), ('FULL_UNKNOWN', 154)]	6	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 0, 'Vitamin'), ('CHEBI_27300', 'vitamin D', 70, 'vitamin D'), ('UBERON_0002048', 'lung', 84, 'lung')]
PMC4377896	3/2015	S148-PMC4377896	['this MAY BE attributable to the synergistic EFFECTS of Food [34] and ASSOCIATED with fish being a source of OTHER Nutrients which are IMPORTANT for infant development such as Iodine and Vitamin D. presently, there HAVE BEEN NO randomised control TRIALS examining Neurocognitive outcomes ASSOCIATED with Prenatal multivitamin use and infant Neurodevelopment, and these are UNLIKELY to occur given ethical IMPLICATIONS of such [35].']	[('INCOMPLETE_EVIDENCE', 5), ('SUPERFICIAL_RELATIONSHIP', 44), ('SUPERFICIAL_RELATIONSHIP', 69), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 108), ('IMPORTANT_CONSIDERATION', 134), ('INCOMPLETE_EVIDENCE', 214), ('FULL_UNKNOWN', 224), ('SUPERFICIAL_RELATIONSHIP', 287), ('PROBABLE_UNDERSTANDING', 372), ('IMPORTANT_CONSIDERATION', 404)]	10	[('CHEBI_33290', 'food', 55, 'food'), ('CHEBI_33284', 'nutrient', 114, 'nutrients'), ('CHEBI_24859', 'iodine atom', 175, 'iodine'), ('CHEBI_27300', 'vitamin D', 186, 'vitamin D'), ('GO_0050905', 'neuromuscular process', 263, 'neurocognitive'), ('GO_0007565', 'female pregnancy', 303, 'prenatal'), ('GO_0007399', 'nervous system development', 340, 'neurodevelopment')]
PMC4405493	4/2015	S1-PMC4405493	['the EFFECT of Vitamin D deficiency in Pregnancy is UNKNOWN, but HAS BEEN ASSOCIATED with adverse Pregnancy outcomes.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('FULL_UNKNOWN', 51), ('INCOMPLETE_EVIDENCE', 64), ('SUPERFICIAL_RELATIONSHIP', 73)]	4	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('GO_0007565', 'female pregnancy', 38, 'pregnancy'), ('GO_0007565', 'female pregnancy', 97, 'pregnancy')]
PMC4405493	4/2015	S19-PMC4405493	['HOWEVER, the EFFECT of less SEVERE Vitamin D deficiency and insufficiency on maternal and fetal outcomes during Pregnancy is LESS CLEAR.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 13), ('IMPORTANT_CONSIDERATION', 28), ('FULL_UNKNOWN', 125)]	4	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('GO_0007565', 'female pregnancy', 112, 'pregnancy')]
PMC4405493	4/2015	S127-PMC4405493	['it is UNCLEAR WHETHER Vitamin D deficiency is causal in the DISPARITIES in adverse Pregnancy outcomes between caucasians and african americans.']	[('FULL_UNKNOWN', 6), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 14), ('IMPORTANT_CONSIDERATION', 60)]	3	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('GO_0007565', 'female pregnancy', 83, 'pregnancy')]
PMC4405493	4/2015	S157-PMC4405493	['HOWEVER, WHETHER Vitamin D deficiency is a RISK FACTOR for Gestational diabetes in itself OR IF Vitamin D supplementation CAN PREVENT gdm is YET UNKNOWN [72].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 9), ('SUPERFICIAL_RELATIONSHIP', 43), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 93), ('INCOMPLETE_EVIDENCE', 122), ('SUPERFICIAL_RELATIONSHIP', 126), ('FULL_UNKNOWN', 141)]	7	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('GO_0007565', 'female pregnancy', 59, 'gestational'), ('CHEBI_27300', 'vitamin D', 96, 'vitamin D')]
PMC4417995	4/2015	S4-PMC4417995	['as of today, the ROLE of Vitamin D in ad is FAR FROM CLEAR; ADDITIONAL STUDIES ARE PARTICULARLY NEEDED in order to confirm the PROMISING therapeutic ROLE of Vitamin D supplementation in childhood ad.']	[('SUPERFICIAL_RELATIONSHIP', 17), ('FULL_UNKNOWN', 44), ('FUTURE_WORK', 60), ('FUTURE_WORK', 71), ('IMPORTANT_CONSIDERATION', 83), ('INCOMPLETE_EVIDENCE', 127), ('PROBABLE_UNDERSTANDING', 127), ('SUPERFICIAL_RELATIONSHIP', 149)]	8	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 157, 'vitamin D')]
PMC4427001	4/2015	S38-PMC4427001	['currently, LITTLE IS KNOWN about Postpartum Vitamin D status in women with history of gdm and POSSIBLE RELATIONSHIP between 25(Oh)D Plasma levels measured at the time of gdm diagnosis and the degree of Glucose (in)tolerance Postpartum.']	[('FULL_UNKNOWN', 11), ('INCOMPLETE_EVIDENCE', 94), ('SUPERFICIAL_RELATIONSHIP', 103)]	3	[('GO_0007565', 'female pregnancy', 33, 'postpartum'), ('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 124, '25(OH)D'), ('UBERON_0001969', 'blood plasma', 132, 'plasma'), ('CHEBI_17234', 'glucose', 202, 'glucose'), ('GO_0007565', 'female pregnancy', 224, 'postpartum')]
PMC4448820	5/2015	S289-PMC4448820	['ALTHOUGH NEW DATA ARE NEEDED to FURTHER ELUCIDATE the magnitude of these RELATIONS, IT IS CLEAR that Vitamin A has multiple Genetically MEDIATED EFFECTS on the Immune Response via the activities of atra.']	[('ANOMALY_CURIOUS_FINDING', 0), ('FULL_UNKNOWN', 9), ('FUTURE_WORK', 9), ('FUTURE_WORK', 32), ('FUTURE_WORK', 40), ('SUPERFICIAL_RELATIONSHIP', 73), ('PROBABLE_UNDERSTANDING', 84), ('SUPERFICIAL_RELATIONSHIP', 136), ('SUPERFICIAL_RELATIONSHIP', 145)]	9	[('CHEBI_27300', 'vitamin D', 101, 'vitamin A'), ('SO_0000704', 'gene', 124, 'genetically'), ('GO_0006955', 'immune response', 160, 'immune response'), ('UBERON_0002405', 'immune system', 160, 'immune')]
PMC4448820	5/2015	S351-PMC4448820	['because this mechanism has the POTENTIAL to alter the global abundance of Methyl Donors, and because Vitamin A has general actions on Cell Differentiation, it is UNKNOWN whether these EFFECTS are indirect OR WHETHER specific Genes are targeted for epigenetic Regulation by Vitamin A in vivo.']	[('INCOMPLETE_EVIDENCE', 31), ('FULL_UNKNOWN', 162), ('SUPERFICIAL_RELATIONSHIP', 184), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 205), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 208)]	5	[('CHEBI_6842', 'methoxychlor', 74, 'methyl donors'), ('CHEBI_27300', 'vitamin D', 101, 'vitamin A'), ('GO_0030154', 'cell differentiation', 134, 'cell differentiation'), ('SO_0000704', 'gene', 225, 'genes'), ('GO_0065007', 'biological regulation', 259, 'regulation'), ('CHEBI_27300', 'vitamin D', 273, 'vitamin A')]
PMC4448820	5/2015	S572-PMC4448820	['an Animal study INDICATED that a high Vitamin A intake MAY BE LINKED to asthma (164), an ASSOCIATION that REMAINS TO BE STUDIED in Humans.']	[('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 55), ('SUPERFICIAL_RELATIONSHIP', 62), ('SUPERFICIAL_RELATIONSHIP', 89), ('FULL_UNKNOWN', 106)]	5	[('NCBITaxon_33208', 'Metazoa', 3, 'animal'), ('CHEBI_27300', 'vitamin D', 38, 'vitamin A'), ('NCBITaxon_9606', 'Homo sapiens', 131, 'humans')]
PMC4448820	5/2015	S586-PMC4448820	['also, ALTHOUGH it IS CLEAR that inflammation is ASSOCIATED with decreased Serum Retinol and rbp concentrations, the ROLE of Vitamin A supplementation on inflammation and its MARKERS is LESS CLEAR.']	[('ANOMALY_CURIOUS_FINDING', 6), ('PROBABLE_UNDERSTANDING', 18), ('SUPERFICIAL_RELATIONSHIP', 48), ('SUPERFICIAL_RELATIONSHIP', 116), ('SUPERFICIAL_RELATIONSHIP', 174), ('FULL_UNKNOWN', 185), ('INCOMPLETE_EVIDENCE', 185)]	7	[('UBERON_0001977', 'blood serum', 74, 'serum'), ('CHEBI_26536', 'retinoic acid', 80, 'retinol'), ('CHEBI_27300', 'vitamin D', 124, 'vitamin A')]
PMC4488777	5/2015	S30-PMC4488777	['since 2013, the database of the us national library of medicine national institutes of health (pubmed) has gained 2050 NEW publications about Vitamin D and contains 62,427 articles regarding THIS subject.']	[('FULL_UNKNOWN', 119), ('QUESTION_ANSWERED_BY_THIS_WORK', 191)]	2	[('CHEBI_27300', 'vitamin D', 142, 'vitamin D')]
PMC4488777	5/2015	S54-PMC4488777	['since our PREVIOUS REVIEW [2], two NEW ORIGINAL papers HAVE BEEN published, EXPLAINING the SIGNIFICANCE of Vitamin D in pcos pathogenesis.']	[('INCOMPLETE_EVIDENCE', 10), ('FULL_UNKNOWN', 35), ('FULL_UNKNOWN', 39), ('INCOMPLETE_EVIDENCE', 55), ('PROBABLE_UNDERSTANDING', 76), ('IMPORTANT_CONSIDERATION', 91)]	6	[('CHEBI_27300', 'vitamin D', 107, 'vitamin D')]
PMC4516109	5/2015	S20-PMC4516109	['clinical presentations include Abdominal pain, vomiting, lethargy, hallucinations, confusion, hypoglycemia, deafness, tinnitus, tachypnea, irritability, Metabolic acidosis, coma and death.15\nrisks of OTHER topical agents, such as Anthralin and Calcipotriol on Human studies are NOT KNOWN and THUS most authors CONTRAINDICATE these treatments.7,15calcipotriol is a by-product of Vitamin D3, OFTEN used in combination with topical Corticosteroids in order to increase their effectiveness and minimize irritation.12nevertheless, studies evidenced its systemic absorption in Humans after application on psoriasis plaques and the development of Vitamin D-induced toxicity after treatment with Calcipotriol TENDS to increase the risk of teratogenicity.12\nALTHOUGH the NUMBER OF cases is LIMITED, coal tar HAS BEEN ASSOCIATED with spontaneous Abortions and congenital disorders, and WAS CONSIDERED Teratogenic in Animal studies.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 200), ('FULL_UNKNOWN', 278), ('PROBABLE_UNDERSTANDING', 292), ('IMPORTANT_CONSIDERATION', 310), ('PROBABLE_UNDERSTANDING', 390), ('SUPERFICIAL_RELATIONSHIP', 701), ('ANOMALY_CURIOUS_FINDING', 749), ('INCOMPLETE_EVIDENCE', 762), ('INCOMPLETE_EVIDENCE', 781), ('INCOMPLETE_EVIDENCE', 799), ('SUPERFICIAL_RELATIONSHIP', 808), ('INCOMPLETE_EVIDENCE', 876)]	12	[('UBERON_0000916', 'abdomen', 31, 'abdominal'), ('GO_0008152', 'metabolic process', 153, 'metabolic'), ('CHEBI_37510', 'anthralin', 230, 'anthralin'), ('CHEBI_50749', 'calcipotriol', 244, 'calcipotriol'), ('NCBITaxon_9606', 'Homo sapiens', 260, 'human'), ('CHEBI_33279', 'vitamin D5', 378, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 378, 'vitamin D3'), ('CHEBI_50850', 'etabonate ester', 429, 'corticosteroids'), ('NCBITaxon_9606', 'Homo sapiens', 571, 'humans'), ('CHEBI_27300', 'vitamin D', 640, 'vitamin D'), ('CHEBI_50749', 'calcipotriol', 688, 'calcipotriol'), ('GO_0006915', 'apoptotic process', 836, 'abortions'), ('CHEBI_50905', 'teratogenic agent', 891, 'teratogenic'), ('NCBITaxon_33208', 'Metazoa', 906, 'animal')]
PMC4466139	6/2015	S88-PMC4466139	['these two classifications of Vitamin D status are significantly DIVERGENT and the issue of DESIRABLE Vitamin D levels for a given age is a matter of great DEBATE, especially in the light of the Skeletal and Extraskeletal EFFECTS of Vitamin D (these were NOT BEEN INVESTIGATED in this study).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 64), ('IMPORTANT_CONSIDERATION', 91), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 155), ('SUPERFICIAL_RELATIONSHIP', 221), ('FULL_UNKNOWN', 254)]	5	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 101, 'vitamin D'), ('UBERON_0004288', 'skeleton', 194, 'skeletal'), ('UBERON_0001431', 'distal carpal bone 2', 207, 'extraskeletal'), ('CHEBI_27300', 'vitamin D', 232, 'vitamin D')]
PMC4466139	6/2015	S98-PMC4466139	['the mechanisms INVOLVED in this reduction of neonatal 25Ohd levels are NOT YET KNOWN; it MAY BE the result of DIFFERENT Vitamin D binding proteins concentrations OR a different 25Ohd half-life in the neonatal age [23,32].']	[('SUPERFICIAL_RELATIONSHIP', 15), ('FULL_UNKNOWN', 71), ('INCOMPLETE_EVIDENCE', 89), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 110), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 162)]	5	[('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 54, '25OHD'), ('CHEBI_27300', 'vitamin D', 120, 'vitamin D'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 177, '25OHD')]
PMC4516377	6/2015	S13-PMC4516377	['the deficiency of Micronutrients, such as Calcium and Vitamin D, is common in many countries, REGARDLESS OF the nutritional status; HOWEVER, its magnitude is greater in children with excess weight.2,5-7in this context, CONCERNS about the ASSOCIATION between Calcium intake and Serum Vitamin D and Metabolic diseases in children has gained prominence in the scientific world for at least 30 years,8and SEVERAL STUDIES HAVE ATTEMPTED to clarify the several QUESTIONS about the subject,6,9,10as the combination of low Serum 25-Hydroxyvitamin D (25 [Oh] D) and INADEQUATE Calcium Intake HAS BEEN ASSOCIATED with Cardiovascular risk factors such as hypertension, obesity, Metabolic syndrome (ms) and type 2 diabetes mellitus.2,4,5,8that is, the combined deficiency of both Nutrients DESERVE special CONSIDERATION in children.4\nHOWEVER, the RECOMMENDATIONS of Calcium and Vitamin D intake have NOT been PROPOSED for the PREVENTION of noncommunicable chronic diseases, AS the STUDIES are STILL SCARCE, INCONSISTENT and SOMETIMES of poor quality.11ALTHOUGH Vitamin D insufficiency and low Calcium intake are commonly REPORTED, LITTLE IS KNOWN about the EFFECT of these Micronutrients in the prevention and treatment of diseases such as obesity.']	[('INCOMPLETE_EVIDENCE', 94), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 132), ('PROBLEM_COMPLICATION', 219), ('SUPERFICIAL_RELATIONSHIP', 238), ('INCOMPLETE_EVIDENCE', 401), ('IMPORTANT_CONSIDERATION', 417), ('DIFFICULT_TASK', 422), ('INCOMPLETE_EVIDENCE', 422), ('EXPLICIT_QUESTION', 455), ('IMPORTANT_CONSIDERATION', 557), ('INCOMPLETE_EVIDENCE', 583), ('SUPERFICIAL_RELATIONSHIP', 592), ('IMPORTANT_CONSIDERATION', 778), ('FUTURE_WORK', 794), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 822), ('FUTURE_WORK', 835), ('ANOMALY_CURIOUS_FINDING', 888), ('INCOMPLETE_EVIDENCE', 897), ('SUPERFICIAL_RELATIONSHIP', 914), ('PROBABLE_UNDERSTANDING', 962), ('INCOMPLETE_EVIDENCE', 969), ('IMPORTANT_CONSIDERATION', 981), ('INCOMPLETE_EVIDENCE', 987), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 995), ('INCOMPLETE_EVIDENCE', 1012), ('ANOMALY_CURIOUS_FINDING', 1038), ('INCOMPLETE_EVIDENCE', 1109), ('FULL_UNKNOWN', 1119), ('SUPERFICIAL_RELATIONSHIP', 1145)]	29	[('CHEBI_33839', 'macromolecule', 18, 'micronutrients'), ('CHEBI_22313', 'alkaline earth metal atom', 42, 'calcium'), ('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 258, 'calcium'), ('UBERON_0001977', 'blood serum', 277, 'serum'), ('CHEBI_27300', 'vitamin D', 283, 'vitamin D'), ('GO_0008152', 'metabolic process', 297, 'metabolic'), ('UBERON_0001977', 'blood serum', 515, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 521, '25-hydroxyvitamin D'), ('CHEBI_15643', '(6R)-6-(L-erythro-1,2-dihydroxypropyl)-7,8-dihydro-6H-pterin', 542, '25 [OH] D'), ('CHEBI_22313', 'alkaline earth metal atom', 568, 'calcium'), ('GO_0007631', 'feeding behavior', 576, 'intake'), ('UBERON_0004535', 'cardiovascular system', 608, 'cardiovascular'), ('GO_0008152', 'metabolic process', 667, 'metabolic'), ('CHEBI_33284', 'nutrient', 768, 'nutrients'), ('CHEBI_22313', 'alkaline earth metal atom', 854, 'calcium'), ('CHEBI_27300', 'vitamin D', 866, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 1049, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 1081, 'calcium'), ('CHEBI_33839', 'macromolecule', 1161, 'micronutrients')]
PMC4516377	6/2015	S73-PMC4516377	['as these FACTORS are INTERCONNECTED with worsening in the obesity context, the cause-and-effect ASSOCIATION between the two pathologies is NOT yet CLEAR.37\nlee et al.18EMPHASIZED that DIFFERENCES in Serum levels of Vitamin D in RELATION to gender CAN be EXPLAINED by the fact that girls reported having a healthier diet for all questions asked.']	[('SUPERFICIAL_RELATIONSHIP', 9), ('SUPERFICIAL_RELATIONSHIP', 21), ('SUPERFICIAL_RELATIONSHIP', 96), ('FULL_UNKNOWN', 139), ('INCOMPLETE_EVIDENCE', 166), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 184), ('SUPERFICIAL_RELATIONSHIP', 228), ('INCOMPLETE_EVIDENCE', 247), ('PROBABLE_UNDERSTANDING', 254)]	9	[('UBERON_0001977', 'blood serum', 199, 'serum'), ('CHEBI_27300', 'vitamin D', 215, 'vitamin D')]
PMC4516377	6/2015	S82-PMC4516377	['final CONSIDERATIONS\nthe ASSOCIATION between Calcium and Vitamin D with obesity is COMPLEX and much REMAINS TO BE ELUCIDATED.']	[('IMPORTANT_CONSIDERATION', 6), ('SUPERFICIAL_RELATIONSHIP', 25), ('DIFFICULT_TASK', 83), ('FULL_UNKNOWN', 100)]	4	[('CHEBI_22313', 'alkaline earth metal atom', 45, 'calcium'), ('CHEBI_27300', 'vitamin D', 57, 'vitamin D')]
PMC4499946	7/2015	S2-PMC4499946	['IMPORTANTLY, LITTLE IS KNOWN about the EFFECT of maternal Vitamin D status on infant linear growth in communities in south asia where stunting is highly prevalent and maternal-infant Vitamin D status is commonly SUBOPTIMAL.']	[('ANOMALY_CURIOUS_FINDING', 0), ('FULL_UNKNOWN', 13), ('SUPERFICIAL_RELATIONSHIP', 39), ('IMPORTANT_CONSIDERATION', 212)]	4	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 183, 'vitamin D')]
PMC4595656	10/2015	S7-PMC4595656	['it also REMAINS TO BE ESTABLISHED IF there are CRITICAL developmental windows during which Vitamin D is REQUIRED.']	[('FULL_UNKNOWN', 8), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 34), ('IMPORTANT_CONSIDERATION', 47), ('IMPORTANT_CONSIDERATION', 104)]	4	[('CHEBI_27300', 'vitamin D', 91, 'vitamin D')]
PMC4598849	10/2015	S9-PMC4598849	['WHETHER the common Vitamin D deficiency during Pregnancy CONTRIBUTES to any of the GLOBAL adverse fetal growth epidemic REMAINS UNKNOWN.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('EXPLICIT_QUESTION', 0), ('SUPERFICIAL_RELATIONSHIP', 57), ('IMPORTANT_CONSIDERATION', 83), ('FULL_UNKNOWN', 120)]	5	[('CHEBI_27300', 'vitamin D', 19, 'vitamin D'), ('GO_0007565', 'female pregnancy', 47, 'pregnancy')]
PMC4632418	10/2015	S14-PMC4632418	['HOWEVER, it is NOT CLEAR WHETHER a POOR Vitamin D status is ASSOCIATED with the RISK of gdm.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FULL_UNKNOWN', 15), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 25), ('IMPORTANT_CONSIDERATION', 35), ('SUPERFICIAL_RELATIONSHIP', 60), ('IMPORTANT_CONSIDERATION', 80)]	6	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D')]
PMC4832516	10/2015	S136-PMC4832516	['similarly, NO information was AVAILABLE on maternal residential location, individually-measured sunshine exposure, or Vitamin D supplementation during Pregnancy, HOWEVER EVEN the youngest participant in the uk biobank (aged 38 in our analysis) was Conceived during a time when Gestational Vitamin D supplementation was not RECOMMENDED in the uk.']	[('FULL_UNKNOWN', 11), ('ANOMALY_CURIOUS_FINDING', 162), ('ANOMALY_CURIOUS_FINDING', 170), ('FUTURE_WORK', 323)]	4	[('CHEBI_27300', 'vitamin D', 118, 'vitamin D'), ('GO_0007565', 'female pregnancy', 151, 'pregnancy'), ('GO_0070268', 'cornification', 248, 'conceived'), ('GO_0007565', 'female pregnancy', 277, 'gestational'), ('CHEBI_27300', 'vitamin D', 289, 'vitamin D')]
PMC4934634	11/2015	S142-PMC4934634	['it SHOULD BE NOTED that OTHER STUDIES have FAILED TO CONFIRM OBSERVATIONS that lower 25(Oh)D status is ASSOCIATED with the occurrence of Preeclampsia, and it is STILL UNCLEAR WHETHER suboptimal Vitamin D status is a cause, OR an EFFECT, of preeclampsia [55,56].']	[('IMPORTANT_CONSIDERATION', 3), ('ANOMALY_CURIOUS_FINDING', 10), ('ANOMALY_CURIOUS_FINDING', 13), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 24), ('INCOMPLETE_EVIDENCE', 24), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 43), ('ANOMALY_CURIOUS_FINDING', 43), ('DIFFICULT_TASK', 43), ('INCOMPLETE_EVIDENCE', 53), ('INCOMPLETE_EVIDENCE', 61), ('SUPERFICIAL_RELATIONSHIP', 103), ('FULL_UNKNOWN', 161), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 175), ('SUPERFICIAL_RELATIONSHIP', 229)]	14	[('CHEBI_71657', 'versiconol acetate', 85, '25(OH)D'), ('GO_0007128', 'meiotic prophase I', 137, 'preeclampsia'), ('CHEBI_27300', 'vitamin D', 194, 'vitamin D')]
PMC4934634	11/2015	S207-PMC4934634	['it is anticipated that THIS STUDY will provide valuable NEW information on the EFFECTS of maternal Vitamin D status and offspring allergy/asthma outcomes.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 23), ('FULL_UNKNOWN', 56), ('SUPERFICIAL_RELATIONSHIP', 79)]	3	[('CHEBI_27300', 'vitamin D', 99, 'vitamin D')]
PMC4934634	11/2015	S251-PMC4934634	['data regarding long-term high dose Vitamin D supplementation in women of Childbearing age are LACKING.']	[('FULL_UNKNOWN', 94)]	1	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('GO_0007129', 'homologous chromosome pairing at meiosis', 73, 'childbearing')]
PMC4934634	11/2015	S306-PMC4934634	['WHILE the ESSENTIALITY of adequate Vitamin D during Pregnancy is not DISPUTED, CONTROVERSY exists over the RECOMMENDED dietary intake levels, the mathematical approaches to calculating that level, and the endpoints used to determine REQUIREMENTS; the concentrations of circulating 25(Oh)D that denote deficiency, insufficiency and adequacy status; and WHETHER race, body weight or OTHER factors SHOULD BE TAKEN into account when making dietary RECOMMENDATIONS, similarly, it is NOT CLEAR WHAT Vitamin D supplementation regimens are most EFFECTIVE during Pregnancy; WHETHER mother, child OR both SHOULD BE supplemented; and WHETHER there are long-term CONSEQUENCES of supplementation.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 10), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 69), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 79), ('FUTURE_WORK', 107), ('IMPORTANT_CONSIDERATION', 233), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 352), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 381), ('FUTURE_WORK', 395), ('IMPORTANT_CONSIDERATION', 405), ('FUTURE_WORK', 444), ('FULL_UNKNOWN', 478), ('EXPLICIT_QUESTION', 488), ('SUPERFICIAL_RELATIONSHIP', 537), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 565), ('FUTURE_WORK', 595), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 623), ('PROBLEM_COMPLICATION', 651)]	18	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('GO_0007565', 'female pregnancy', 52, 'pregnancy'), ('CHEBI_71657', 'versiconol acetate', 281, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 281, '25(OH ... D'), ('CHEBI_27300', 'vitamin D', 493, 'vitamin D'), ('GO_0007565', 'female pregnancy', 554, 'pregnancy')]
PMC4684854	12/2015	S112-PMC4684854	['AS hypersensitivity outcomes MAY also be seen in those children Born to mothers contaminated with assorted Xenobiotics in Pregnancy [84–89], HOWEVER, it is NOT KNOWN WHETHER the Immune Dysregulation and hypersensitivity MAY BE the consequence of a primary Gestational insufficiency of Vitamin D, OR WHETHER various chemical Toxicants MIGHT play a ROLE by impairing Vitamin D Uptake, Renal synthesis, and assimilation [25,90] WHILE at the same time inducing Immune compromise and hypersensitivity through OTHER mechanisms [91].']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 29), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 141), ('FULL_UNKNOWN', 156), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 166), ('INCOMPLETE_EVIDENCE', 220), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 296), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 299), ('INCOMPLETE_EVIDENCE', 334), ('SUPERFICIAL_RELATIONSHIP', 347), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 425), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 504)]	12	[('GO_0007567', 'parturition', 64, 'born'), ('CHEBI_35703', 'xenobiotic', 107, 'xenobiotics'), ('GO_0007565', 'female pregnancy', 122, 'pregnancy'), ('GO_0001774', 'microglial cell activation', 178, 'immune dysregulation'), ('UBERON_0002405', 'immune system', 178, 'immune'), ('GO_0007565', 'female pregnancy', 256, 'gestational'), ('CHEBI_27300', 'vitamin D', 285, 'vitamin D'), ('CHEBI_35704', 'N(2)-acetyl-L-lysine', 324, 'toxicants'), ('CHEBI_27300', 'vitamin D', 365, 'vitamin D'), ('GO_0071939', 'vitamin A import', 365, 'vitamin D uptake'), ('UBERON_0002113', 'kidney', 383, 'renal'), ('UBERON_0002405', 'immune system', 457, 'immune')]
PMC4691762	12/2015	S13-PMC4691762	['LARGE SCALE trials of Postnatal Vitamin D for any disease outcome are LACKING.']	[('INCOMPLETE_EVIDENCE', 0), ('FULL_UNKNOWN', 70)]	2	[('GO_0007567', 'parturition', 22, 'postnatal'), ('CHEBI_27300', 'vitamin D', 32, 'vitamin D')]
PMC4714725	1/2016	S96-PMC4714725	['ab, a Micronutrients and Herbal supplements\nthere is NO CLEAR EVIDENCE that dietary supplementation with Vitamins, Minerals, herbs, or spices CAN improve diabetes, and there MAY BE safety CONCERNS regarding the long-term use of antioxidant supplements such as Vitamins E and C and Carotene.c Alcohol\nadults with diabetes who drink alcohol SHOULD do so in moderation (no more than one drink per day for Adult women and no more than two drinks per day for Adult men).c\nAlcohol Consumption MAY place People with diabetes at INCREASED risk for delayed hypoglycemia, ESPECIALLY IF taking Insulin or Insulin secretagogues.']	[('FULL_UNKNOWN', 53), ('PROBABLE_UNDERSTANDING', 56), ('INCOMPLETE_EVIDENCE', 142), ('INCOMPLETE_EVIDENCE', 174), ('PROBLEM_COMPLICATION', 188), ('FUTURE_WORK', 339), ('INCOMPLETE_EVIDENCE', 487), ('IMPORTANT_CONSIDERATION', 521), ('ANOMALY_CURIOUS_FINDING', 562), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 573)]	10	[('CHEBI_34850', 'milrinone lactate', 6, 'Micronutrients'), ('NCBITaxon_7955', 'Danio rerio', 25, 'herbal'), ('CHEBI_33277', 'gamma-tocotrienol', 105, 'vitamins'), ('CHEBI_46751', 'quinolizidine', 115, 'minerals'), ('CHEBI_27300', 'vitamin D', 260, 'vitamins E'), ('CHEBI_18245', 'carboxylato group', 275, 'C'), ('PR_000004900', 'complement C3', 275, 'C'), ('CHEBI_23042', 'carotene', 281, 'carotene'), ('CHEBI_30879', 'alcohol', 292, 'Alcohol'), ('UBERON_0007023', 'adult organism', 402, 'adult'), ('UBERON_0007023', 'adult organism', 454, 'adult'), ('CHEBI_30879', 'alcohol', 467, 'Alcohol'), ('GO_0007631', 'feeding behavior', 475, 'consumption'), ('NCBITaxon_10088', 'Mus <genus>', 497, 'people'), ('PR_000045358', 'insulin family protein', 583, 'insulin'), ('PR_000045358', 'insulin family protein', 594, 'insulin')]
PMC4719746	1/2016	S14-PMC4719746	['LITTLE IS KNOWN about the prevalence of Vitamin D deficiency among asian and african Pregnant women living in northern europe, although a FEW SMALL STUDIES from sweden [6,7] and norway [8] report a high prevalence of Vitamin D deficiency among somali and pakistani women.']	[('FULL_UNKNOWN', 0), ('INCOMPLETE_EVIDENCE', 138), ('INCOMPLETE_EVIDENCE', 142)]	3	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('GO_0007565', 'female pregnancy', 85, 'pregnant'), ('CHEBI_27300', 'vitamin D', 217, 'vitamin D')]
PMC4719746	1/2016	S15-PMC4719746	['there are FEW population-based STUDIES exploring Vitamin D deficiency in Pregnancy in today’s multiethnic europe, and LITTLE IS KNOWN about the IMPACT of socioeconomic status or the EFFECT of Vitamin D supplements [9,10].']	[('INCOMPLETE_EVIDENCE', 10), ('FULL_UNKNOWN', 118), ('SUPERFICIAL_RELATIONSHIP', 144), ('SUPERFICIAL_RELATIONSHIP', 182)]	4	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('GO_0007565', 'female pregnancy', 73, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 192, 'vitamin D')]
PMC4719746	1/2016	S54-PMC4719746	['we have NO INFORMATION on the exact dose of Vitamin D supplements taken if SELF-REPORTED intake was >10\xa0μg/day.']	[('FULL_UNKNOWN', 8), ('INCOMPLETE_EVIDENCE', 75)]	2	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D')]
PMC4729160	1/2016	S127-PMC4729160	['it is also LACK OF assessment of the participants’ physical behavior condition which INFLUENCES Vitamin A status of chinese Pregnant women.']	[('FULL_UNKNOWN', 11), ('INCOMPLETE_EVIDENCE', 11), ('SUPERFICIAL_RELATIONSHIP', 85)]	3	[('CHEBI_27300', 'vitamin D', 96, 'vitamin A'), ('GO_0007565', 'female pregnancy', 124, 'pregnant')]
PMC4770602	1/2016	S0-PMC4770602	['EFFECT of Vitamin D supplementation in the reduce RISK of Preeclampsia in nulliparous women\n\nabstract\n\nbackground:\nthe exact ROLE of Vitamin D in the development and severity of Preeclampsia is STILL UNCLEAR.']	[('SUPERFICIAL_RELATIONSHIP', 0), ('IMPORTANT_CONSIDERATION', 50), ('SUPERFICIAL_RELATIONSHIP', 125), ('FULL_UNKNOWN', 194)]	4	[('CHEBI_27300', 'vitamin D', 10, 'vitamin D'), ('GO_0007128', 'meiotic prophase I', 58, 'preeclampsia'), ('CHEBI_27300', 'vitamin D', 133, 'vitamin D'), ('GO_0007128', 'meiotic prophase I', 178, 'preeclampsia')]
PMC4864049	1/2016	S351-PMC4864049	['in addition, WHILE THERE IS EVIDENCE that Vitamin D MAY increase Dna Demethylation of selected Gene Promoters, the mechanisms behind this EFFECT are NOT CLEAR\xa0[162].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 13), ('INCOMPLETE_EVIDENCE', 19), ('INCOMPLETE_EVIDENCE', 52), ('SUPERFICIAL_RELATIONSHIP', 138), ('FULL_UNKNOWN', 149)]	5	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('GO_0006306', 'DNA methylation', 65, 'DNA demethylation'), ('SO_0000704', 'gene', 95, 'gene'), ('SO_0000167', 'promoter', 100, 'promoters')]
PMC4778858	3/2016	S102-PMC4778858	['as addressed PREVIOUSLY by our group [12] and others [27], obese women MAY REQUIRE larger amounts of Vitamin D supplementation compared to normal weight women to provide their neonates with sufficient levels of Vitamin D. YET the definition of neonatal Vitamin D sufficiency has NOT BEEN DETERMINED.']	[('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 71), ('IMPORTANT_CONSIDERATION', 75), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 222), ('ANOMALY_CURIOUS_FINDING', 222), ('FULL_UNKNOWN', 279)]	6	[('CHEBI_27300', 'vitamin D', 101, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 211, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 253, 'vitamin D')]
PMC4778858	3/2016	S118-PMC4778858	['however, Vitamin D levels at the start of Pregnancy among these women are NOT KNOWN.']	[('FULL_UNKNOWN', 74)]	1	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('GO_0007565', 'female pregnancy', 42, 'pregnancy')]
PMC4778858	3/2016	S120-PMC4778858	['WHETHER the Vitamin D amount of 400–600 iu of D2Or D3In most Prenatal Vitamin formulations is sufficient to maintain levels > 30 ng/ml, especially among obese women, REMAINS UNKNOWN.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FULL_UNKNOWN', 166)]	2	[('CHEBI_27300', 'vitamin D', 12, 'vitamin D'), ('PR_000011011', 'neurobeachin-like protein 1', 46, 'D2or D3in'), ('GO_0007565', 'female pregnancy', 61, 'prenatal'), ('CHEBI_33229', 'vitamin (role)', 70, 'vitamin')]
PMC4785305	3/2016	S25-PMC4785305	['the 2010 institute of medicine (iom) report on dietary reference intakes for Calcium and Vitamin D RECOMMENDED 600\u2005iu to Pregnant women as the recommended daily allowance (rda), the rda being the dose that is projected to allow at least 97.5% of the Pregnant women population to reach the DESIRABLE target 25(Oh)D level ≥50\u2005nmol/l.29this RECOMMENDATION was BASED ON OBSERVATIONAL studies, NONE of which were conducted in the middle east.29CONVERSELY, the Endocrine society 2011 GUIDELINES RECOMMENDED that 1500–2000\u2005iu daily of Vitamin D is NEEDED to reach a target 25(Oh)D level ≥75\u2005nmol/l (a RECOMMENDATION that was graded as weak with moderate quality of evidence).30the american college of obstetricians and gynecologists (acog) does not RECOMMEND screening for Vitamin D level in Pregnancy, and abides by the iom RECOMMENDATIONS.31moreover, the who 2012 guidelines on Vitamin D replacement during Pregnancy DID NOT RECOMMEND vitamin D supplementation as part of Prenatal care.32this was based ON a meta-analysis of Vitamin D trials during Pregnancy, which IDENTIFIED a LIMITED NUMBER of high-quality studies DEMONSTRATING a beneficial EFFECT of supplementation on maternal and neonatal outcomes, and CONCLUDED that FURTHER randomised controlled trials (rcts) ARE NEEDED.33in the uk, HOWEVER, Pregnant women are CONSIDERED AT RISK of Vitamin D deficiency, and supplementation with 400\u2005iu daily is REQUIRED.34\nit is NOT CLEAR WHETHER any of the above RECOMMENDED doses are applicable to non-western populations, with lower baseline Vitamin D levels, such as in lebanon and other middle eastern countries.']	[('FUTURE_WORK', 99), ('IMPORTANT_CONSIDERATION', 289), ('FUTURE_WORK', 338), ('INCOMPLETE_EVIDENCE', 357), ('INCOMPLETE_EVIDENCE', 366), ('INCOMPLETE_EVIDENCE', 389), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 437), ('PROBABLE_UNDERSTANDING', 478), ('FUTURE_WORK', 489), ('FUTURE_WORK', 541), ('IMPORTANT_CONSIDERATION', 541), ('FUTURE_WORK', 594), ('FUTURE_WORK', 742), ('FUTURE_WORK', 818), ('INCOMPLETE_EVIDENCE', 912), ('FUTURE_WORK', 920), ('ANOMALY_CURIOUS_FINDING', 998), ('ANOMALY_CURIOUS_FINDING', 998), ('INCOMPLETE_EVIDENCE', 1061), ('INCOMPLETE_EVIDENCE', 1074), ('INCOMPLETE_EVIDENCE', 1113), ('SUPERFICIAL_RELATIONSHIP', 1140), ('INCOMPLETE_EVIDENCE', 1205), ('FUTURE_WORK', 1220), ('FUTURE_WORK', 1264), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1288), ('IMPORTANT_CONSIDERATION', 1316), ('INCOMPLETE_EVIDENCE', 1316), ('IMPORTANT_CONSIDERATION', 1327), ('IMPORTANT_CONSIDERATION', 1401), ('FULL_UNKNOWN', 1419), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1429), ('FUTURE_WORK', 1454)]	33	[('CHEBI_31341', 'calcium dihydroxide', 77, 'Calcium'), ('CHEBI_28384', 'vitamin K', 89, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 89, 'Vitamin'), ('GO_0007565', 'female pregnancy', 121, 'pregnant'), ('GO_0007565', 'female pregnancy', 250, 'pregnant'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 309, 'OH)D'), ('PR_000013502', 'parvalbumin alpha', 311, ')D'), ('UBERON_0005063', 'left ventricular compact myocardium', 455, 'Endocrine'), ('CHEBI_27300', 'vitamin D', 528, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 566, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 566, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 766, 'vitamin D'), ('GO_0007565', 'female pregnancy', 785, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 873, 'vitamin D'), ('GO_0007565', 'female pregnancy', 902, 'pregnancy'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 938, 'D'), ('GO_0007565', 'female pregnancy', 967, 'prenatal'), ('CHEBI_27300', 'vitamin D', 1020, 'vitamin D'), ('GO_0007565', 'female pregnancy', 1044, 'pregnancy'), ('GO_0007565', 'female pregnancy', 1297, 'pregnant'), ('CHEBI_27300', 'vitamin D', 1338, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 1535, 'vitamin D')]
PMC4785305	3/2016	S168-PMC4785305	['furthermore, GIVEN the LACK OF EVIDENCE-BASED guidelines that define the OPTIMAL rda for Vitamin D supplementation during Pregnancy in our population, and the LIMITED NUMBER of randomised clinical trials completed so far in our region, this trial will fill an IMPORTANT KNOWLEDGE GAP.']	[('PROBABLE_UNDERSTANDING', 13), ('INCOMPLETE_EVIDENCE', 23), ('IMPORTANT_CONSIDERATION', 73), ('INCOMPLETE_EVIDENCE', 159), ('IMPORTANT_CONSIDERATION', 260), ('FULL_UNKNOWN', 270)]	6	[('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('GO_0007565', 'female pregnancy', 122, 'pregnancy')]
PMC4811441	3/2016	S2-PMC4811441	['the pathophysiology of the Development Of Hypertension In Pregnancy is UNKNOWN, but studies SUGGEST an ASSOCIATION with Vitamin D status, measured as 25-Hydroxyvitamin D (25(Oh)D).']	[('FULL_UNKNOWN', 71), ('INCOMPLETE_EVIDENCE', 92), ('SUPERFICIAL_RELATIONSHIP', 103)]	3	[('GO_0002234', 'detection of endoplasmic reticulum overloading', 27, 'development of hypertension in'), ('GO_0007565', 'female pregnancy', 58, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 120, 'vitamin D'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 150, '25-hydroxyvitamin D'), ('CHEBI_33010', 'chromide(1-)', 173, '(OH)D')]
PMC5487839	3/2016	S131-PMC5487839	['an increased risk of malformations events has NOT been OBSERVED in Humans (LIMITED DATA) [360]cvitamin dthe ROLE for Vitamin D supplementation in Pregnancy is CONTROVERSIAL, BUT there is NO EVIDENCE of a reduction in adverse Pregnancy outcomes (e.g., Preeclampsia, Stillbirth, neonatal death) [361] or improvement in bone Mineral content in children in studies in which supplementation was given INDEPENDENTLY from Blood levels [362].']	[('FULL_UNKNOWN', 46), ('INCOMPLETE_EVIDENCE', 75), ('SUPERFICIAL_RELATIONSHIP', 108), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 159), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 174), ('INCOMPLETE_EVIDENCE', 187), ('SUPERFICIAL_RELATIONSHIP', 396)]	7	[('NCBITaxon_9606', 'Homo sapiens', 67, 'humans'), ('CHEBI_27300', 'vitamin D', 117, 'vitamin D'), ('GO_0007565', 'female pregnancy', 146, 'pregnancy'), ('GO_0007565', 'female pregnancy', 225, 'pregnancy'), ('GO_0007128', 'meiotic prophase I', 251, 'preeclampsia'), ('GO_0001966', 'thigmotaxis', 265, 'stillbirth'), ('CHEBI_46662', 'mineral', 322, 'mineral'), ('UBERON_0000178', 'blood', 415, 'blood')]
PMC4896250	4/2016	S4150-PMC4896250	['HOWEVER, the EFFECT of Vitamin D on house dust Mite (hdm) sensitization in patients with ad has NOT BEEN ESTABLISHED.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 13), ('FULL_UNKNOWN', 96)]	3	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('CHEBI_46662', 'mineral', 47, 'mite')]
PMC4896250	4/2016	S7049-PMC4896250	['a496 the EFFECT of Cord Serum 25-Hydroxyvitamin D (25(Oh)D) on the development of atopic dermatitis in first 3 years of Life : cocoa study\n\nhyun-ju cho1, youn ho shin2, eun lee3, young-ho kim3, darae lee3, mi-jin kang4, song-i yang5, kangmo ahn6, kyung won kim7, yoon hee kim7, hye-sung won3, soo hyun kim2, suk-joo choi6, young han kim7, jong kwan jun8, eun-jin kim9, jeom gyu lee9, so-yeon lee5, soo-jong hong1, dongin suh10\n\n1department of pediatrics, childhood asthma atopy center, environmental health center, asan medical center, university of ulsan college of medicine, south korea;2cha medical center;3asan medical center;4asan institute for Life science, asan medical center;5hallym university sacred Heart hospital;6samsung medical center;7yonsei university college of medicine;8seoul national university college of medicine;9korea national institute of health;10seoul national university hospital\n\ncorrespondence: hyun-ju cho – department of pediatrics, childhood asthma atopy center, environmental health center, asan medical center, university of ulsan college of medicine, south korea\nbackground: the ASSOCIATION between Serum Vitamin D deficiency at Birth and atopic dermatitis (ad) is UNCERTAIN.']	[('SUPERFICIAL_RELATIONSHIP', 9), ('SUPERFICIAL_RELATIONSHIP', 1115), ('FULL_UNKNOWN', 1201)]	3	[('UBERON_0000948', 'heart', 19, 'Cord'), ('UBERON_0001977', 'blood serum', 24, 'Serum'), ('CHEBI_27844', "2',3'-cyclic AMP", 30, '25-Hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 51, '25(OH)D'), ('UBERON_0000104', 'life cycle', 120, 'Life'), ('UBERON_0000104', 'life cycle', 650, 'Life'), ('UBERON_0000948', 'heart', 710, 'Heart'), ('UBERON_0001977', 'blood serum', 1135, 'serum'), ('CHEBI_27300', 'vitamin D', 1141, 'vitamin D'), ('GO_0007567', 'parturition', 1165, 'birth')]
PMC4998950	4/2016	S0-PMC4998950	['maternal Vitamin D deficiency and the risk of autism spectrum disorders: population-based study\n\nabstract\n\nbackground\nmaternal Vitamin D deficiency MAY increase risk of autism spectrum disorder (asd), BUT DIRECT EVIDENCE IS LACKING.']	[('INCOMPLETE_EVIDENCE', 148), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 201), ('INCOMPLETE_EVIDENCE', 205), ('FULL_UNKNOWN', 224)]	4	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 127, 'vitamin D')]
PMC4998950	4/2016	S10-PMC4998950	['environmental and Genetic FACTORS APPEAR equally IMPORTANT,1ALTHOUGH asd with and without intellectual disability MAY IN PART have DIFFERENT origins.2,3\nin high-latitude countries such as sweden, children of mothers with dark complexion are at PARTICULARLY elevated RISK of asd with intellectual disability.3because such women OFTEN have very low Vitamin d levels due to Melanin absorption of uvb radiation, maternal Vitamin D deficiency HAS BEEN SUGGESTED to CONTRIBUTE to asd risk in offspring.4,5indeed, experimentally induced Vitamin D deficiency in Pregnant dams is REPORTED to AFFECT foetal Neurodevelopment and behaviour in Adult offspring in Rats,4AND a RECENT STUDY DEMONSTRATED lower neonatal Vitamin D levels in children with asd compared with their siblings.6\nearly Life Vitamin D deficiency is THUS a POSSIBLE RISK FACTOR for asd, BUT direct SUPPORT of an ASSOCIATION IS LACKING.4maternal hypovitaminosis d is treatable, THUS INVESTIGATION of the matter IS WARRANTED.']	[('SUPERFICIAL_RELATIONSHIP', 26), ('ANOMALY_CURIOUS_FINDING', 34), ('IMPORTANT_CONSIDERATION', 49), ('ANOMALY_CURIOUS_FINDING', 59), ('INCOMPLETE_EVIDENCE', 114), ('INCOMPLETE_EVIDENCE', 118), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 131), ('ANOMALY_CURIOUS_FINDING', 244), ('IMPORTANT_CONSIDERATION', 244), ('IMPORTANT_CONSIDERATION', 266), ('PROBABLE_UNDERSTANDING', 327), ('INCOMPLETE_EVIDENCE', 438), ('SUPERFICIAL_RELATIONSHIP', 460), ('INCOMPLETE_EVIDENCE', 571), ('SUPERFICIAL_RELATIONSHIP', 583), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 655), ('INCOMPLETE_EVIDENCE', 662), ('INCOMPLETE_EVIDENCE', 675), ('PROBABLE_UNDERSTANDING', 807), ('INCOMPLETE_EVIDENCE', 814), ('SUPERFICIAL_RELATIONSHIP', 823), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 844), ('INCOMPLETE_EVIDENCE', 855), ('SUPERFICIAL_RELATIONSHIP', 869), ('INCOMPLETE_EVIDENCE', 881), ('FULL_UNKNOWN', 884), ('PROBABLE_UNDERSTANDING', 934), ('FUTURE_WORK', 939), ('FUTURE_WORK', 967)]	29	[('SO_0000704', 'gene', 18, 'genetic'), ('CHEBI_33229', 'vitamin (role)', 347, 'vitamin'), ('CHEBI_25179', 'melanins', 371, 'melanin'), ('CHEBI_27300', 'vitamin D', 417, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 530, 'vitamin D'), ('GO_0007565', 'female pregnancy', 554, 'pregnant'), ('GO_0007399', 'nervous system development', 597, 'neurodevelopment'), ('UBERON_0007023', 'adult organism', 631, 'adult'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 650, 'rats'), ('CHEBI_27300', 'vitamin D', 703, 'vitamin D'), ('UBERON_0000104', 'life cycle', 778, 'life'), ('CHEBI_27300', 'vitamin D', 783, 'vitamin D')]
PMC4998950	4/2016	S45-PMC4998950	['there are, HOWEVER, biological UNDERPINNINGS of a TRUE ASSOCIATION AS experimental studies INDICATE CRITICAL ROLES of Vitamin D in the Development and functioning Of the Brain.4\nIN SUMMARY, our results SUPPORT, BUT DO NOT PROVE, the HYPOTHESIS that maternal Vitamin D status is IMPLICATED in the aetiology of asd with comorbid intellectual disability.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 11), ('SUPERFICIAL_RELATIONSHIP', 31), ('PROBABLE_UNDERSTANDING', 50), ('SUPERFICIAL_RELATIONSHIP', 55), ('PROBABLE_UNDERSTANDING', 67), ('INCOMPLETE_EVIDENCE', 91), ('IMPORTANT_CONSIDERATION', 100), ('SUPERFICIAL_RELATIONSHIP', 109), ('INCOMPLETE_EVIDENCE', 178), ('INCOMPLETE_EVIDENCE', 202), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 211), ('FULL_UNKNOWN', 215), ('INCOMPLETE_EVIDENCE', 233), ('SUPERFICIAL_RELATIONSHIP', 278)]	14	[('CHEBI_27300', 'vitamin D', 118, 'vitamin D'), ('GO_0050887', 'determination of sensory modality', 135, 'development ... of ... brain'), ('UBERON_0000955', 'brain', 170, 'brain'), ('CHEBI_27300', 'vitamin D', 258, 'vitamin D')]
PMC5035678	4/2016	S148-PMC5035678	['CONSISTENT with our results, THESE STUDIES have FOUND that Vitamin D is ineffective or has UNCERTAIN EFFECTS.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 29), ('INCOMPLETE_EVIDENCE', 48), ('FULL_UNKNOWN', 91), ('SUPERFICIAL_RELATIONSHIP', 101)]	5	[('CHEBI_27300', 'vitamin D', 59, 'vitamin D')]
PMC4829940	5/2016	S19-PMC4829940	['ALTHOUGH a NUMBER OF STUDIES have REPORTED inverse ASSOCIATIONS between maternal Vitamin D status and Postnatal health outcomes, systematic reviews SHOW that there is STILL substantial heterogeneity between studies in terms of methodology and results, and FEW or NO randomized TRIALS HAVE BEEN performed[6],[8],[10],[11].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 34), ('SUPERFICIAL_RELATIONSHIP', 51), ('INCOMPLETE_EVIDENCE', 148), ('IMPORTANT_CONSIDERATION', 167), ('INCOMPLETE_EVIDENCE', 256), ('FULL_UNKNOWN', 263), ('INCOMPLETE_EVIDENCE', 284)]	10	[('CHEBI_27300', 'vitamin D', 81, 'vitamin D'), ('GO_0007567', 'parturition', 102, 'postnatal')]
PMC4859539	5/2016	S15-PMC4859539	['to address this GAP in the literature, the AIM of THIS follow-up STUDY was TO DETERMINE IF maternal Vitamin D status during Pregnancy and/or a child’s current Vitamin D status AFFECT the circulating concentration of Cathelicidin in healthy children years after Delivery.']	[('FULL_UNKNOWN', 16), ('QUESTION_ANSWERED_BY_THIS_WORK', 43), ('QUESTION_ANSWERED_BY_THIS_WORK', 50), ('QUESTION_ANSWERED_BY_THIS_WORK', 75), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 88), ('SUPERFICIAL_RELATIONSHIP', 176)]	6	[('CHEBI_27300', 'vitamin D', 100, 'vitamin D'), ('GO_0007565', 'female pregnancy', 124, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 159, 'vitamin D'), ('PR_000006009', 'alpha-catulin', 216, 'cathelicidin'), ('GO_0007567', 'parturition', 261, 'delivery')]
PMC4859539	5/2016	S104-PMC4859539	['additionally, the LACK OF CORRELATION MAY SUGGEST that circulating Cathelicidin concentration is NOT REFLECTIVE of WHAT is happening at the cellular level, and in this regard, cathelicidin mrna Expression by Immune Cells or target Tissue MAY BE a BETTER indicator of Vitamin D’s long-term EFFECT on the Cathelicidin system.']	[('INCOMPLETE_EVIDENCE', 18), ('SUPERFICIAL_RELATIONSHIP', 26), ('INCOMPLETE_EVIDENCE', 38), ('INCOMPLETE_EVIDENCE', 42), ('FULL_UNKNOWN', 97), ('EXPLICIT_QUESTION', 115), ('INCOMPLETE_EVIDENCE', 238), ('FUTURE_PREDICTION', 247), ('SUPERFICIAL_RELATIONSHIP', 289)]	9	[('CHEBI_3364', 'Canthiumine', 67, 'cathelicidin'), ('GO_0010467', 'gene expression', 194, 'expression'), ('CL_0000738', 'leukocyte', 208, 'immune cells'), ('UBERON_0002405', 'immune system', 208, 'immune'), ('UBERON_0000479', 'tissue', 231, 'tissue'), ('CHEBI_27300', 'vitamin D', 267, 'vitamin D'), ('CHEBI_3364', 'Canthiumine', 303, 'cathelicidin'), ('PR_000006009', 'alpha-catulin', 303, 'cathelicidin')]
PMC4889866	5/2016	S129-PMC4889866	['the result SHOWED no correlation between maternal Vitamin D status and neonatal Tlr9 triggered cytokine response (supplement 2), THOUGH such conclusion NEEDED to be INTERPRETED with CAUTION for the null CORRELATION MIGHT be DUE TO LACK OF POWER OWING TO SMALL number of test samples.']	[('INCOMPLETE_EVIDENCE', 11), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 129), ('ANOMALY_CURIOUS_FINDING', 129), ('FUTURE_WORK', 152), ('FULL_UNKNOWN', 165), ('INCOMPLETE_EVIDENCE', 182), ('SUPERFICIAL_RELATIONSHIP', 203), ('INCOMPLETE_EVIDENCE', 215), ('PROBLEM_COMPLICATION', 224), ('INCOMPLETE_EVIDENCE', 231), ('PROBLEM_COMPLICATION', 231), ('PROBLEM_COMPLICATION', 245), ('INCOMPLETE_EVIDENCE', 254)]	13	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D'), ('PR_000001155', 'Toll-like receptor 4', 80, 'TLR9')]
PMC4897157	5/2016	S106-PMC4897157	['ALTHOUGH the UNDERLYING mechanism REMAINS TO BE CLEARLY ESTABLISHED, seasonal differences in Ultraviolet B exposure, and PERHAPS also Vitamin D levels, MAY BE INVOLVED in the development of allergic diseases718).']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 13), ('FULL_UNKNOWN', 34), ('INCOMPLETE_EVIDENCE', 121), ('INCOMPLETE_EVIDENCE', 152), ('SUPERFICIAL_RELATIONSHIP', 159)]	6	[('CHEBI_72754', 'bisphenol AF', 93, 'ultraviolet B'), ('CHEBI_27300', 'vitamin D', 134, 'vitamin D')]
PMC4897157	5/2016	S148-PMC4897157	['third, we COULD NOT directly examine the RELATIONSHIP between Vitamin D status and allergic disease prevalence BECAUSE Serum Vitamin D levels were NOT RECORDED.']	[('DIFFICULT_TASK', 10), ('SUPERFICIAL_RELATIONSHIP', 41), ('PROBLEM_COMPLICATION', 111), ('ANOMALY_CURIOUS_FINDING', 147), ('FULL_UNKNOWN', 147)]	5	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('UBERON_0001977', 'blood serum', 119, 'serum'), ('CHEBI_27300', 'vitamin D', 125, 'vitamin D')]
PMC4930210	7/2016	S10-PMC4930210	['there is also EVIDENCE that Pregnancy RISKS MAY BE mitigated by Vitamin D supplementation, ALTHOUGH the optimal daily dose is NOT CLEAR [2].']	[('INCOMPLETE_EVIDENCE', 14), ('IMPORTANT_CONSIDERATION', 38), ('INCOMPLETE_EVIDENCE', 44), ('ANOMALY_CURIOUS_FINDING', 91), ('FULL_UNKNOWN', 126)]	5	[('GO_0007565', 'female pregnancy', 28, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 64, 'vitamin D')]
PMC4930210	7/2016	S144-PMC4930210	['ALTHOUGH the physiological ROLE of the c3-epimerization pathway has NOT YET BEEN ELUCIDATED, there are INDICATIONS that it has SOME anti-proliferative activity and differentiation activity ONLY at levels of APPROXIMATELY 10%-30%, respectively, COMPARED TO non-epimeric Vitamin D Metabolites [11,12].']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 27), ('FULL_UNKNOWN', 68), ('INCOMPLETE_EVIDENCE', 103), ('INCOMPLETE_EVIDENCE', 127), ('ANOMALY_CURIOUS_FINDING', 189), ('INCOMPLETE_EVIDENCE', 189), ('INCOMPLETE_EVIDENCE', 207), ('ANOMALY_CURIOUS_FINDING', 244)]	9	[('CHEBI_27300', 'vitamin D', 269, 'vitamin D'), ('CHEBI_25212', 'metabolite', 279, 'metabolites')]
PMC4930210	7/2016	S147-PMC4930210	['THESE FINDINGS EMPHASIZE THE NEED for FURTHER identification of the functional ROLE and clinical SIGNIFICANCE of 3-Epi-25(Oh)D3In the assessment of Vitamin D status in Pregnant women, given the fact that the cut-off for Vitamin D sufficiency in Pregnancy is UNCLEAR.']	[('INCOMPLETE_EVIDENCE', 0), ('IMPORTANT_CONSIDERATION', 15), ('INCOMPLETE_EVIDENCE', 25), ('FUTURE_WORK', 29), ('FUTURE_WORK', 38), ('SUPERFICIAL_RELATIONSHIP', 79), ('IMPORTANT_CONSIDERATION', 97), ('FULL_UNKNOWN', 258)]	8	[('CHEBI_15616', '(3S,5S)-3,5-diaminohexanoic acid', 113, '3-epi-25(OH)D3in'), ('PR_000002325', 'dynein light chain 1, cytoplasmic', 125, 'D3in'), ('CHEBI_27300', 'vitamin D', 148, 'vitamin D'), ('GO_0007565', 'female pregnancy', 168, 'pregnant'), ('CHEBI_27300', 'vitamin D', 220, 'vitamin D'), ('GO_0007565', 'female pregnancy', 245, 'pregnancy')]
PMC4949006	7/2016	S149-PMC4949006	['THERE ARE NO STUDIES clearly SHOWING DIFFERENCES in maternal outcomes or fetal survival, Birth weight, or Gestational length relative to Vitamin D,118but studies on bone health (and Lung function and asthma at age 6 years119) SUPPORT a level of AT LEAST 50 nmol/l, which implies a need for some supplementation for all Pregnant women.120–123\n\nCalcium\nwomen lose 3% to 5% of their bone mass while Lactating but rapidly regain it within 6 months after weaning.']	[('FULL_UNKNOWN', 0), ('INCOMPLETE_EVIDENCE', 10), ('INCOMPLETE_EVIDENCE', 29), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 37), ('INCOMPLETE_EVIDENCE', 226), ('PROBABLE_UNDERSTANDING', 245)]	6	[('GO_0007567', 'parturition', 89, 'birth'), ('GO_0007565', 'female pregnancy', 106, 'gestational'), ('CHEBI_27300', 'vitamin D', 137, 'vitamin D'), ('UBERON_0002048', 'lung', 182, 'lung'), ('GO_0007565', 'female pregnancy', 319, 'pregnant'), ('CHEBI_31341', 'calcium dihydroxide', 343, 'Calcium'), ('GO_0007594', 'puparial adhesion', 396, 'lactating')]
PMC4949006	7/2016	S195-PMC4949006	['there is NO GOOD current EVIDENCE to SHOW value in supplementation for iron and vitamins A, B6, B12, A, e, or D at this time, ALTHOUGH there are many SUGGESTIVE STUDIES for Vitamin D. all Pregnant women SHOULD BE ENCOURAGED to eat a balanced diet rich in fresh or frozen fruits and vegetables, high-quality Carbohydrates including whole grains, and with a good mix of proteins from beans, lean meats, fish, and seafood.']	[('FULL_UNKNOWN', 9), ('INCOMPLETE_EVIDENCE', 25), ('INCOMPLETE_EVIDENCE', 37), ('ANOMALY_CURIOUS_FINDING', 126), ('INCOMPLETE_EVIDENCE', 150), ('FUTURE_WORK', 203), ('FUTURE_WORK', 213)]	7	[('PR_000004370', 'asialoglycoprotein receptor 2', 89, 'A'), ('PR_000004690', 'B-cell lymphoma/leukemia 11A', 92, 'B6'), ('PR_000004738', 'class E basic helix-loop-helix protein 22', 96, 'B12'), ('PR_000004370', 'asialoglycoprotein receptor 2', 101, 'A'), ('PR_000006444', 'diacylglycerol kinase delta', 110, 'D'), ('CHEBI_27300', 'vitamin D', 173, 'vitamin D'), ('GO_0007565', 'female pregnancy', 188, 'pregnant'), ('CHEBI_16646', 'carbohydrate', 307, 'carbohydrates')]
PMC4976416	7/2016	S85-PMC4976416	['conclusion\nDESPITE development of new Formulations for use in cosmetics and skin care products, there is a LACK OF controlled clinical trials providing a rationale for well-defined dosages and clinical indications for oral and topical Vitamin E. after so MANY YEARS of RESEARCH on Vitamin E, it is STILL UNCLEAR as to WHETHER millions of dollars worth of Vitamin E products paid for by patients and consumers have been of any benefit.']	[('ANOMALY_CURIOUS_FINDING', 11), ('INCOMPLETE_EVIDENCE', 107), ('INCOMPLETE_EVIDENCE', 255), ('INCOMPLETE_EVIDENCE', 269), ('FULL_UNKNOWN', 298), ('IMPORTANT_CONSIDERATION', 298), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 318)]	7	[('CHEBI_38864', 'propetamphos', 38, 'formulations'), ('CHEBI_27300', 'vitamin D', 235, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 281, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 355, 'vitamin E')]
PMC4971719	8/2016	S93-PMC4971719	['NO threshold has been ESTABLISHED for prevention of other diseases HYPOTHESIZED to be RELATED to Vitamin D status [43,45–47].']	[('FULL_UNKNOWN', 0), ('INCOMPLETE_EVIDENCE', 67), ('SUPERFICIAL_RELATIONSHIP', 86)]	3	[('CHEBI_27300', 'vitamin D', 97, 'vitamin D')]
PMC4973215	8/2016	S99-PMC4973215	['corresponding maternal Vitamin D status at different Gestations during Pregnancy was UNKNOWN.']	[('FULL_UNKNOWN', 85)]	1	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('GO_0007565', 'female pregnancy', 53, 'gestations'), ('GO_0007565', 'female pregnancy', 71, 'pregnancy')]
PMC4979151	8/2016	S0-PMC4979151	['Prenatal high-dose Vitamin D3Supplementation has balanced EFFECTS on Cord Blood th1 and th2 Responses\n\nabstract\n\nbackground\nantenatal Vitamin D3(vitd3) supplementation significantly increases maternal and neonatal 25-Hydroxyvitamin D3(25(Oh)D3) concentration, YET the EFFECT of an improvement in maternal-fetal Vitamin D status on the neonatal immune response is UNCLEAR.']	[('SUPERFICIAL_RELATIONSHIP', 58), ('ANOMALY_CURIOUS_FINDING', 260), ('SUPERFICIAL_RELATIONSHIP', 268), ('FULL_UNKNOWN', 363)]	4	[('GO_0007565', 'female pregnancy', 0, 'Prenatal'), ('CHEBI_52915', 'phosphatediyl group', 19, 'vitamin D3supplementation'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 19, 'vitamin D3supplementation'), ('UBERON_0002240', 'spinal cord', 69, 'cord'), ('UBERON_0000178', 'blood', 74, 'blood'), ('GO_0060033', 'anatomical structure regression', 92, 'responses'), ('CHEBI_33279', 'vitamin D5', 134, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 134, 'vitamin D3'), ('CHEBI_63991', '15-epi-lipoxin B4', 214, '25-hydroxyvitamin D3'), ('PR_000001177', 'D(2) dopamine receptor', 232, 'D3'), ('CHEBI_62946', 'ammonium sulfate', 235, '25(OH)D3'), ('PR_000001177', 'D(2) dopamine receptor', 241, 'D3'), ('CHEBI_27300', 'vitamin D', 311, 'vitamin D')]
PMC4979151	8/2016	S35-PMC4979151	['there is NO standard classification of Vitamin D status based on 25(Oh)D3Concentrations in Cord Blood; THUS, for the PURPOSE of the PRESENT STUDY we stratified the participants into four groups based on Serum 25(Oh)D concentrations as done earlier [20] :(1) ≥76\xa0nmol/l (high); (2) 50–75\xa0nmol/l (moderate); (3) 30–49\xa0nmol/l (low); (4) <30\xa0nmol/l (very low).']	[('FULL_UNKNOWN', 9), ('PROBABLE_UNDERSTANDING', 103), ('QUESTION_ANSWERED_BY_THIS_WORK', 117), ('QUESTION_ANSWERED_BY_THIS_WORK', 132)]	4	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D'), ('CHEBI_73735', 'gadoterate', 65, '25(OH)D3concentrations'), ('PR_000029608', 'DISP complex protein LRCH3', 65, '25 ... OH ... D3concentrations'), ('UBERON_0002240', 'spinal cord', 91, 'cord'), ('UBERON_0000178', 'blood', 96, 'blood'), ('UBERON_0001977', 'blood serum', 203, 'serum'), ('CHEBI_71657', 'versiconol acetate', 209, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 209, '25(OH)D')]
PMC4989298	8/2016	S362-PMC4989298	['the study conclusions were that there was not SUFFICIENT evidence to establish a causal CONNECTION; there were also NO RANDOMISED clinical trial (rct) on the effect of supplementation of Vitamin D and risk of asthma.']	[('IMPORTANT_CONSIDERATION', 46), ('SUPERFICIAL_RELATIONSHIP', 88), ('FULL_UNKNOWN', 116)]	3	[('CHEBI_27300', 'vitamin D', 187, 'vitamin D')]
PMC4989298	8/2016	S370-PMC4989298	['published an exhaustive review CONCLUDING that there were NO conclusive DATA identifying a POSSIBLE dose of Vitamin D resulting in PREVENTION of Food allergy [126].']	[('INCOMPLETE_EVIDENCE', 31), ('PROBABLE_UNDERSTANDING', 31), ('FULL_UNKNOWN', 58), ('INCOMPLETE_EVIDENCE', 91), ('SUPERFICIAL_RELATIONSHIP', 131)]	5	[('CHEBI_27300', 'vitamin D', 108, 'vitamin D'), ('CHEBI_33290', 'food', 145, 'food')]
PMC4990268	8/2016	S362-PMC4990268	['HOWEVER, there is significant heterogeneity in results with benefit EVIDENT in settings with significant maternal Vitamin A deficiency but no benefit when maternal Vitamin A deficiency is LACKING.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 68), ('FULL_UNKNOWN', 188)]	3	[('CHEBI_27300', 'vitamin D', 114, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 164, 'vitamin A')]
PMC4992225	8/2016	S63-PMC4992225	['ACCORDING TO OUR KNOWLEDGE, THERE WAS NO clinical trial that has evaluated the effectiveness of Vitamin D on Perinatal depression.']	[('INCOMPLETE_EVIDENCE', 0), ('PROBABLE_UNDERSTANDING', 10), ('FULL_UNKNOWN', 28)]	3	[('CHEBI_27300', 'vitamin D', 96, 'vitamin D'), ('GO_0036268', 'swimming', 109, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 109, 'perinatal')]
PMC4992225	8/2016	S105-PMC4992225	['the multivitamin supplementations contained 200–400\xa0iu of Vitamin D.\n\nsample size and statistical analysis\nwe COULD NOT FIND a similar study to use its means for determining the sample size.']	[('FULL_UNKNOWN', 110)]	1	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D')]
PMC4992225	8/2016	S182-PMC4992225	['they were suffering from Vitamin D deficiency BASED ON NEW perspective towards normal Serum Vitamin D concentration [46].']	[('SUPERFICIAL_RELATIONSHIP', 46), ('FULL_UNKNOWN', 55)]	2	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('UBERON_0001977', 'blood serum', 86, 'serum'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin D')]
PMC4992225	8/2016	S238-PMC4992225	['PREVIOUS clinical TRIALS, in which Vitamin D supplementations were consumed during Pregnancy [18,58], HAVE NOT EVALUATED the Antenatal and Postnatal depression disorders.']	[('INCOMPLETE_EVIDENCE', 0), ('FULL_UNKNOWN', 102), ('FULL_UNKNOWN', 107)]	3	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('GO_0007565', 'female pregnancy', 83, 'pregnancy'), ('GO_0007567', 'parturition', 125, 'antenatal'), ('GO_0007567', 'parturition', 139, 'postnatal')]
PMC4992225	8/2016	S240-PMC4992225	['ON THE OTHER HAND, the EFFECT of Vitamin D on depression in non-Pregnant People are NOT entirely CLEAR.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 23), ('FULL_UNKNOWN', 84)]	3	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('GO_0007565', 'female pregnancy', 64, 'pregnant'), ('NCBITaxon_10088', 'Mus <genus>', 73, 'people')]
PMC4992225	8/2016	S281-PMC4992225	['also, SINCE more than 95\xa0% of the mothers had lower than 30\xa0ng/ml Serum 25-Hydroxyvitamin D concentration, it is NOT CLEAR IF the same results WOULD BE OBSERVED in mothers with higher levels of 25-Hydroxyvitamin D. THEREFORE, we SUGGEST FURTHER clinical TRIALS, using 2000\xa0iu Vitamin D on a larger population, mothers with high levels of depression, and high Serum 25-Hydroxyvitamin D concentrations.']	[('PROBLEM_COMPLICATION', 6), ('FULL_UNKNOWN', 113), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 123), ('FUTURE_PREDICTION', 143), ('INCOMPLETE_EVIDENCE', 152), ('PROBABLE_UNDERSTANDING', 215), ('INCOMPLETE_EVIDENCE', 229), ('FUTURE_WORK', 237)]	8	[('UBERON_0001977', 'blood serum', 66, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 72, '25-hydroxyvitamin D'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 194, '25-hydroxyvitamin D'), ('CHEBI_27300', 'vitamin D', 276, 'vitamin D'), ('UBERON_0001977', 'blood serum', 359, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 365, '25-hydroxyvitamin D')]
PMC4993554	8/2016	S175-PMC4993554	['although Liver is a rich source of key Nutrients such as Iron and Folate, avoiding it in Pregnancy is RECOMMENDED as it contains a high level of Vitamin A and the upper safer limit is UNCERTAIN.52a high dose of Vitamin A in Pregnancy poses a SERIOUS risk of Birth defects.53ALTHOUGH our study DID NOT provide information on HOW this low awareness of Vitamin A-rich source Food COULD AFFECT Pregnant women’s Food choices, written comments (open text sections of the survey) in the PRESENT STUDY INDICATED that SOME women MAY BE INFLUENCED by some of nonevidence-based information.']	[('FUTURE_WORK', 102), ('FULL_UNKNOWN', 184), ('IMPORTANT_CONSIDERATION', 242), ('ANOMALY_CURIOUS_FINDING', 272), ('INCOMPLETE_EVIDENCE', 293), ('EXPLICIT_QUESTION', 324), ('INCOMPLETE_EVIDENCE', 377), ('SUPERFICIAL_RELATIONSHIP', 383), ('QUESTION_ANSWERED_BY_THIS_WORK', 480), ('INCOMPLETE_EVIDENCE', 494), ('INCOMPLETE_EVIDENCE', 509), ('INCOMPLETE_EVIDENCE', 520), ('SUPERFICIAL_RELATIONSHIP', 527)]	13	[('UBERON_0002107', 'liver', 9, 'liver'), ('CHEBI_33284', 'nutrient', 39, 'nutrients'), ('CHEBI_24870', 'ion', 57, 'iron'), ('CHEBI_30863', '5-azaorotic acid', 66, 'folate'), ('GO_0007565', 'female pregnancy', 89, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 145, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 211, 'vitamin A'), ('GO_0007565', 'female pregnancy', 224, 'pregnancy'), ('GO_0007567', 'parturition', 258, 'birth'), ('CHEBI_27300', 'vitamin D', 350, 'vitamin A'), ('CHEBI_33290', 'food', 372, 'food'), ('GO_0007565', 'female pregnancy', 390, 'pregnant'), ('CHEBI_33290', 'food', 407, 'food')]
PMC4997421	8/2016	S23-PMC4997421	['THEREFORE, the OBJECTIVE of THIS STUDY was to use nhanes data to EXAMINE the Retinol status of women of Childbearing age in the united states, and TO ASSESS the IMPACT of poverty and race, as well as OTHER INDICATORS that have NOT previously BEEN EXAMINED in this population, including Food security and use of supplemental nutrition assistance programs (snap), on Vitamin A status.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('QUESTION_ANSWERED_BY_THIS_WORK', 28), ('QUESTION_ANSWERED_BY_THIS_WORK', 65), ('QUESTION_ANSWERED_BY_THIS_WORK', 147), ('SUPERFICIAL_RELATIONSHIP', 161), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 200), ('SUPERFICIAL_RELATIONSHIP', 206), ('FULL_UNKNOWN', 227)]	9	[('CHEBI_26536', 'retinoic acid', 77, 'retinol'), ('GO_0007129', 'homologous chromosome pairing at meiosis', 104, 'childbearing'), ('CHEBI_33290', 'food', 286, 'food'), ('CHEBI_27300', 'vitamin D', 365, 'vitamin A')]
PMC5029041	9/2016	S112-PMC5029041	['multiple Micronutrient supplements decrease lbw, fgr and stillbirths [69]; HOWEVER, WHETHER deficiencies of Micronutrients such as zinc, Calcium and Vitamin A INTERACT with malaria in Pregnancy REMAINS UNCLEAR [70].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 75), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 84), ('SUPERFICIAL_RELATIONSHIP', 159), ('FULL_UNKNOWN', 194)]	4	[('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 9, 'micronutrient'), ('CHEBI_33839', 'macromolecule', 108, 'micronutrients'), ('CHEBI_22313', 'alkaline earth metal atom', 137, 'calcium'), ('CHEBI_27300', 'vitamin D', 149, 'vitamin A'), ('GO_0007565', 'female pregnancy', 184, 'pregnancy')]
PMC5051327	9/2016	S19-PMC5051327	['SEVERAL STUDIES HAVE REPORTED increased frequency of emergency caesarean Delivery in RELATION to low Vitamin D,1415but NO PREVIOUS STUDY HAS BEEN particularly designed to study the RELATION between low Vitamin D levels, measured as 25-Hydroxy\xa0(Oh) Vitamin D, in early Pregnancy and the RISK for fetal distress/Birth asphyxia.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 16), ('SUPERFICIAL_RELATIONSHIP', 85), ('FULL_UNKNOWN', 119), ('INCOMPLETE_EVIDENCE', 131), ('INCOMPLETE_EVIDENCE', 137), ('SUPERFICIAL_RELATIONSHIP', 181), ('IMPORTANT_CONSIDERATION', 286)]	8	[('GO_0007567', 'parturition', 73, 'delivery'), ('CHEBI_27300', 'vitamin D', 101, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 202, 'vitamin D'), ('CHEBI_29991', 'L-aspartate(1-)', 232, '25-hydroxy (OH)'), ('CHEBI_27300', 'vitamin D', 248, 'vitamin D'), ('GO_0007565', 'female pregnancy', 268, 'pregnancy'), ('GO_0007567', 'parturition', 310, 'birth')]
PMC5085625	9/2016	S38-PMC5085625	['ALTHOUGH the biological ROLE of Vitamin D HAS BEEN studied extensively, the consequences of its deficiency for maternal, fetal and neonatal health are STILL UNCLEAR [4,22,24].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 24), ('INCOMPLETE_EVIDENCE', 42), ('FULL_UNKNOWN', 151)]	5	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D')]
PMC5085625	9/2016	S96-PMC5085625	['the mechanism through which a low concentration of Vitamin D CONTRIBUTES to preeclampsia is STILL UNCLEAR.']	[('SUPERFICIAL_RELATIONSHIP', 61), ('FULL_UNKNOWN', 92)]	2	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D')]
PMC5085625	9/2016	S109-PMC5085625	['ALTHOUGH preeclampsia HAS BEEN LINKED to maternal Vitamin D insufficiency/deficiency, STILL LITTLE IS KNOWN on POTENTIAL differences in Placental Metabolism Of this Vitamin in uncomplicated and preeclamptic Pregnancies [32].']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 22), ('SUPERFICIAL_RELATIONSHIP', 31), ('ANOMALY_CURIOUS_FINDING', 86), ('IMPORTANT_CONSIDERATION', 86), ('FULL_UNKNOWN', 92), ('INCOMPLETE_EVIDENCE', 111)]	7	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D'), ('GO_0007565', 'female pregnancy', 136, 'placental'), ('UBERON_0001987', 'placenta', 136, 'placental'), ('GO_0006583', 'melanin biosynthetic process from tyrosine', 146, 'metabolism of ... vitamin'), ('CHEBI_33229', 'vitamin (role)', 165, 'vitamin'), ('GO_0007565', 'female pregnancy', 207, 'pregnancies')]
PMC5039809	10/2016	S1-PMC5039809	['TO OUR KNOWLEDGE, the ASSOCIATIONS between maternal Vitamin A status and offspring Bone Development have NOT previously BEEN ELUCIDATED.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 22), ('FULL_UNKNOWN', 105)]	3	[('CHEBI_27300', 'vitamin D', 52, 'vitamin A'), ('GO_0048539', 'bone marrow development', 83, 'bone development')]
PMC5045784	10/2016	S80-PMC5045784	['current american academy of pediatrics GUIDELINES34RECOMMEND Vitamin D intake of 400\u2009iu per day for all children but there are NO specific GUIDELINES for preterm infants.']	[('PROBABLE_UNDERSTANDING', 39), ('PROBABLE_UNDERSTANDING', 39), ('FULL_UNKNOWN', 127)]	3	[('CHEBI_27300', 'vitamin D', 61, 'vitamin D')]
PMC5062906	10/2016	S16-PMC5062906	['WHILE the biological IMPORTANCE of these subtle changes REMAINS UNCLEAR, they WARRANT AN INVESTIGATION of epigenome-wide EFFECTS of maternal Vitamin D depletion.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('IMPORTANT_CONSIDERATION', 21), ('FULL_UNKNOWN', 56), ('FUTURE_WORK', 78), ('SUPERFICIAL_RELATIONSHIP', 121)]	6	[('CHEBI_27300', 'vitamin D', 141, 'vitamin D')]
PMC5062906	10/2016	S38-PMC5062906	['VERY LITTLE IS KNOWN about the ROLE of Vitamin D in epigenetic mechanisms.']	[('FULL_UNKNOWN', 0), ('SUPERFICIAL_RELATIONSHIP', 31)]	2	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D')]
PMC5062906	10/2016	S243-PMC5062906	['WHILE maternal Vitamin D deficiency resulted in both phenotypic and epigenetic changes in both generations, it REMAINS UNCLEAR WHETHER the Dna Methylation changes are causally LINKED to the phenotypic outcomes.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('FULL_UNKNOWN', 111), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 127), ('EXPLICIT_QUESTION', 127), ('SUPERFICIAL_RELATIONSHIP', 176)]	6	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D'), ('GO_0006306', 'DNA methylation', 139, 'DNA methylation')]
PMC5064894	10/2016	S37-PMC5064894	['first, THERE HAVE BEEN NO STUDIES examining the EFFECT of Prenatal Vitamin D supplementation on a primary outcome of laboratory-confirmed Viral Respiratory infections in the first 6\xa0months of Life, a high-risk period for both Vitamin D deficiency and Respiratory Tract infections.']	[('FULL_UNKNOWN', 7), ('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 48)]	4	[('GO_0007565', 'female pregnancy', 58, 'prenatal'), ('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('NCBITaxon_1', 'root', 138, 'viral'), ('UBERON_0001004', 'respiratory system', 144, 'respiratory'), ('UBERON_0000104', 'life cycle', 192, 'life'), ('CHEBI_27300', 'vitamin D', 226, 'vitamin D'), ('UBERON_0000065', 'respiratory tract', 251, 'respiratory tract')]
PMC5064894	10/2016	S38-PMC5064894	['second, the ROLE of Prenatal Vitamin D as a DETERMINANT of susceptibility to specific Viral infections has NOT BEEN EXAMINED.']	[('SUPERFICIAL_RELATIONSHIP', 12), ('SUPERFICIAL_RELATIONSHIP', 44), ('FULL_UNKNOWN', 107)]	3	[('GO_0007565', 'female pregnancy', 20, 'prenatal'), ('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('NCBITaxon_1', 'root', 86, 'viral')]
PMC5064894	10/2016	S39-PMC5064894	['third, THERE HAVE BEEN NO STUDIES assessing the ASSOCIATION between Vitamin D supplementation and quantitative Nasal carriage of streptococcus pneumoniae (pneumococcus), the most IMPORTANT cause of bacterial lrti in young children worldwide.']	[('FULL_UNKNOWN', 7), ('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 48), ('IMPORTANT_CONSIDERATION', 179)]	5	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('UBERON_0000004', 'nose', 111, 'nasal')]
PMC5084041	10/2016	S32-PMC5084041	['FEW STUDIES have investigated Vitamin D status longitudinally in a large cohort of Pregnant women, and knowledge of change in Vitamin D status during Pregnancy and its DETERMINANTS are LACKING.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 168), ('FULL_UNKNOWN', 185)]	3	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('GO_0007565', 'female pregnancy', 83, 'pregnant'), ('CHEBI_27300', 'vitamin D', 126, 'vitamin D'), ('GO_0007565', 'female pregnancy', 150, 'pregnancy')]
PMC5129897	10/2016	S23-PMC5129897	['the PURPOSE of THIS NEW STUDY is to revisit Vitamin D concentrations of canadians and to ESTIMATE the economic BENEFIT of increasing 25(Oh)D concentrations, with the knowledge that overall 25(Oh)D concentrations have gone down since our PREVIOUS STUDY.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('FULL_UNKNOWN', 20), ('INCOMPLETE_EVIDENCE', 89), ('IMPORTANT_CONSIDERATION', 111), ('INCOMPLETE_EVIDENCE', 237)]	6	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 133, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 139, 'D'), ('CHEBI_71657', 'versiconol acetate', 189, '25(OH)D')]
PMC5118763	12/2016	S203-PMC5118763	['in conclusion, women assigned to the mmn regimen had a higher concentration of Plasma Vitamin B-12, ALTHOUGH the PUBLIC HEALTH SIGNIFICANCE of the size of the EFFECT is UNCERTAIN.']	[('ANOMALY_CURIOUS_FINDING', 100), ('IMPORTANT_CONSIDERATION', 113), ('IMPORTANT_CONSIDERATION', 127), ('SUPERFICIAL_RELATIONSHIP', 159), ('FULL_UNKNOWN', 169)]	5	[('UBERON_0001969', 'blood plasma', 79, 'plasma'), ('CHEBI_27300', 'vitamin D', 86, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 86, 'vitamin B-12')]
PMC5146866	12/2016	S99-PMC5146866	['TO THE BEST OF OUR KNOWLEDGE, NO PRIOR STUDY has investigated the clinical status of neonates in ASSOCIATION with cb Vitamin D levels.']	[('PROBABLE_UNDERSTANDING', 0), ('FULL_UNKNOWN', 30), ('SUPERFICIAL_RELATIONSHIP', 97)]	3	[('CHEBI_27300', 'vitamin D', 117, 'vitamin D')]
PMC5155676	12/2016	S20-PMC5155676	['ALTHOUGH Vitamin D supplementation CAN improve maternal 25(Oh)D status (10), LITTLE IS KNOWN about HOW maternal characteristics MIGHT INFLUENCE the 25(Oh)d achieved after supplementation.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 35), ('FULL_UNKNOWN', 77), ('EXPLICIT_QUESTION', 99), ('INCOMPLETE_EVIDENCE', 128), ('SUPERFICIAL_RELATIONSHIP', 134)]	6	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 56, '25(OH)D'), ('CHEBI_30778', 'gallic acid', 148, '25(OH)')]
PMC5155676	12/2016	S125-PMC5155676	['ALTHOUGH OUR FINDINGS are NOVEL, and MAY enable the development of individualized ADVICE for Antenatal Vitamin D supplementation, there are a NUMBER OF LIMITATIONS which SHOULD BE CONSIDERED in the INTERPRETATION of this study.']	[('ANOMALY_CURIOUS_FINDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 9), ('FULL_UNKNOWN', 26), ('INCOMPLETE_EVIDENCE', 37), ('FUTURE_WORK', 82), ('INCOMPLETE_EVIDENCE', 142), ('INCOMPLETE_EVIDENCE', 152), ('PROBLEM_COMPLICATION', 152), ('FUTURE_WORK', 170), ('FUTURE_WORK', 180), ('INCOMPLETE_EVIDENCE', 198)]	11	[('GO_0007567', 'parturition', 93, 'antenatal'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin D')]
PMC5318550	2/2017	S19-PMC5318550	['HOWEVER, an integral test of these POSSIBLE explanations for the RISK of POOR Neurodevelopmental outcomes is LACKING and newer HYPOTHESES, such as variation in Vitamin D levels, HAVE NOT BEEN INVESTIGATED.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 35), ('IMPORTANT_CONSIDERATION', 65), ('IMPORTANT_CONSIDERATION', 73), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 109), ('FULL_UNKNOWN', 109), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 127), ('INCOMPLETE_EVIDENCE', 127), ('FULL_UNKNOWN', 178), ('IMPORTANT_CONSIDERATION', 178)]	10	[('GO_0007399', 'nervous system development', 78, 'neurodevelopmental'), ('CHEBI_27300', 'vitamin D', 160, 'vitamin D')]
PMC5322422	2/2017	S67-PMC5322422	['HOWEVER, authors SPECULATE these ESTIMATES are lower than the actual figures because the number of exclusively Breastfed infants who do not receive intramuscular Vitamin K are UNKNOWN.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 17), ('INCOMPLETE_EVIDENCE', 33), ('FULL_UNKNOWN', 176)]	4	[('GO_0007567', 'parturition', 111, 'breastfed'), ('CHEBI_27300', 'vitamin D', 162, 'vitamin K')]
PMC5332602	3/2017	S53-PMC5332602	['the normal ranges of the levels of these elements in the Plasma or Serum of conventional Suckling Piglets are 44 to 91\xa0mg/dl for Glucose, 5.8 to 8.1\xa0g/dl for protein, 3.2 to 4.2\xa0g/dl for Albumin, 100 to 350\xa0ng/ml for Vitamin A, 0.4 to 5\xa0μg/ml for Vitamin E, and 50 to 150\xa0ng/ml for Selenium; HOWEVER, the respective ranges in gn Pigs are NOT ESTABLISHED.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 292), ('ANOMALY_CURIOUS_FINDING', 292), ('FULL_UNKNOWN', 338)]	3	[('UBERON_0001969', 'blood plasma', 57, 'plasma'), ('UBERON_0001977', 'blood serum', 67, 'serum'), ('GO_0001967', 'suckling behavior', 89, 'suckling'), ('NCBITaxon_33208', 'Metazoa', 98, 'piglets'), ('CHEBI_17234', 'glucose', 129, 'glucose'), ('PR_000005908', 'alpha-crystallin B chain', 187, 'albumin'), ('CHEBI_27300', 'vitamin D', 217, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 247, 'vitamin E'), ('CHEBI_27568', 'selenium atom', 282, 'selenium'), ('NCBITaxon_10088', 'Mus <genus>', 329, 'pigs')]
PMC5340372	3/2017	S1-PMC5340372	['HOWEVER, the RELATIONSHIP between Vitamin D levels and Lung function in infancy has NOT BEEN INVESTIGATED.']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 13), ('FULL_UNKNOWN', 84)]	3	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('UBERON_0002048', 'lung', 55, 'lung')]
PMC5340372	3/2017	S25-PMC5340372	['HOWEVER, the RELATIONSHIP between Vitamin D levels and Respiratory function during infancy has NOT YET been clarified.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 13), ('FULL_UNKNOWN', 95)]	3	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 55, 'respiratory')]
PMC5340372	3/2017	S130-PMC5340372	['HOWEVER, the exact ASSOCIATION between single Cord-Serum Vitamin D level and Postnatal immunity is UNCLEAR.']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 19), ('FULL_UNKNOWN', 99)]	3	[('UBERON_0002240', 'spinal cord', 46, 'cord'), ('UBERON_0001977', 'blood serum', 51, 'serum'), ('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('GO_0007567', 'parturition', 77, 'postnatal')]
PMC5351212	3/2017	S10-PMC5351212	['conclusions\nthis work RAISES the POSSIBILITY that early dietary supplementation with Vitamin D MAY open NEW AVENUES for a successful attenuation or EVEN PREVENTION of Neurodevelopmental disorders following maternal inflammation during Pregnancy.']	[('EXPLICIT_QUESTION', 22), ('INCOMPLETE_EVIDENCE', 33), ('INCOMPLETE_EVIDENCE', 95), ('FULL_UNKNOWN', 104), ('FUTURE_WORK', 108), ('ANOMALY_CURIOUS_FINDING', 148), ('SUPERFICIAL_RELATIONSHIP', 153)]	7	[('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('GO_0007399', 'nervous system development', 167, 'neurodevelopmental'), ('GO_0007565', 'female pregnancy', 235, 'pregnancy')]
PMC5372327	3/2017	S3-PMC5372327	['it REMAINS UNCLEAR WHETHER the RECOMMENDED doses are sufficient for the wide array of OTHER EFFECTS of Vitamin D. the vidi trial performed in finland is the FIRST large randomised controlled study for evaluation of the EFFECTS of different Vitamin D supplemental doses in infancy on:\nbone strength\ninfections and immunity\nallergy, atopy and asthma\nCognitive development\nGenetic Regulation Of Mineral Homeostasis\n\nmethods/design\nvidi, a randomised controlled double-blinded single-centre intervention study is conducted in infants from the age of 2\xa0weeks to 24\xa0months.']	[('FULL_UNKNOWN', 3), ('INCOMPLETE_EVIDENCE', 3), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 19), ('FUTURE_WORK', 31), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 86), ('SUPERFICIAL_RELATIONSHIP', 92), ('INCOMPLETE_EVIDENCE', 157), ('SUPERFICIAL_RELATIONSHIP', 219)]	8	[('CHEBI_27300', 'vitamin D', 103, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 240, 'vitamin D'), ('GO_0050890', 'cognition', 348, 'cognitive'), ('SO_0000704', 'gene', 370, 'genetic'), ('GO_1900046', 'regulation of hemostasis', 378, 'regulation of ... homeostasis'), ('CHEBI_46662', 'mineral', 392, 'mineral')]
PMC5372327	3/2017	S127-PMC5372327	['results from this study will LIKELY generate NOVEL EVIDENCE-BASED INFORMATION for improving Vitamin D status among the paediatric population worldwide.']	[('PROBABLE_UNDERSTANDING', 29), ('FULL_UNKNOWN', 45), ('INCOMPLETE_EVIDENCE', 51), ('INCOMPLETE_EVIDENCE', 66)]	4	[('CHEBI_27300', 'vitamin D', 92, 'vitamin D')]
PMC5368580	4/2017	S184-PMC5368580	['the transport mechanisms INVOLVED with niacin and Vitamin B-6 are UNKNOWN (11,35).']	[('SUPERFICIAL_RELATIONSHIP', 25), ('FULL_UNKNOWN', 66)]	2	[('CHEBI_27300', 'vitamin D', 50, 'vitamin B'), ('PR_000017255', 'Vang-like protein 1', 50, 'vitamin B-6')]
PMC5385921	4/2017	S1-PMC5385921	['the ASSOCIATION between Vitamin D deficiency during Gestation, a CRITICAL period in Neurodevelopment, and asd is NOT WELL UNDERSTOOD.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('IMPORTANT_CONSIDERATION', 65), ('FULL_UNKNOWN', 113)]	3	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('GO_0007565', 'female pregnancy', 52, 'gestation'), ('GO_0007399', 'nervous system development', 84, 'neurodevelopment')]
PMC5405075	4/2017	S13-PMC5405075	['HOWEVER, it REMAINS UNCLEAR WHETHER maternal Vitamin D deficiency MAY CONTRIBUTE to the development of childhood asthma OR it is the consequence of a GENERALLY altered biochemistry.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('FULL_UNKNOWN', 12), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 28), ('INCOMPLETE_EVIDENCE', 66), ('SUPERFICIAL_RELATIONSHIP', 70), ('PROBABLE_UNDERSTANDING', 150)]	7	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D')]
PMC5405075	4/2017	S96-PMC5405075	['SHIFTING the discussion to a clinical platform, Vitamin D administration during Pregnancy has NOT YET been justified.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FULL_UNKNOWN', 94)]	2	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('GO_0007565', 'female pregnancy', 80, 'pregnancy')]
PMC5418719	5/2017	S100-PMC5418719	['HOWEVER, the exact and efficient timing of Vitamin D-dependent absorption of calcium REMAINS UNKNOWN in preterm infants.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FULL_UNKNOWN', 85)]	2	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D')]
PMC5474873	6/2017	S161-PMC5474873	['we had NO biological DATA on Vitamin D levels, which COULD have established a clear LINK to Vitamin D, ALTHOUGH it is WELL KNOWN that sun exposure is the MOST IMPORTANT DETERMINANT of Vitamin D status (9,13).']	[('FULL_UNKNOWN', 7), ('INCOMPLETE_EVIDENCE', 53), ('SUPERFICIAL_RELATIONSHIP', 84), ('ANOMALY_CURIOUS_FINDING', 103), ('INCOMPLETE_EVIDENCE', 118), ('PROBABLE_UNDERSTANDING', 154), ('IMPORTANT_CONSIDERATION', 159), ('SUPERFICIAL_RELATIONSHIP', 169)]	8	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 184, 'vitamin D')]
PMC5489519	6/2017	S2-PMC5489519	['WHILE Tumor Necrosis Factor-Related Apoptosis Inducing Ligand (Trail) HAS BEEN IMPLICATED in Cellular growth/Apoptosis, Immune Cell function and Bone-Resorbing Osteoclast formation, the Expression of Trail in Human milk as a function of Vitamin D status in mothers REMAINS UNKNOWN.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 70), ('SUPERFICIAL_RELATIONSHIP', 79), ('FULL_UNKNOWN', 265)]	4	[('PR_000000035', 'BMP receptor type-1A', 6, 'tumor necrosis factor-related apoptosis inducing ligand'), ('GO_0006915', 'apoptotic process', 36, 'apoptosis'), ('PR_000001949', 'tumor necrosis factor ligand superfamily member 4', 63, 'TRAIL'), ('GO_0006915', 'apoptotic process', 93, 'cellular ... apoptosis'), ('CL_0000738', 'leukocyte', 120, 'immune cell'), ('UBERON_0002405', 'immune system', 120, 'immune'), ('GO_0046849', 'bone remodeling', 145, 'bone-resorbing'), ('CL_0000092', 'osteoclast', 160, 'osteoclast'), ('GO_0010467', 'gene expression', 186, 'expression'), ('PR_000001949', 'tumor necrosis factor ligand superfamily member 4', 200, 'TRAIL'), ('NCBITaxon_9606', 'Homo sapiens', 209, 'human'), ('CHEBI_27300', 'vitamin D', 237, 'vitamin D')]
PMC5489519	6/2017	S20-PMC5489519	['HOWEVER, it is UNKNOWN WHETHER Vitamin D deficiency in Lactating mothers Modulates the Expression of cellular factor(s) in Human Milk that is ASSOCIATED with Immune health and Skeletal Development in breastfeeding infants.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('FULL_UNKNOWN', 15), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 23), ('SUPERFICIAL_RELATIONSHIP', 142)]	5	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('GO_0007594', 'puparial adhesion', 55, 'lactating'), ('GO_0065007', 'biological regulation', 73, 'modulates'), ('GO_0010467', 'gene expression', 87, 'expression'), ('NCBITaxon_9606', 'Homo sapiens', 123, 'human'), ('UBERON_0001913', 'milk', 129, 'milk'), ('UBERON_0002405', 'immune system', 158, 'immune'), ('GO_0001501', 'skeletal system development', 176, 'skeletal development'), ('UBERON_0004288', 'skeleton', 176, 'skeletal')]
PMC5513133	7/2017	S231-PMC5513133	['the ROLE of Fish Oils in pe REMAINS UNCERTAIN and SIMILARLY poses a CHALLENGE in determining an isolated EFFECT of Vitamin D supplementation, UNLESS studies are designed such that they CONSIDER this.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 28), ('FULL_UNKNOWN', 36), ('SUPERFICIAL_RELATIONSHIP', 50), ('DIFFICULT_TASK', 68), ('SUPERFICIAL_RELATIONSHIP', 105), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 142), ('FUTURE_WORK', 142), ('INCOMPLETE_EVIDENCE', 185)]	9	[('CHEBI_39279', 'halomethane', 12, 'fish oils'), ('CHEBI_27300', 'vitamin D', 115, 'vitamin D')]
PMC5524288	7/2017	S0-PMC5524288	['maternal 25(Oh)D concentrations ≥40 ng/ml ASSOCIATED with 60% lower Preterm Birth RISK among general obstetrical patients at an urban medical center\n\nabstract\n\nbackground\nGIVEN the HIGH RATE of Preterm Birth (ptb) nationwide and data from rcts DEMONSTRATING risk reduction with Vitamin D supplementation, the medical university of south carolina (musc) implemented a NEW standard of care for Pregnant women to receive Vitamin D testing and supplementation.']	[('SUPERFICIAL_RELATIONSHIP', 42), ('IMPORTANT_CONSIDERATION', 82), ('INCOMPLETE_EVIDENCE', 171), ('IMPORTANT_CONSIDERATION', 181), ('INCOMPLETE_EVIDENCE', 244), ('FULL_UNKNOWN', 367)]	6	[('CHEBI_71657', 'versiconol acetate', 9, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 9, '25(OH)D'), ('GO_0007565', 'female pregnancy', 68, 'preterm birth'), ('GO_0007565', 'female pregnancy', 194, 'preterm birth'), ('CHEBI_27300', 'vitamin D', 278, 'vitamin D'), ('GO_0007565', 'female pregnancy', 392, 'pregnant'), ('CHEBI_27300', 'vitamin D', 418, 'vitamin D')]
PMC5524288	7/2017	S24-PMC5524288	['trials, the medical university of south carolina (musc) INITIATED a NEW standard of care for Pregnant women that included routine Vitamin D testing and supplementation in september 2015.']	[('INCOMPLETE_EVIDENCE', 56), ('FULL_UNKNOWN', 68)]	2	[('GO_0007565', 'female pregnancy', 93, 'pregnant'), ('CHEBI_27300', 'vitamin D', 130, 'vitamin D')]
PMC5537904	7/2017	S17-PMC5537904	['WHILE NUMEROUS STUDIES HAVE REPORTED that higher maternal Vitamin D intake (from Food and/or dietary supplements) is ASSOCIATED with increased Prenatal and/or cord Blood 25(Oh)D levels [14,15,16,17], it is NOT CLEAR WHETHER this TRANSLATES TO an EFFECT on neonatal adiposity.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 6), ('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 117), ('FULL_UNKNOWN', 206), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 216), ('SUPERFICIAL_RELATIONSHIP', 229), ('SUPERFICIAL_RELATIONSHIP', 246)]	8	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('CHEBI_33290', 'food', 81, 'food'), ('GO_0007565', 'female pregnancy', 143, 'prenatal'), ('UBERON_0000178', 'blood', 164, 'blood'), ('CHEBI_71657', 'versiconol acetate', 170, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 176, 'D')]
PMC5537904	7/2017	S171-PMC5537904	['IT IS POSSIBLE that VARIATIONS in absorption and specific sources of Vitamin D (D2Versus D3) ACCOUNT FOR our differing ESTIMATE, and THUS should be INTERPRETED with caution.']	[('INCOMPLETE_EVIDENCE', 0), ('DIFFICULT_TASK', 20), ('PROBABLE_UNDERSTANDING', 93), ('INCOMPLETE_EVIDENCE', 119), ('PROBABLE_UNDERSTANDING', 133), ('FULL_UNKNOWN', 148)]	6	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('PR_000006770', 'cytoplasmic dynein 1 heavy chain 1', 80, 'D2versus D3')]
PMC5537904	7/2017	S180-PMC5537904	['we used season of Birth as a crude measurement of sun exposure because we DID NOT have direct measures of uvb-synthesized Vitamin D, and THUS our results for the relative CONTRIBUTION of Oral Intake versus sun exposure SHOULD BE INTERPRETED with CAUTION.']	[('INCOMPLETE_EVIDENCE', 74), ('PROBABLE_UNDERSTANDING', 137), ('SUPERFICIAL_RELATIONSHIP', 171), ('FUTURE_WORK', 219), ('FULL_UNKNOWN', 229), ('INCOMPLETE_EVIDENCE', 246)]	6	[('GO_0007567', 'parturition', 18, 'birth'), ('CHEBI_27300', 'vitamin D', 122, 'vitamin D'), ('UBERON_0000165', 'mouth', 187, 'oral'), ('GO_0007631', 'feeding behavior', 192, 'intake')]
PMC5546866	8/2017	S0-PMC5546866	['response to antenatal Cholecalciferol supplementation is ASSOCIATED with common Vitamin D–related Genetic variants\n\nabstract\n\ncontext:\nSingle-Nucleotide Polymorphisms (Snps) in Genes RELATED to Vitamin D Metabolism HAVE BEEN ASSOCIATED with Serum 25-Hydroxyvitamin D [25(Oh)D] concentration, BUT these RELATIONSHIPS have NOT BEEN EXAMINED following Antenatal Cholecalciferol supplementation.']	[('SUPERFICIAL_RELATIONSHIP', 57), ('SUPERFICIAL_RELATIONSHIP', 183), ('INCOMPLETE_EVIDENCE', 215), ('SUPERFICIAL_RELATIONSHIP', 225), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 292), ('SUPERFICIAL_RELATIONSHIP', 302), ('FULL_UNKNOWN', 321)]	7	[('CHEBI_16113', 'cholesterol', 22, 'Cholecalciferol'), ('CHEBI_28384', 'vitamin K', 80, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 80, 'Vitamin D'), ('SO_0000704', 'gene', 98, 'Genetic'), ('SO_0000694', 'SNP', 135, 'Single-nucleotide polymorphisms'), ('SO_0000694', 'SNP', 168, 'SNPs'), ('SO_0000704', 'gene', 177, 'genes'), ('CHEBI_27300', 'vitamin D', 194, 'vitamin D'), ('GO_0018977', '1,1,1-trichloro-2,2-bis-(4-chlorophenyl)ethane metabolic process', 202, 'D metabolism'), ('UBERON_0001977', 'blood serum', 241, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 247, '25-hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 268, '25(OH)D'), ('GO_0007567', 'parturition', 349, 'antenatal'), ('CHEBI_52550', 'theopalauamide', 359, 'cholecalciferol')]
PMC5579643	8/2017	S64-PMC5579643	['HOWEVER, clinical trials on Vitamin D supplementation in children and the POSSIBLE ROLE in preventing Food allergy are LACKING.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 74), ('SUPERFICIAL_RELATIONSHIP', 83), ('FULL_UNKNOWN', 119)]	4	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('CHEBI_33290', 'food', 102, 'food')]
PMC5638722	8/2017	S125-PMC5638722	['secondly, we also DO NOT HAVE data related to OTHER dietary factors which COULD BE INTERFERING with Vitamin D level.']	[('FULL_UNKNOWN', 18), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 46), ('INCOMPLETE_EVIDENCE', 74), ('SUPERFICIAL_RELATIONSHIP', 83)]	4	[('CHEBI_27300', 'vitamin D', 100, 'vitamin D')]
PMC5623264	9/2017	S108-PMC5623264	['vitamin a supplementation with other Micronutrients (Iron\xa0+\xa0Folate) compared with Micronutrient supplementation without Vitamin A had a positive EFFECT and reduced the risk of lbw by 33%.24HOWEVER, THESE FINDINGS are from a study involving only hiv-positive women and when comparing Vitamin A supplementation alone versus placebo or no treatment, a reduction of lbw could NOT be OBSERVED.']	[('SUPERFICIAL_RELATIONSHIP', 145), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 187), ('INCOMPLETE_EVIDENCE', 198), ('FULL_UNKNOWN', 372)]	4	[('CHEBI_33839', 'macromolecule', 37, 'micronutrients'), ('CHEBI_24870', 'ion', 53, 'iron'), ('CHEBI_30863', '5-azaorotic acid', 60, 'folate'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 82, 'micronutrient'), ('CHEBI_27300', 'vitamin D', 120, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 283, 'vitamin A')]
PMC5664622	9/2017	S114-PMC5664622	['AS Vitamin D concentration was measured immediately before the Delivery, we LACK DATA on pre-Pregnancy, as well as the first Trimester of Pregnancy, values.']	[('PROBABLE_UNDERSTANDING', 0), ('FULL_UNKNOWN', 76)]	2	[('CHEBI_27300', 'vitamin D', 3, 'vitamin D'), ('GO_0007567', 'parturition', 63, 'delivery'), ('GO_0007565', 'female pregnancy', 93, 'pregnancy'), ('GO_0009294', 'DNA mediated transformation', 125, 'trimester'), ('GO_0007565', 'female pregnancy', 138, 'pregnancy')]
PMC5716389	9/2017	S43-PMC5716389	['there is NO INFORMATION on the ASSOCIATION between maternal Vitamin A status during Pregnancy and infant Immune Response.']	[('FULL_UNKNOWN', 9), ('SUPERFICIAL_RELATIONSHIP', 31)]	2	[('CHEBI_27300', 'vitamin D', 60, 'vitamin A'), ('GO_0007565', 'female pregnancy', 84, 'pregnancy'), ('GO_0006955', 'immune response', 105, 'immune response'), ('UBERON_0002405', 'immune system', 105, 'immune')]
PMC5634602	10/2017	S1-PMC5634602	['response to Vitamin D supplementation and IMPACT on outcomes in preterm infants is NOT WELL UNDERSTOOD.']	[('SUPERFICIAL_RELATIONSHIP', 42), ('FULL_UNKNOWN', 83)]	2	[('CHEBI_27300', 'vitamin D', 12, 'vitamin D')]
PMC5706533	11/2017	S173-PMC5706533	['although we intend to update this review regularly (the platform for FUTURE real time dissemination is STILL TO BE DETERMINED), we project LIMITED aggregate gains from the 35 MOSTLY SMALL TRIALS of Prenatal Vitamin D supplementation trials that are registered as completed, ongoing, or planned.']	[('FUTURE_WORK', 69), ('FULL_UNKNOWN', 103), ('INCOMPLETE_EVIDENCE', 139), ('INCOMPLETE_EVIDENCE', 175), ('INCOMPLETE_EVIDENCE', 182)]	5	[('GO_0007565', 'female pregnancy', 198, 'prenatal'), ('CHEBI_27300', 'vitamin D', 207, 'vitamin D')]
PMC5706533	11/2017	S178-PMC5706533	['what is already known on THIS topic\nnumerous randomised trials and systematic reviews of Vitamin D supplementation during Pregnancy HAVE BEEN published, with CONFLICTING results and conclusions\nrecommendations regarding Vitamin D supplementation vary widely among medical and professional organisations, and who currently RECOMMENDS against routine Prenatal Vitamin D supplementation\n\nwhat THIS STUDY adds\nsystematic review and meta-analyses of 43 trials including 8406 participants SHOWED that Prenatal Vitamin D supplementation was ASSOCIATED with increased maternal and cord Serum 25-Hydroxyvitamin D concentrations, increased mean birth weight, reduced the risk of small for Gestational age, reduced the risk of wheeze in offspring, and increased infant length at one year of age\nthere was a LACK OF EVIDENCE OF benefits of Prenatal Vitamin D supplementation for maternal health conditions RELATED to Pregnancy, no effect on other Birth outcomes of PUBLIC HEALTH IMPORTANCE such as Preterm Birth, and SCANT EVIDENCE on safety outcomes\nFEW of the trials were designed to test the EFFECT of Vitamin D on clinical or functional outcomes, and most trials were SMALL and at overall high or UNCERTAIN risk of bias\nthirty five planned or ongoing Prenatal Vitamin D trials COULD contribute an additional 12\u2009530 participants to FUTURE systematic reviews\n\npubmed central:']	[('QUESTION_ANSWERED_BY_THIS_WORK', 25), ('INCOMPLETE_EVIDENCE', 132), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 158), ('FUTURE_WORK', 322), ('QUESTION_ANSWERED_BY_THIS_WORK', 390), ('INCOMPLETE_EVIDENCE', 483), ('SUPERFICIAL_RELATIONSHIP', 534), ('INCOMPLETE_EVIDENCE', 796), ('SUPERFICIAL_RELATIONSHIP', 894), ('IMPORTANT_CONSIDERATION', 953), ('IMPORTANT_CONSIDERATION', 967), ('INCOMPLETE_EVIDENCE', 1005), ('INCOMPLETE_EVIDENCE', 1039), ('SUPERFICIAL_RELATIONSHIP', 1083), ('INCOMPLETE_EVIDENCE', 1160), ('FULL_UNKNOWN', 1189), ('INCOMPLETE_EVIDENCE', 1269), ('FUTURE_WORK', 1323)]	18	[('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('GO_0007565', 'female pregnancy', 122, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 220, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 228, 'D'), ('GO_0007565', 'female pregnancy', 349, 'prenatal'), ('CHEBI_27300', 'vitamin D', 358, 'vitamin D'), ('GO_0007565', 'female pregnancy', 495, 'prenatal'), ('CHEBI_27300', 'vitamin D', 504, 'vitamin D'), ('UBERON_0001977', 'blood serum', 578, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 584, '25-hydroxyvitamin D'), ('GO_0007565', 'female pregnancy', 679, 'gestational'), ('GO_0007565', 'female pregnancy', 828, 'prenatal'), ('CHEBI_27300', 'vitamin D', 837, 'vitamin D'), ('GO_0007565', 'female pregnancy', 905, 'pregnancy'), ('GO_0007567', 'parturition', 935, 'birth'), ('GO_0007565', 'female pregnancy', 986, 'preterm'), ('GO_0007567', 'parturition', 994, 'birth'), ('CHEBI_27300', 'vitamin D', 1093, 'vitamin D'), ('GO_0007565', 'female pregnancy', 1243, 'prenatal'), ('CHEBI_27300', 'vitamin D', 1252, 'vitamin D')]
PMC5707701	11/2017	S183-PMC5707701	['secondly, LITTLE IS KNOWN about the levels of Vitamins A and E in maternal Plasma ASSOCIATED with the corresponding Milk, which would be better than dietary Intake to assess maternal Nutrient status, DUE TO the IMPOSSIBILITY to collect such samples in our research.']	[('FULL_UNKNOWN', 10), ('SUPERFICIAL_RELATIONSHIP', 82), ('PROBLEM_COMPLICATION', 200), ('PROBLEM_COMPLICATION', 211)]	4	[('CHEBI_27300', 'vitamin D', 46, 'vitamins A'), ('PR_000004480', 'V-type proton ATPase catalytic subunit A', 46, 'vitamins A'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 61, 'E'), ('UBERON_0001969', 'blood plasma', 75, 'plasma'), ('UBERON_0001913', 'milk', 116, 'milk'), ('GO_0007631', 'feeding behavior', 157, 'intake'), ('CHEBI_33284', 'nutrient', 183, 'nutrient')]
PMC5707701	11/2017	S187-PMC5707701	['indeed, our results SHOWED that all of these milks, except for colostrum, did not meet an infant’s nutritional REQUIREMENT of Vitamin E. HOWEVER, we COULD NOT ESTIMATE the POSSIBLE supply of Vitamin A to the infant in the present study, DUE TO the LACKING detection of Retinol in Human milk.']	[('INCOMPLETE_EVIDENCE', 20), ('IMPORTANT_CONSIDERATION', 111), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 137), ('DIFFICULT_TASK', 149), ('INCOMPLETE_EVIDENCE', 155), ('INCOMPLETE_EVIDENCE', 172), ('PROBLEM_COMPLICATION', 237), ('FULL_UNKNOWN', 248)]	8	[('CHEBI_27300', 'vitamin D', 126, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 191, 'vitamin A'), ('CHEBI_26536', 'retinoic acid', 269, 'retinol'), ('NCBITaxon_9606', 'Homo sapiens', 280, 'human')]
PMC5732505	12/2017	S26-PMC5732505	['POOR maternal Vitamin D status HAS BEEN RELATED to fetal growth restriction [15] BUT it is UNKNOWN WHETHER maternal Vitamin D status ASSOCIATES with Birth size in infants with normal Birth weight.']	[('IMPORTANT_CONSIDERATION', 0), ('INCOMPLETE_EVIDENCE', 31), ('SUPERFICIAL_RELATIONSHIP', 40), ('ANOMALY_CURIOUS_FINDING', 81), ('FULL_UNKNOWN', 91), ('EXPLICIT_QUESTION', 99), ('SUPERFICIAL_RELATIONSHIP', 133)]	7	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D'), ('GO_0007567', 'parturition', 149, 'birth'), ('GO_0007567', 'parturition', 183, 'birth')]
PMC5758521	1/2018	S0-PMC5758521	['vitamin a and e nutritional status in RELATION to leptin, adiponectin, Igf-I and Igf-Ii in early Life - a Birth cohort study\n\nabstract\nthe Metabolic health EFFECTS of Vitamin A and E nutritional status in early Life are largely UNKNOWN.']	[('SUPERFICIAL_RELATIONSHIP', 38), ('SUPERFICIAL_RELATIONSHIP', 156), ('FULL_UNKNOWN', 228)]	3	[('PR_000008919', 'interferon alpha-6', 71, 'IGF-I'), ('PR_000002046', 'interferon regulatory factor 4', 81, 'IGF-II'), ('UBERON_0000104', 'life cycle', 97, 'Life'), ('GO_0007567', 'parturition', 106, 'Birth'), ('GO_0008152', 'metabolic process', 139, 'metabolic'), ('CHEBI_27300', 'vitamin D', 167, 'vitamin A'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 181, 'E'), ('UBERON_0000104', 'life cycle', 211, 'life')]
PMC5758521	1/2018	S9-PMC5758521	['however, the Metabolic health EFFECTS of Vitamin A and E nutritional status in early Life remain largely UNKNOWN.']	[('SUPERFICIAL_RELATIONSHIP', 30), ('FULL_UNKNOWN', 105)]	2	[('GO_0008152', 'metabolic process', 13, 'metabolic'), ('CHEBI_27300', 'vitamin D', 41, 'vitamin A'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 55, 'E'), ('UBERON_0000104', 'life cycle', 85, 'life')]
PMC5812027	2/2018	S24-PMC5812027	['THUS, the ASSOCIATION between Vitamin D status and neonatal Birth size is NOT CLEAR and WARRANTS FURTHER INVESTIGATION.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 10), ('FULL_UNKNOWN', 74), ('FUTURE_WORK', 88)]	4	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('GO_0007567', 'parturition', 60, 'birth')]
PMC5812027	2/2018	S122-PMC5812027	['WHETHER Vitamin D Metabolism is altered in Placental dysfunction in UNCLEAR and WARRANTS FURTHER INVESTIGATION.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FULL_UNKNOWN', 68), ('FUTURE_WORK', 80)]	3	[('CHEBI_27300', 'vitamin D', 8, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 8, 'vitamin D metabolism'), ('UBERON_0001987', 'placenta', 43, 'placental')]
PMC5827025	2/2018	S15-PMC5827025	['ALTHOUGH SOME POTENTIAL INFLUENT FACTORS for Vitamin D status, such as seasonality, age, smoking, race and ethnicity HAVE BEEN IDENTIFIED in SEVERAL case-control STUDIES6–8, research REPORTS on the INFLUENT FACTORS for Gestational Vitamin D status in a population-based cohort are LACKING.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 14), ('SUPERFICIAL_RELATIONSHIP', 24), ('SUPERFICIAL_RELATIONSHIP', 33), ('INCOMPLETE_EVIDENCE', 117), ('INCOMPLETE_EVIDENCE', 127), ('INCOMPLETE_EVIDENCE', 141), ('INCOMPLETE_EVIDENCE', 162), ('INCOMPLETE_EVIDENCE', 183), ('SUPERFICIAL_RELATIONSHIP', 198), ('SUPERFICIAL_RELATIONSHIP', 207), ('FULL_UNKNOWN', 281), ('INCOMPLETE_EVIDENCE', 281)]	15	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('GO_0007565', 'female pregnancy', 219, 'gestational'), ('CHEBI_27300', 'vitamin D', 231, 'vitamin D')]
PMC5838372	3/2018	S82-PMC5838372	['the SAFETY dose during Pregnancy is NOT CLEAR, but hollis et al (20) SHOWED that Vitamin D supplementation of 4000 iu/day for achieving adequate levels was SAFE and EFFECTIVE in Pregnant women.']	[('IMPORTANT_CONSIDERATION', 4), ('FULL_UNKNOWN', 36), ('INCOMPLETE_EVIDENCE', 69), ('IMPORTANT_CONSIDERATION', 156), ('SUPERFICIAL_RELATIONSHIP', 165)]	5	[('GO_0007565', 'female pregnancy', 23, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 81, 'vitamin D'), ('GO_0007565', 'female pregnancy', 178, 'pregnant')]
PMC5838372	3/2018	S84-PMC5838372	['HOWEVER, the levels of Vitamin D insufficiency and deficiency are NOT CLEARLY defined and the discussion about the prevalence Vitamin D deficiency is ONGOING (22,23).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FULL_UNKNOWN', 66), ('IMPORTANT_CONSIDERATION', 150)]	3	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 126, 'vitamin D')]
PMC5941617	5/2018	S4-PMC5941617	['AT PRESENT, the prevalence of Vitamin D deficiency is high in italian children and adolescents, and national RECOMMENDATIONS on Vitamin D supplementation during pediatric age are LACKING.']	[('INCOMPLETE_EVIDENCE', 0), ('FUTURE_WORK', 109), ('FULL_UNKNOWN', 179)]	3	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 128, 'vitamin D')]
PMC5941617	5/2018	S32-PMC5941617	['caption (table-wrap): table 2\n\ndefinition of Vitamin D status according to several societies and organizations in the last 10\xa0yearssociety/organizationyearsevere deficiencydeficiencyinsufficiencysufficiency/adequacycanadian pediatric society [8]2007–<\u2009 10\xa0ng/ml10–29\xa0ng/ml≥ 30\xa0ng/mllawson wilkins pediatric Endocrine society [9]2008<\u2009 5\xa0ng/ml5–14\xa0ng/ml15–19\xa0ng/ml≥ 20\xa0ng/mlinstitute of medicine [10]2011–<\u2009 12\xa0ng/ml12–20\xa0ng/mla≥ 20\xa0ng/mlthe Endocrine society [11]2011–<\u2009 20\xa0ng/ml21–29\xa0ng/ml≥ 30\xa0ng/mlbritish paediatric and adolescent bone group [12]2012–<\u200910\xa0ng/ml10–19\xa0ng/ml≥ 20\xa0ng/mlfrench society of paediatrics [13]2012–<\u2009 20\xa0ng/ml–≥ 20\xa0ng/mlasociación espanola de pediatría (spain) [14]2012–<\u2009 20\xa0ng/ml–≥ 20\xa0ng/mlfederal commission for nutrition (switzerland) [15]2012<\u200910\xa0ng/ml<\u2009 20\xa0ng/ml–≥ 20\xa0ng/mlnordic nutrition recommendations [16]2012–<\u2009 12\xa0ng/ml12–20\xa0ng/ml≥ 20\xa0ng/mlgerman nutrition society [17]2012–––≥ 20\xa0ng/mlhealth council of the netherlands [18]2012–––≥ 12\xa0ng/mleuropean society for paediatric gastroenterology hepatology and nutrition [19]2013<\u200910\xa0ng/ml<\u2009 20\xa0ng/ml–≥ 20\xa0ng/mlcentral europe [20]2013–< 20\xa0ng/ml20–29\xa0ng/ml≥ 30\xa0ng/mlsociety for adolescent health and medicine [21]2013–<\u2009 20\xa0ng/ml20–29\xa0ng/ml≥ 30\xa0ng/mlaustralia/new zealand [22]2013<\u2009 5\xa0ng/ml5–11\xa0ng/ml12–19\xa0ng/ml≥ 20\xa0ng/mlamerican academy of pediatrics [23]2014–<\u2009 20\xa0ng/ml–≥ 20\xa0ng/mljapanese society for bone and Mineral research, japan Endocrine societyb[24]2015–<\u2009 20\xa0ng/ml––scientific advisory committee on nutrition [25]2016–––≥ 10\xa0ng/mleuropean Food safety authority [26]2016–––≥ 20\xa0ng/mlunited arab emirates [27]2016–<\u2009 20\xa0ng/ml20–29\xa0ng/ml≥ 30\xa0ng/mlglobal consensus for rickets [28]2016–<\u2009 12\xa0ng/ml12–19\xa0ng/ml≥ 20\xa0ng/mljapanese society for bone and Mineral research, japan Endocrine societyc[29]2017–<\u2009 20\xa0ng/ml20–29\xa0ng/ml≥ 30\xa0ng/mleuropean academy of pediatrics [30]2017definition of Vitamin D status is UNCLEAR DUE TO a lack OF consensus\navitamin D inadequacy\nbdiagnostic criteria for rickets\ncassessment criteria for Vitamin D deficiency/insufficiency (authors REPORTED that DIFFERENT criteria MAY BE needed for children)\nsevere Vitamin D deficiency is DEFINED as 25(Oh)d levels <\u200910\xa0ng/ml by SEVERAL authors and societies BECAUSE the risk of rickets is high below this cut-off also in presence of an adequate Calcium intake [31–33] (see chapter “nutritional rickets”).']	[('FULL_UNKNOWN', 1894), ('PROBLEM_COMPLICATION', 1902), ('ANOMALY_CURIOUS_FINDING', 1916), ('ANOMALY_CURIOUS_FINDING', 1916), ('INCOMPLETE_EVIDENCE', 2053), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 2067), ('INCOMPLETE_EVIDENCE', 2086), ('PROBABLE_UNDERSTANDING', 2145), ('INCOMPLETE_EVIDENCE', 2185), ('PROBABLE_UNDERSTANDING', 2215)]	10	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('UBERON_0005063', 'left ventricular compact myocardium', 307, 'Endocrine'), ('UBERON_0005063', 'left ventricular compact myocardium', 441, 'Endocrine'), ('CHEBI_46662', 'mineral', 1396, 'Mineral'), ('GO_0009790', 'embryo development', 1420, 'Endocrine'), ('UBERON_0005063', 'left ventricular compact myocardium', 1420, 'Endocrine'), ('CHEBI_33290', 'food', 1533, 'Food'), ('CHEBI_46662', 'mineral', 1738, 'Mineral'), ('GO_0009790', 'embryo development', 1762, 'Endocrine'), ('UBERON_0005063', 'left ventricular compact myocardium', 1762, 'Endocrine'), ('CHEBI_27300', 'vitamin D', 1874, 'vitamin D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 1938, 'D'), ('CHEBI_27300', 'vitamin D', 2009, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 2121, 'vitamin D'), ('CHEBI_30778', 'gallic acid', 2156, '25(OH)'), ('CHEBI_22313', 'alkaline earth metal atom', 2302, 'calcium')]
PMC5941617	5/2018	S137-PMC5941617	['AT PRESENT, the exact timing and proportion of Vitamin D-dependent absorption of Calcium and Phosphorus in preterm infants is UNKNOWN [122].']	[('INCOMPLETE_EVIDENCE', 0), ('FULL_UNKNOWN', 126)]	2	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 81, 'calcium'), ('CHEBI_35885', 'secondary phosphine', 93, 'phosphorus')]
PMC5941617	5/2018	S319-PMC5941617	['HOWEVER, it is UNCLEAR WHETHER the OBSERVED Vitamin D deficiency/insufficiency is TO BE CONSIDERED a consequence of the infection itself OR IF it plays a ROLE in determining susceptibility to infections or the severity of the disease.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FULL_UNKNOWN', 15), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 23), ('INCOMPLETE_EVIDENCE', 35), ('INCOMPLETE_EVIDENCE', 82), ('INCOMPLETE_EVIDENCE', 88), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 140), ('SUPERFICIAL_RELATIONSHIP', 154)]	8	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D')]
PMC5941617	5/2018	S366-PMC5941617	['OBSERVATIONAL studies on the RELATIONSHIP between Vitamin D in Pregnancy and wheezing, asthma, and allergies Development in early Life SHOWED UNCLEAR results.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 29), ('INCOMPLETE_EVIDENCE', 135), ('FULL_UNKNOWN', 142)]	4	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D'), ('GO_0007565', 'female pregnancy', 63, 'pregnancy'), ('GO_0048513', 'animal organ development', 109, '... development'), ('UBERON_0000104', 'life cycle', 130, 'life')]
PMC5941617	5/2018	S411-PMC5941617	['negative results were obtained in term of primary PREVENTION by Vitamin D supplementation in a RECENT meta-analysis and conclusions were that the EFFECTS of Vitamin D supplementation REMAIN UNCERTAIN [353].']	[('SUPERFICIAL_RELATIONSHIP', 50), ('INCOMPLETE_EVIDENCE', 95), ('SUPERFICIAL_RELATIONSHIP', 146), ('INCOMPLETE_EVIDENCE', 183), ('FULL_UNKNOWN', 190)]	5	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 157, 'vitamin D')]
PMC5941617	5/2018	S420-PMC5941617	['a meta-analysis of six case-control studies and two cohort-studies SHOWED a reduction of the RISK of t1dm in later Life (odds ratio: 0.71; 95% ci 0.51–0.98) in infants who were supplemented with Vitamin D compared with controls, ALTHOUGH the needed time of supplementation and the dose are STILL UNCLEAR [377–379].']	[('INCOMPLETE_EVIDENCE', 67), ('IMPORTANT_CONSIDERATION', 93), ('ANOMALY_CURIOUS_FINDING', 229), ('FULL_UNKNOWN', 290)]	4	[('UBERON_0000104', 'life cycle', 115, 'life'), ('CHEBI_27300', 'vitamin D', 195, 'vitamin D')]
PMC5941617	5/2018	S705-PMC5941617	['it is UNCERTAIN IF Vitamin D deficiency MAY worsen Metabolic profile of obese children and adolescents.']	[('FULL_UNKNOWN', 6), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 16), ('INCOMPLETE_EVIDENCE', 40)]	3	[('CHEBI_27300', 'vitamin D', 19, 'vitamin D'), ('GO_0008152', 'metabolic process', 51, 'metabolic')]
PMC5941617	5/2018	S713-PMC5941617	['autism\n\nautistic Individuals frequently develop nutritional deficiencies, especially in presence of Food selectivity; causal RELATIONSHIP with Vitamin D deficiency is UNCERTAIN.']	[('SUPERFICIAL_RELATIONSHIP', 125), ('FULL_UNKNOWN', 167)]	2	[('NCBITaxon_1', 'root', 17, 'individuals'), ('CHEBI_33290', 'food', 100, 'food'), ('CHEBI_27300', 'vitamin D', 143, 'vitamin D')]
PMC5941617	5/2018	S729-PMC5941617	['CONSIDERING AVAILABLE EVIDENCE, PARTICULARLY the LACK OF italian studies, at PRESENT we DO NOT RECOMMEND OTHER modalities DIFFERENT from daily or weekly administration of Vitamin D to treat asymptomatic Vitamin D deficiency.']	[('INCOMPLETE_EVIDENCE', 0), ('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 12), ('IMPORTANT_CONSIDERATION', 32), ('INCOMPLETE_EVIDENCE', 49), ('QUESTION_ANSWERED_BY_THIS_WORK', 77), ('FULL_UNKNOWN', 88), ('FUTURE_WORK', 95), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 105), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 122)]	10	[('CHEBI_27300', 'vitamin D', 171, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 203, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 211, 'D')]
PMC5956785	5/2018	S140-PMC5956785	['the 2013, systematic literature review of 19 childhood arthritis STUDIES REPORTED Vitamin D status (14 reporting 25(Oh)D and 11 reporting 1,25(Oh)D) SUGGESTED that at that time there was NO CLEAR LINK between Vitamin D status and children with chronic arthritis [12].']	[('INCOMPLETE_EVIDENCE', 65), ('INCOMPLETE_EVIDENCE', 73), ('INCOMPLETE_EVIDENCE', 149), ('FULL_UNKNOWN', 187), ('SUPERFICIAL_RELATIONSHIP', 196)]	5	[('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 113, '25(OH)D'), ('PR_000012046', 'oxysterol-binding protein-related protein 11', 116, 'OH ... D'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 143, 'OH)D'), ('CHEBI_27300', 'vitamin D', 209, 'vitamin D')]
PMC5956785	5/2018	S256-PMC5956785	['also HOW they IMPACT the biological Response involving Vitamin D and inflammation REMAINS UNCLEAR.']	[('EXPLICIT_QUESTION', 5), ('SUPERFICIAL_RELATIONSHIP', 14), ('FULL_UNKNOWN', 82)]	3	[('GO_0060033', 'anatomical structure regression', 36, 'response'), ('CHEBI_27300', 'vitamin D', 55, 'vitamin D')]
PMC5956785	5/2018	S277-PMC5956785	['further, the RELATIONSHIP between Vitamin D status and disease activity in children with jia is STILL UNCLEAR.']	[('SUPERFICIAL_RELATIONSHIP', 13), ('FULL_UNKNOWN', 96)]	2	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D')]
PMC6011374	6/2018	S14-PMC6011374	['HOWEVER, INCONSISTENCIES between studies reflect UNCERTAINTY about the true EFFECT of Vitamin D deficiency on Pregnancy outcome [5,6].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 9), ('FULL_UNKNOWN', 49), ('SUPERFICIAL_RELATIONSHIP', 76)]	4	[('CHEBI_27300', 'vitamin D', 86, 'vitamin D'), ('GO_0007565', 'female pregnancy', 110, 'pregnancy')]
PMC6039335	7/2018	S287-PMC6039335	['THUS, the dietary Vitamin C requirement for beef cattle is NOT SPECIFIED in the nrc [146].']	[('PROBABLE_UNDERSTANDING', 0), ('FULL_UNKNOWN', 59)]	2	[('CHEBI_27300', 'vitamin D', 18, 'vitamin C')]
